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1. INTRODUCTION 
Siddhars are men with supernatural power and Medical wisdom. All their 
doing were highly intertwined with nature. They have combined their Medical works 
with astrology, alchemy & philosophy. They were robust in the concept “Nature that 
causes diseases and it is again nature effects their cure” and it is therefore necessary 
that the physician should know the principles of nature. 
According to the Siddhars concept 
n{<mk<kqz<!dt<tOk!hq{<ml<!
hq{<mk<kqz<!dt<tOk!n{<ml<!
! ! ! ! ! ! ! .sm<jmLeq!Riel</< << << < !
Siddhars were proficient with formulations that treat and prevent ailments. 
The formulations were either purely herbal or animal or metals or a combination of 
herbomineral or metals. Thus for preparing medicine, Siddhars solely depend on 
natural wealth.  
The Siddha system based on three vital humours namely vatham, pitham and 
kabam. Siddha is the first system to emphasize on food habits. If human beings have 
any alteration in food habits, it will affect the vital elements of their body.  
According to Thiruvalluvar, 
liX!hicz<zik!d{<c!lXk<K{<{q!
DX!hicz<jz!dbqIg<G/!
- Thirukkural!
One of the ancient siddhar Yugi had classified the diseases into 4448 types. 
He had classified Urinary disorder into 
1. Neerinai  Arukkal  Noigal 
2. Neerinai  Perukkal  Noigal 
Kalladaippu (renal stone) disease comes under Neerinai Arukkal Noigal. 
In our siddha system Urolithiasis may be compared to Kalladaippu is the most 
common diseases of present society due to modern life style and abnormal diet habits. 
Kalladaippu is a common disease of urinary tract which has the following 
symptoms, Neer erichal (burning micturation), urinary obstruction (Neer adaippu), 
low back ache, referred pain in genital organs and tip of penis, abnormal deposits in 
the urine. In modern science, these symptoms can be correlated with ’urolithiasis’. 
  
 
 
   2 PRE CLINICAL  STUDY OF  VENKARA CHUNNAM 
 
‘Urolithiasis is a common disorder estimated to occur in approximately 12% 
of population with a recurrence rate of 70% - 80% in male and 47% - 60% in female. 
In India, 5% of people are seeing affected by kidney stones and 8-10% people 
who have life time risk of passing the kidney stone. The recurrence rate for urinary 
calculi is very high, approximately 50% among the Indian population. In 2013, 
Kidney stone prevalence is higher in men (66%) in compare to females and common 
with age group 31-40 years. During the last two decades the rate of renal stone 
recurrence was about 75%. 
The prevalence figures of stone disease observed in developing country in 
tropical regions are similar to rates of western countries with incidence of renal colic 
particularly high in warm months. Ultimately, in our country, the climatic condition 
prevailing here plays a major role along with abnormal diet habits, insufficient water 
intake, and sedentary life style.  
The efficacy of invasive therapies such as extra corporal shock-wave 
lithotripsy and ureteroscopy has been proven by several studies.  However these 
techniques are not risk free and they are problematic and quite expensive and 
complication. 
In our Siddha system the number of drugs has been prepared from the 
medicinal plants which are source of drugs for Kalladaippu. 
Drug means any substance that when taken into a living organism may modify 
physiological system or pathological states. Siddhars were persons of highly cultured 
intellectual & spiritual faculties with a very vast boundless knowledge about medicine 
and alchemy.  
A drug possessing high therapeutic index is said to be safe. Reaction to a drug 
in a subject may vary in accordance with various factors which includes anaphylaxis, 
idiosyncrasy or accidental overdosing. Variation of dose, duration alters the medicine 
and makes it a poison. 
Dose and duration of administration of drug is much more important for 
clinical practice. It is the duty of a physician to ensure that the patient is receiving the 
correct dose and is harmless. Or else, the physician will be charged for his medical 
negligence under legal aspects.  
According to Anuboga vaithiya navaneetham, part 3 page no 25, 26 there was 
a preparation of VENKARA CHUNNAM which is indicated for Kalladaippu. I have 
selected the drug to evaluate for its Lithotriptic, Diuretic, and Anti-Spasmodic 
(smooth muscle relaxants) activities.  
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2. AIM AND OBJECTIVES 
AIM: 
The main aim of this dissertation work is to do a scientific validation of 
VENKARA CHUNNAM for its Lithotriptic, Diuretic, Anti-spasmodic activities in 
treating Kalladaippu (Urolithiasis) disease. 
 
OBJECTIVES: 
The main objective of the present study is safety and efficacy of the 
VENKARA CHUNNAM in the treatment of kalladaippu, the following methodology 
was adopted to evaluate the drug and its standardization studies. 
1. Collection of literature evidence regarding the trial medicine. 
2. Identification of the drugs in the VENKARA CHUNNAM. 
3. Preparation of the trial medicine as per the text. 
4. Physico – chemical analysis of the test drug. 
5. Biochemical analysis of the test drug. 
6. Phytochemical analysis of the test drug. 
7. Instrumental analysis of the test drug. 
8. Evaluation of acute and sub-acute toxicity of the test drug according to the 
OECD guidelines. 
9. Evaluation of pharmacological activity of the test drug. 
 Lithotriptic activity 
 Diuretic activity 
 Anti - spasmodic activity 
10. Antimicrobial activity of the test drug. 
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3. REVIEW OF LITERATURE 
3.1 VENKARAM (BORAX) 
3.1.1 GUNAPADAM ASPECT 
Among minerals there is 25 karasaram. It is divided into 10 natural and 15 
artificial. Venkaram belongs to Natural type. 
SYNONYMS: 
ou{<givh<OhIkjeOb!uqtl<hg<!OgT!
OlkqeqObiI!kr<gTg<G!dVg<gqeliGR<!
sr<givl<!OhizOu!sk<okz<ziliGl<!
sk<kieh<!ohiiqgiiqg<!GOmivqbiGl<!
Porikaram, Karam, Urukkinam, Danganam, Urukkumithiran, 
Thoomathaiyadakki. 
nr<giiq!mr<g{Lli!lmr<gik!
Klk<jk!nmr<gh<!h{<{q!
ohir<giiq!svg<Gg<G!lqk<KV!Oubie!
ohiiqgiiq!keg<gqjsf<k!OhVliOl/!
Urukkinam, Porikari, Kudori, Ankari, Danganam, Ponkari, Sarakku mithru 
-bogar nikandu 1200 page.no – 5 
OTHER NAMES 
 Karam, Pethagamani, Uruku Mithiran,Siripari, Porikaram, Urukinam, 
Santhani, Kudoori, Tanganam, Dhoomathai Adaki,  
- Sattamuni Nigandu 
 Karam, Porikaram, Urukinam, Urukumitharan, Tanganam, Dhoomathai 
Adaki.       
-Gunapadam Thathu Jeevam 
 Vedikaram, Kabeeram, Kabesam, Kudori, Kurinchanam 
-Pachilai Mooligai Agarathi 
 Logasuthi Karakam, Thiravi, Thiravangam, Malatherasathin Sambaram, 
                    -Nigandu Rathina Kaaram 
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PANCHA BOOTHAMSAM 
Vengaram is vaayu boothamsam as declained through this song 
  nxqf<K!ogit<!oucBh<Hl<!sUm<cEh<Hl<!
nvgvi!OkBoue<Ox!nxqbziGl<!
okiqf<K!hii<!our<givf<!KVsq!v{<Ml<!
kqxlie!uiBoue<x!osh<hziGl<!
-Bogar Kaarasaara Thurai 
VERNACULAR NAMES: 
Tamil   -  Vengaram, Venkaram 
Sanskrit  -  Tankana, Tunkana, Rasashodhan 
English  -  Borax, Tincal, Sodium Biborate,  
Sodium Borate,, Biboratc of Soda,  
tynkal, Biborate of sodium, 
Pyroborate sodium, Tetraborate sodium, 
Hindi   -  Tinkal, Tincal, Sohaga 
Gujarati  -  Tankana, Khara 
Malayalam  -  Pongaaram 
Telugu   -  Veligaram, Elegaram 
Urdu   -  Tankar, Suhaga 
Bengali& 
Punjabi  -   Sohaga, Suhaga, Tinkar, Tinkal 
Arab   -  Buraekes - Saghah 
Persi   -  Tinkar - Tankar 
Tibetean  -  Chusal 
Kanada  -    Biligara 
Burma   -  Lakhiya 
Malay   -  Pijar, Palleri 
-The Wealth of India page-199. 
 
ORIGIN AND OCCURRENCE: 
Borax is obtained is California abundantly. It is in Tibet and Nepal. In India it 
is found in Ladakh and Puga valley of Kashmir. Tincal contains about 55% of borax.  
Naturally it is obtained along with sand and dust. The borax available in shops is not 
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pure. Hence four in parts of Hot water and a small amount of calcium carbonate 
(lime) are added to it, filtered, insolates and heated till the water evaporates 
completely. The salt so obtained is pure and can be used.  
Leh in Ladakh district of Jammu and Kashmir 
Surendranagar district of Gujarat 
Nagpur and Jaipur districts of Rajasthan 
UttarPradesh 
California, USA and Kramer 
Argentina, China, Peru and Chile 
SearlesLake 
SOURCE 
Borax occurs as natural deposits. Tincal is the name given to crudeBorax. It is 
found in masses by evaporation of water, on shores of dried uplakes and also obtained 
from the mud of lakes. 
COMPOSITION: 
Na2O  : 16.25% 
B203  : 36.60 % 
H20  : 47.24 % 
Sodium : 12.06 % 
Boron  : 11.34 % 
Hydrogen : 05.29 % 
Oxygen : 71.32 % 
SYNTHETIC PREPARATIONS (VAIPPU): 
INGREDIENTS: 
GROUP – A 
1. Fuller’s earth (Pooneeru)  - 1.3 Litre (1 Padi) 
2. Water    - 10.4 Litre (8 Padi) 
GROUP - B 
1. Alum ( Cheenam )  - 3500 gm (100 Palam) 
2. Potassium nitrate ( Vediuppu ) - 219 gm (6 ¼ Palam) 
3. Milk spurge burnt ash  - 1.3 Litre 
4. Indian liquorice leaf juice  - 1.3 Litre 
5. Castor Oil 
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Fuller’s earth is dissolved in water and filtered. Group – B drugs are added to 
the above filtrate and insolates. It becomes black. Then the order 3 drugs are added to 
it and heated with Kamalakkini for 96 minutes. Then it is placed in an earthen pot 
with wider mouth and insolates. At the end, the product is collected.  
                                                                                  -Bogar 7000, Irandam kaandam.  
CHARACTERS OF VENKARAM 
- Clear, white and luster 
- Dissolved in water, undissolved in alcohol. 
- When kept in open air white colour layer formed in upper part of 
venkaram 
- When venkaram is fried the water content lost, small hole obtained in fried 
venkaram. 
SPECIALITIES: 
givole<!xqkx<Gh<OhI!uf<k!OkK!
! ! gm<MOl!nXhk<K!fiZ!kiKl<!
givole<!xqkx<Gh<OhI!uf<k!kiOz!!
! ! gcsie!UhvsF~x<!xqv{<MR<!sk<kil<!
givole<!xqkx<Gh<OhI!uf<k!oke<xiz<!
! ! gm<mik!sivf<kieq!kx<Gt<!gm<Ml<!
givole<!xqkx<Gh<OhI!uf<k!kiOz!
! ! gtr<GGV!sqf<K~vk<!kikq!giO{/!
• It is very important drug for preparing parpam, Chendooram and guru. 
• It had the capacity to make Kattu of 64 Paadaanam. 
• Make 120 Ubarasam into Satthu medicine form. 
• Make karam into Kattu medicine form. 
       -Bogar 7000 irandamaayiram. 
ORGANOLEPTIC CHARACTERS: 
Taste    - Sweet with astringent 
Potency (Veeriyam)  - Heat (Veppam) 
Biotransformation (pirivu) - Pungent (Kaarpu) 
Sweet and astringent taste of Venkaram has earth, water and air elements. 
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ACTIONS: 
Lithotriptic  
Diuretic 
Astringent 
Antiseptic 
- Indian Materia Medica  
Internal 
Refrigerant 
Diuretic 
Emmenogogue 
Lithotriptic 
Parturifaceient 
External 
Sedative 
Alterative 
Antiseptic 
Astringent 
                                             - Gunapadam thaathu jeeva vagupu 
GENERAL PROPERTIES: 
‘osixqHjmob{<!Ge<lfjl!Osiiq!bisl<!
hxqgqvg{q!gz<Zel<!he<Oeib<!.!ofxqjbk<!
kmr<g{r<g!hr<gqVlq!si<h<huqmR<sk<kq!
dbqiqmr<g{r<g!zg<gqx<Ohi!ole</!
 
It relieves toad skin, carbuncle, 8 types of gunmam, itching, bleeding biles, 
renal calculi, dental disease, urinary tract infections, kapam, poison due to snake etc. 
                                                                               - Gunapadam thaathu jeeva vagupu 
our<givg<!G{lqoke<X!uqkLmEjvg<gg<!Ogtib<!
sr<giv!liGf<Oki]f<!ke<jeOb!sr<gvqg<G!
Lr<ge!Zkuqbqz<zi!Ukvk<kqz<!uiBlix<Xl<!
ohir<gqb!-Vlz<!lif<kl<!Ohig<gqM!L{<jlkiOe 
 It relieves thositha thodam, uthiravaayu, cough indigestion 
!
our<giviR<!Osk<Klk<jk!OuXh{<[!OlgMG!
kr<Gsqz!fQI!Lxqbk<!kie<!uir<Gl<!
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It relieves kabha diseases, urinary disorders. It also used in delayed labour, 
oral ulcer, ulcer in nipple, anaemia due to menorrhagia, dysmenorrhoea, convulsion, 
post-partum bleeding. It used in delayed labour for uterine contractibility 
                                       - Gunapadam thathu jeeva vaguppupage no.326,327. 
 
  Externally it is used for antiseptic. It also cures oral ulcer, herpes zoster, renal 
stone, irritation in urethra, pre-eclampsia. It helps uterine contraction. 
                                                                   - Tamil English agarathi pg no 3896 
PURIFCATION OF BORAX:!
1. Borax is bundled and hanged in the buffalo’s dung solution and boiled. The 
bundle is cleaned with fresh water and insolates to get it in purified form. 
2. Borax is bundled and kept buried in buffalo’s dung for 3 days and then 
washed and dried. 
3. It is washed in cow’s dung solution. 
4. It is soaked in buffalo’s urine for 72 minutes (3Nazhigai). 
5. It is fried in an earthen pan and triturated with vinegar (or) lime juice and 
dried. 
6. It is fried till the moisture completely evaporates. 
7. It is triturated with lemon juice or rice washed water and dried. 
8. It is soaked in lemon juice or vinegar or five leaved chaste tree leaf juice    
(Nocchi leaf) and dried. 
     -Gunapadam Thathu Jeeva Vagupu, Page-328 
MEDICINAL USES: 
• Borax (35 gm) dissolved in water (10.4 Litre) is used as a mouth wash in case 
of oral ulcers and sore throat. It is also used as a wash for anal fissures and 
ulcer. 
• Borax (4.2 gm) mixed with pig’s ghee (21 ml) is applied over the painful anus 
for anorectal diseases. 
• Borax (16.8 gm) mixed with water may be used as an irritation solution for 
bladder wash in case of urethritis. Borax powder (2.1 gm) mixed with 
cinnamon bark powder (650 mg) can be given along with gruel 1 to 2 hours 
four times a day for relief of labour pain during delayed labour. In addition, 
borax powder (650 mg) is given once in every six hours for pain relief. 
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• Roasted borax (650 mg – 1300 mg) is given with tender coconut water for 
urinary tract infection. 
• Borax 65 mg to 325 mg mixed with breast milk is given to children for relief 
of pain and convulsions. 
• It is capable of removing stones from the bladder and kidney. 
• It can be used during delivery time to increase the labourpains and for fits, 
• It cures toad skin, ringworm, peptic ulcer, bladder stone,dysuria etc, 
• Its solution is used as lotion and for gargling. 
• Take purified borax (4.2gm) and added with purified honey (35gm) and apply 
for mouth ulcer (stomatitis). It is called as venkara mathu. 
• Purified borax mix with ghee or butter and used for mouth ulcer, tongue ulcer, 
fissure in lips. it is refrigent to the body. 
• Borax (35gm) dissolved in water (10.4litres) is used as mouth wash in case of 
oral cancer, sore throat, oral inflammation due to mercury poisoning. It used 
as gaggling. 
• It is also used as external wash for anal fissure and ulcer 
• Borax (4.2gm) mixed with water and used as in burning micturition. 
• Externally it is used in skin disease, mosquito bite, pricking heat. 
• Borax (4.2gm) mixed with vinegar (4.2ml) and externally used for ringworm, 
venereal itching. 
• Borax (260-520 mg) with betel leaf used as fever with rigor. 
• Borax (325mg), pepper (195mg), honey (4ml) mixed well and taken for 
cough, asthma three times per day. 
• Venkaram used in drug toxicity 
i) Abrus precatorius (Kundrimani) poison: 2gm purified borax mixed with 
water and given for abrus poison 
ii) (Naabi) Aconitum ferox poison: Purified borax mixed with cows ghee and 
given for naabi poison 
-Agathiyar vidapradhi vida thiratu 
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OTHER PREPARATIONS OF VENKARAM:  
1.VENKARA PARPAM: 
Dose : 260 – 390 mg (2 – 3 Kundri) 
Adjuvant : Honey or ghee 
Indications : kidney stone, obstruction of urethra, burning 
  micturition, 
                                                   - Anuboga vaidhiya navaneetham part III, page 24 
2.VENKARA CHENDOORAM:  
Dose : 650- 1040 mg (5 – 8 Kundri) 
Adjuvant  : Tender coconut water 
                      Indications : Kalladaippu, Oliguria 
   Burning micturition  
                                                  - Anuboga vaidhiya navaneetham part III, page 27 
3.SIRUNEER KALLUKU KUDINEER 
Dose  :  30 – 60ml (0.25-0.5alakku) 
Indications :  kalladaippu, 
                                                    - Anuboga vaidhiya navaneetham part III, page 24 
4.ARATHARA PARPAM 
Dose  :  130mg  
Adjuvant :  tender coconut water, venkaaya chaaru. 
Indications :  kalladaippu, sathaiadaippu, neer erichal, neer kaduppu. 
                                                          - Anuboga vaidhiya navaneetham part II, page 76 
5.ASTA GUNMA THIRAVAGAM 
Dose  : 5-10 drops 
Adjuvant :  chukku kudineer, nerunji vaer kudineer 
Indications : kalladaippu, neeradaippu, sathaiadaippu, gunmam 
                                                         - Anuboga vaidhiya navaneetham part III, page 83 
6.VEDIUPPU SEYANNER 
Dose  : 4-10 drops 
Adjuvant :  Ilaneer, nerunji vaer kudineer and fruit juice. 
Indications : kalladaippu, sathaiadaippu, neerkattu and neer erichal. 
                                                        - Anuboga vaidhiya navaneetham part III, page 78 
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7.KAARA SUDA SATHU PARPAM 
Dose  : 12 – 18 gm 
Adjuvant :  honey 
Indications : kalladaippu, neeradaippu,  
                                         - Sighicha rathina deepam part II, page 218 
8.SATHURMUGA PARPAM: 
Dose  : 130-260mg 
Adjuvant :  honey and ghee 
Indications : kalladaippu, neeradaippu, sathaiadaippu 
                     - Pathartha guna vilakam thaathu jeevam, kannusaamy pillai, page 212 
9.ERUKAARA PARPAM: 
Dose   :  130-260mg 
Adjuvant :  tender coconut 
Indications  : kalladaippu, neeradaippu, sathaiadaippu 
                            -Pathartha Guna Vilakkam (Thathu Jeeva Varkam) Page No. 174  
10.SILASATHU PARPAM 
Dose  : 130-260 mg 
Adjuvant :  butter 
Indications :  kalladaippu, sathaiadaippu, neeradaippu, neerkadupu  
  and neer erichal. 
                                           - Koshaiye anuboga vaidhya brahma ragasiyam page 110. 
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3.1.2 GEOCHEMICAL ASPECT: 
 Borax, a hydrated sodium tetraborate, is one of the most important of boran 
minerals. Borax is a white to greyish, greenish or bluish coloured granular mineral 
crystallizing in mono clinic system. It occurs in the form of large transparent 
prismatic crystals resembling in shape the crystals of augite; also in lumps and 
compact glassy masses.  
CHEMICAL NAME: 
Borax, Sodium biborate, Sodium tetraborate 
CHEMICAL FORMULA: 
Na2B4O7.10H2O 
MINIING AND PREPARATION: 
Borates are obtained commercially from: 
1. Bedded deposits beneath old play as shallow saline and alkaline tertiary lakes. 
2. Brines of saline lakes and marshes. 
3. Encrustations around playas and 
4. Hot springs and fumaroles. 
The bedded borate deposits are extracted by underground mining methods and 
the mined material is crushed and roasted to remove the water separated from the clay 
and refined to borax. Brines containing borax are pumped out and the various 
constituents are separated by complicated chemical treatment, which is essentially 
evaporation followed by fractional crystallization with careful control of temperature 
and concentration.  
During evaporation, the sodium carbonate, sulphide and chloride are 
precipitated then, when saturation with potassium chloride occurs, rapid cooling 
causes it to be precipitated and further cooling gives borax and other salts, which are 
then refined to pure borax. Borax is obtained by boiling native calcium borate with 
solution of sodium carbonate. 
Ca2B6O11  + 2Na2C03 ––––˃  Na2B407 + 2NaB02+2CaC03 
CalciumBorate   + SodiumCarbonate
––––˃Borax 
CLASSIFICATION OF BORAX 
There are 2 types of borax available 
• Dana class 
• Sturz class 
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OTHER FORMS OF BORAX: 
Borax exists in three forms. 
1. Ordinary or Prismatic borax which is decahydrate or monoclinic, 
Na2B4O7.10H2O. This is the common form of borax and is obtained when a 
solution of the salt is crystallised at room temperature (ie, < 600). 
2. Octahedral or jeweller’s borax which is penta – hydrate, Na2B4O7.5H2O and 
is obtained when the solution is crystallised above 600C. 
3. Borax glass or Anhydrous which is the anhydrous form, Na2B4O7 and is 
obtained by heating the ordinary borax above its melting point until all the 
water of crystallization is given off. It is a colourless glassy mass (density = 
2.37), absorbs moisture from air and gradually converted into decahydrate 
form. 
PHYSICAL PROPERTIES: 
Boron trioxide-  36.6 
Soda                -  16.2 
Water  -  47.2 
H  - 2-2.5 
Nature  - Crystalline Lumps 
Colour  - White, sometimes greyish 
Streak  - White, Translucent to opaque 
Cleavage - Poor 
Fracture - Conchoidal 
Lustre  - Vitreous to resinous sometimes earthy 
Tenacity - Brittle 
Transparency - Translucent 
Hardness - 2 to 2.5 
Sp. Gr  - 1.65 to 1.7 
Taste  - Saline alkaline 
Mol weight  - 381.37 gm 
Density - 1.71 
Habit  -  transparent, prismatic crystals, lumbs glossy masses 
Radioactivity - Grapi = 0, Borax is not radio active 
Solubility - Soluble in cold water, Glycerine 
Insoluble in alcohol 
- Internet: wwwmindat.org. 
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Fatal dose - 15 to 20 grams for adults 
5 Grams for children 
50gm/100ml blood indicates borax poisoning 
-Modis. Medical jurisprudence and toxicology 
Borax is sold in transparent, colourless, crystalline masses with coolsaltish 
odour and styptic taste. 
- Tamil - English Dictionary (Tamil Perakarathy) 
 
CHEMICAL PROPERTIES: 
EFFECT OF HEAT: 
1. Heated on a burner flame using blowpipe, bubbles up and fuses to a clear 
glassy bead. 
2. It colours the flame yellow due to sodium and when moistened with sulphuric 
acid and alcohol, given a green flame due to boron. 
       Na2B407.H20   → on heating    →Na2B407  →    B203+  2NaB02 
   -10H20               Boric anhydride  
Sodium meta borate 
(Glassy Mass) 
REACTION WITH ACIDS: 
1. With hydrochloric acid gives yellow colour solution in cold condition and on 
boiling dissolves completely. 
2. With sulphuric acid gives colourless solution in cold condition and on boiling 
dissolves completely. 
SOLUBILITY IN WATER: 
 Borax is completely soluble in purified water producing an alkaline solution as 
tested by a red litmus paper turning blue.  
TEST FOR IDENTITY: 
1. A mixture of ethyl alcohol with boric acid burns with a green edged flame due 
to the formation of ethyl borate. 
2. Solution in water in acidic in nature. 
TEST FOR PURITY: 
It is tested for arsenic, heavy metals, and sulphate and alcohol insoluble 
substances (determined by dissolving 1 gm in 10ml of boiling alcohol, when the 
solution should not be more than faintly turbid).  
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3.1.3. LATERAL RESEARCH 
1. MINIMUM INHIBITORY AND MINIMUM BACTERICIDAL 
CONCENTRACTIONS OF BORON COMPOUNDS AGAINST SEVERAL 
BACTERIAL STRAINS: 
Tuek J Med Sci 2012; 42 (sup.2): 1423 – 1429 
ABSTRACT: 
Borax compounds are essential micronutrients for many organisms. However, 
they negatively affect plant, soil, and water micro flora if excessive amounts exist in 
irrigation water. Therefore, this study aimed to define the minimum inhibitory 
concentrations (MICs) and minimum bactericidal concentrations (MBCs) of boric 
acid and borax by selecting the bacteria that can survive in all environments. 
The antibacterial efficacy of boric acid borax against several bacterial strains was 
evaluated 3 times with the macro dilution broth method. 
 The MICs and MBCs of boric acid were obtained as 3.80 mg/ml, 3.80 mg/ml, 
7.60 mg/ml, and 7.60 mg/ml, against the bacterial activities of Staphylococcus aureus, 
Acinetobacter septicus, Escherichia coli, and Pseudomonas aeruginosa, respectively. 
The MICs and MBCs of borax were obtained as 23.80 mg/ml, 23.80 mg/ml, 47.60 
mg/ml, and 47.60mg/ml against the above bacteria, respectively. 
                                                     -Available on: www.dergipark.ulakbim.gov.tr 
 
2. EFFECT OF BORAX ON IMMUNE CELL PROLIFERATION AND 
SISTER CHROMATID EXCHANGE IN HUMAN CHROMOSOMES 
Journal of Occupational Medicine and Toxicology 2009,  doi: 10.1186/1745-
6673-4-27 Accepted: 30 October 2009. Author Malinee Pongsavee at al. 
ABSTRACT  
  Background: Borax is used as a food additive. It becomes toxic when 
accumulated in the body. It causes vomiting, fatigue and renal failure. Methods: The 
heparinized blood samples from 40 healthy men were studied for the impact of borax 
toxicity on immune cell proliferation (lymphocyte proliferation) and sister chromatid 
exchange in human chromosomes. The MTT assay and Sister Chromatid Exchange 
(SCE) technic were used in this experiment with the borax concentrations of 0.1, 0.15, 
0.2, 0.3 and 0.6 mg/ml. Results: It showed that the immune cell proliferation 
(lymphocyte proliferation) was decreased when the concentrations of borax increased. 
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The borax concentration of 0.6 mg/ml had the most effectiveness to the lymphocyte 
proliferation and had the highest cytotoxicity index (CI). The borax concentrations of 
0.15, 0.2, 0.3 and 0.6 mg/ml significantly induced sister chromatid exchange in 
human chromosomes (P < 0.05). Conclusion: Borax had effects on immune cell 
proliferation (lymphocyte proliferation) and induced sister chromatid exchange in 
human chromosomes. Toxicity of borax may lead to cellular toxicity and genetic 
defect in human. 
                                                             -http://www.occup-med.com/content/4/1/27 
 
3. HISTOLOGICAL EVALUATION OF THE EFFECTS OF BORAX 
OBTAINED FROM VARIOUS SOURCES IN DIFFERENT RAT ORGANS 
Int. J. Morphol., 33(1):255-261, 2015.  
SUMMARY: Boron is an essential element for life and intake via different sources 
into the body. Because effects of boron and compounds on the body has not been 
studied enough especially in tissue level, we planned this study to evaluate the effects 
of borax the most in taken form of boron compound on different intra abdominal 
organs histologically and also clinically. 42 male rats divided into equal 7 groups and 
different toxicological doses consistent with its LD50 dose (5000 mg/kg/d) were 
administered by gavage except control and sham groups. In the study, 2 different 
kinds of borax one of which was produced for research and the other for agriculture 
but the same formulation were used and their effects were also compared. As a result 
it was found that borax did not cause any histological changes in kidney, large 
intestine, liver and stomach in lower doses. But if doses were increased, a slightly 
inflammatory cell migration was detected without clinical signs in liver and large 
intestine. However, when a single very high dose of borax was administered, very 
high edema, inflammatory cell migration and neovascularization was observed and 
clinically 2 out of 6 rats died within 5 hours. We suggested that very high dose intake 
of borax may cause sudden death and also during long periods and higher dose intake 
may pave the way of inflammatory bowel diseases. At the same time, in boron related 
studies we advise that the kind of boron and also their source should be evaluated 
carefully and the most suitable compound should be chosen in case of faulty results.  
KEY WORDS: Borax; Inflammatory bowel disease; Histopathology; Toxicology. 
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3.2 MORINGA OLEIFERA 
3.2.1 GUNAPADAM ASPECT 
Tamil Name: 
Murungai 
Botanical Name: 
Moringa oleifera   
Other Names: 
 Drumstick tree, Horse Radish tree 
 ftqeole<x!hizvS!obe<Xl<!OhV!
! fzlie!giiq&zq!obe<Xl<!OhV!
! ntqe!ole<x!uSeiq!obe<Xl<!OhV!
! nkxR<sq!um!LVr<jg!obe<Xl<!OhV!
! ltqe!ole<x!likul<!hiqzioee<Xl<!OhV!
l{g<Ogiz!&zqobe<X!lkx<Gh<!OhV!
oktqeole<X!kqjs!LVr<jg!obe<Xl<!OhV!
kqVuie!gim<M!LVr<jg!bke<!OhOv!
Paalarasu, Karimooli, Vasunari, Vada murungai, Madhavam, Manakola Mooli 
     -Pancha Kaviya Nigandu pg 252 
Vernacular Names: 
Sanskrit   – Shobhanjana 
Hindi    – Mungna, Sainjna, Shajna 
Bengali   - Sajina 
Marathi   – Achajhada, Shergi 
Gujarathi   – Midhusaragaru 
Telugu   –  Mulaga 
Tamil    –  Murungai 
Kannadam   –  Nugge 
Malayalam   – Muringa 
Assam   –  Saijna 
Orissa    –  Sajina 
Punjab   –  sainjna 
Wealth of India page no. 426 
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HABITAT 
 Moringa tree is growing in Himalayan forest naturally. It is cultivated in India, 
Burma and Sri Lanka.                            Gunapadam Mooligai Vagupu pg no 771. 
HABIT: Tree 
PART USED: Whole plant 
TYPES: 
Kodi murungai (Indigofera arcuata) 
Kaattu murungai (Hydysarum sennoiles) 
Thavasu murungai (Justicia iranquevar) 
Gunapadam Mooligai Vagupu page.no 771. 
ORGANOLEPTIC CHARATERS 
Taste    
 Bitter, astringent, Sweet 
Potency   
 Cold 
Transformation  
Unripped fruit – sweet 
Bark, Root – sour. 
 Gunapadam Mooligai Vagupu page.no 771. 
ACTION 
Antispasmodic 
Stimulant 
Expectorant 
Diuretic 
Tonic 
Emmenagogue 
Abortifaecient 
Acrid 
Vosiceant 
Antilithic   -Gunapadam Mooligai Vagupu page.no 771. 
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GENERAL PROPERTIES: 
LVr<jgOui<h<!hm<jmg<G!&M!ghk<Oki!
omiVR<Gxis<!se<eqgvl<!YMl<!.!nVr<geg!
um<jmh<ohiVLjzbib<!uib<ouiMuq!mr<gTOlx<!
hm<jmg<Gh<!OhiOl!hxf<K 
Moringa root bark used for kapha disease, tridosham 
Stem bark used for vatha disease and few toxins. 
Gunapadam Mooligai Vagupu page.no 773 
MEDICINAL USES: 
• Stem bark juice and acalypha indica (Kuppaimeni) juice mixed with gingely 
oil and apply externally for eczema, scabies. Stem bark juice used in metalic 
parpam 
                     Gunapadam Mooligai Vagupu page.no 775 
• Moringa stem bark boiled with water and taked it as decotion form to arthritis, 
paralysis, epilepsy, post portem epilepsy. 
                                    Sarabendirar siddha maruthuva sudar page.no 277 
• Moringa stem bark with mustard seed make it into paste form and apply 
externally to arthritis. 
                                                       Pathartha guna bothini page.no 56 
• Moringa reduces the body heat 
• It relieves joint pain 
• It acts as diuretic, expectorant 
• It acts on nerves by avoiding epilepsy 
Namnaattu keerai vagaikal, Tamil Nadu 
Agricultural University,page.no 100. 
• All parts of the tree are considered medicinal and used in the treatment of 
rheumatism, ascites, venomous, bites cardiac and circulatory stimulants. 
-Wealth of India Page.no 426 
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OTHER PREPARATIONS OF MURUNGAIPATTAI:  
MURUNGAIPATTAI KUDINEER 
Dose  : 30 – 60 ml 
Indications : kalladaippu, neeradaippu, sathaiadaippu, vatham,   
           soolai 
-Theriyar Kudineer 100, page 37 
NETTI THYLAM 
Dose  : 4 drops 
Indications : kalladaippu, neeradaippu, sathaiadaippu, gunmam 
- Sarabendirar Vaidhya Rathnavali, page 118 
BOOTHA KARAPPAN THYLAM 
Dose  : 2 drops 
Adjuvant :  Milk 
Indications : neeradaippu, karappan 
Ennai vagadam, page 40 
SARVA NOI LINGA CHENDOORAM 
Dose  :130-195 mg 
Adjuvant : honey and ghee 
Indications : kalladaippu, sathaiadaippu,vaatha pitha kapha diseases 
                                                      -Anuboga vaidhiya navaneetham part IV, page 52 
 
MAHABOOPATHI MATHIRAI: 
Dose  :  1 to 2 tablet 
Indications  :  kalladaippu, sathaiadaippu,vaatha pitha kapha diseases 
                                                      -Kaikanda anuboga Vaidhya perunkural, page 174 
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3.2.2 BOTANICAL ASPECT 
SYNONYMS: 
Drumstick tree,  
Horse radish tree 
TAXONOMICAL CLASSIFICATION: 
Kingdom :  Plant Kingdom 
Division  : Angiosperms 
Class  : Dicotyledons 
Subclass : Disciflorae 
Series  : Sapindales 
Family  : Moringaceae 
Genus  : Moringa 
HABITAT: 
A small or medium sized about 10 m. high found wild in the sub Himalayan 
tract, from Chenap eastwards to Sarda and cultivated all over the plains of India. 
HABIT: Tree 
PART USED: Whole Plant 
A BRIEF HISTORY ABOUT MORINGA OLEIFERA 
BARK  - Corky bark, grey in colour.  
  Deeply fissured with easily breakable branches 
WOOD  - Soft. 
ROOT  - Pungent 
LEAVES  - Tripinnate  
RACHIS  - Slender, thickened and articulation at the base.pinnae of  
pinnules, deciduous, their rhacchides very slender articulated  
and with a gland at the articulations. 
LEAFLETS  - 12-20 by 6-10mm. The lateral leaflets elliptic and the terminal  
ones obovate and slightly larger than the lateral ones 6-9 pairs  
pale beneath. 
PETIOLE  - Slender, petiole of the terminal leaflets is 3-6mm is length. 
GLANDS  - Linear, hairs panicles spreading. 
FLOWERS  - White in colour large puberulous axillary panicles, honey  
scented  1 inch in diameter 
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CALYX  - Linear, lanceolate reflexed. 
PETALS  – Narrowly spathulate veined. 
STAMENS  - 5 fertile altenating with 5-7 antherless one 
OVARY  - Oblong, Villous, hairy. 
PODS  - Reach up to 45cm length .9 ribbred, pendylous. 
CULTIVATION 
The tree is indigenous to North - West India and is plentiful on recent alluvial 
land in or near sandy beds of rivers and streams. It is often cultivated in hedges and 
homeyards. It grows in all types of soils, except stiff clays and thrives best under 
thetropical insular climate of South India. The tree can be propagated by seeds or 
from cuttings. Cuttings are preferred. Plants raised from seeds produce fruits of 
inferior quality 
TYPES 
JAFFNA - Grown in parts of South India produces fruits 60 - 90 cm. in length. 
CHAVAKACHERI - Also a Jaffna type , bears fruits as long as 90 - 120 cm. 
CHEM MURUNGAI - Is a type yielding pods with red tips. 
The tree is not affected by any serious disease in India. A foot - rot, caused by 
Diplodia sp., has been observed in Madras. Two caterpillars and a strmborer are 
known to affect the tree. The hairy caterpillar, Eitplerote mollifera Wlk., causes 
defoliation, it is controlled by spraying the tree with fish oil - rosin soap or BHC., or 
by I buring with lighted torch. 
PHYTO CHEMISTRY 
Analysis of pods gave the following values, moisture, 86 - 97 protein 2.57 % 
Fat 0.1% carbohydrate 3.7 %, fiber 8 %, & mineral matter 2 %, Calcium 30 mgs. 
Phosphorus 110 mg, iron 5.3 mg, copper 3.1 mg, iodine 8 mgs, and oxalic acid are 
present. 
The Leaves are rich in carotene and ascorbic acid analysis gave the following 
values moisture 75 % protein 6.7 % Fat 0.7% carbohydrate 13.4 %, fiber 0.9 %, 
&mineral matter 2.3 %, Calcium 440 mg, Phosphorus70 mg, iron 7 mg. Copper 1.1 
mgs, iodine 5 mg are present . 
The flowers contains traces of alkaloids, they also contain acid value 10.5 , the 
ash is rich in potassium and calcium.  
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The seeds are oleaginous. Analysis of the kernel gave the following values, 
moisture 4 % protein 38.4 %, fat 34.7 % , carbohydrate I % , fiber 8.5 % , & mineral 
matter 3.4 % . 
ALKALOIDS 
The bark contains two alkaloids moringine which is identical with 
benzylamine and moringinine belonging to the sympathomimetic group of bases. An 
alkaloid named spirochin, has been isolated from the roots. 
ANTIBIOTICS 
Antibiotics - Pressed juice of the leaves of the plant show strong antibacterial 
activcity against Micrococcus pyogenes var. aureus, Escherichia coli and Bacillus 
subtilis. The leaf juice is bacteriostatic in a dilution of 1:1,00,000. 
The roots contain an active antibiotic principle, pterygospermin which is 
obtained as a low - melting unstable substance with a characteristic odour, soluble 
inorganic solvents but benzyl isothiocyanate, it is more stable in phosphate buffer 
than water. Pterygospermin inhibits the growth of many Gram positive and Gram-
negative bacteria. In higher concentrations, it is active against fungi. 
The Gums stem of the tree exudes a gum which is initially white in colour 
butchanges to reddish brown or brownish black on exposure. It is a polyuronide 
consisting of arabinose, galactose and glucuronicacid .Rhamnose is present in traces. 
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3.2.3 LATERAL RESEARCH 
1. DIURETIC ACTIVITY OF MORINGA OLEIFERA LEAVES EXTRACT IN 
SWISS ALBINO RATS 
The pharma innovation journal (www.thepharmajournal.com) 2016, 5(3): 08-
10  ISSN: 2277- 7695 Author : Rohithsingh Tahkur, Geetha Soren at al 
ABSTRACT:  
Background: Moringa Olifera commonly known as drumstick belongs to the 
Moringaceae family. A number of medicinal properties attributed to different parts of 
M. Olifera. we evaluated diuretic activity of alcoholic extract of Moringa oleifera 
leaves in swiss albino rats compared with hydrochlorothaizide. Methods: In first 
group, six albino rats was kept as control, was given only 0.9% normal saline 25ml/kg 
body weight orally. Another group of 6 rats were fed with normal saline 25ml/kg 
along with standard hydrochlorothiazide 2.5mg/kg. The Third, fourth and fifth groups 
of 6 rats each were taken as test group and the crude extract of Moringa Oleifera 
which was obtained in liquid form along with normal saline was given, keeping the 
volume constant, in doses of 50,100 and 200mg/kg bodyweight. Metabolism cage was 
used to collect urine in beakers for a period of 5 hours and 24 hours. Analysis of the 
data was done using ANOVA and Tuckey test. P values of less than 0.05 were 
considered significant. Results: After 5 hours of urine analysis-The urinary volume of 
the control group was 7.3±0.2 mL and the urinary excretion of Na+, K+ and Cl- are 
77.7±1.2 mEq/L, 21±1 mEq/L and 262.2±0.5 mEq/L respectively. The urinary 
volume of the standard group was 13.37±0.95 mL and the urinary excretion of Na+, 
K+ and Cl- are 168.4±3.39 mEq/L, 16±0.62 mEq/L and 147.46±5.79 mEq/L. After 24 
hours of urine analysis-The urinary volume of the control group was 13.7±0.5 mL and 
the urinary excretion of Na+,K+ and Cl- are 63.72±0.56, 22.05±0.34 and 265.5±1 
mEq/L respectively. The urinary volume of the Standard group was 4.13±0.73 mL 
and the urinary excretion of Na+,K+ and Cl- are 173±45, 20.01±0.15 and 
151.41±6.52 mEq/L Conclusion: Moringa oleifera leaves extract produced dose 
dependant diuretic action which is greater than control lesser than hydrochloro 
thiazide. The extract showed dose dependent saluretic effect. On the other hand, 
potassium sparing activity was not observed.  
Keywords: Moringa Olifera, hydrochlorothiazide, Diuretic Action, Swiss albino 
Rats, Metabolism cage  
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2. PHARMACOGNOSTIC AND PHYTOCHEMICAL INVESTIGATIONS ON 
THE BARK OF MORINGA OLEIFERA LAM  
Indian Journal of Natural Products and Resources, Vol. 4(1), March 2013, pp. 96-101 
Author : Sholapur, Hansan Pasha N.Patil, at al 
 
ABSTRACT 
Moringa oleifera Lam. belonging to the Moringaceae family is a highly valued 
plant, distributed in many countries of the tropics and subtropics. It’s some of the 
common names include Horseradish tree, Drumstick tree, Benzolive tree, Shajna, 
Nugge mara and Sigru. The bark is widely used as emmenagouge, rubefacient, 
anticancerous, antitubercular, antifungal, cardiac and circulatory stimulant. It is 
necessary to ascertain the authenticity of this crude drug when it is used for 
therapeutic purpose. Hence, the present study was under taken for systematic 
pharmacognostical evaluation of the bark of the plant with respect to macroscopy, 
microscopy and physico-chemical parameters. The TLC profile was developed for 
petroleum ether and ethanolic extract of the bark. Preliminary phytochemical 
investigation indicated the presence of carbohydrates, triterpenoids, isothiocynate 
glycosides, tannins and steroids. These established parameters could be used in 
identification and authentication of the crude drug. Keywords: Moringa oleifera, 
Horseradish tree, Drumstick tree, Bark, Macroscopy, Microscopy, Fluorescence 
analysis, Phytochemical. 
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3.3 UPPILANG KODI 
3.3.1 GUNAPADAM ASPECT 
Tamil name:  
Uppilang kodi 
Botanical name:  
Pentatropis microphylla 
Other names:  
Ambarvel, Uppili, Uppili Ver, Parparam 
Vernacular Names: 
Sanskrit  :  vlauka, dhidaparni, kaka nasa, kaka nasika,   
            shringarati, suryavalli, sunasika. 
Marathi  :  shingrota 
Malayalam  :  parpparam, paparam. 
Hindi   :  ambervel. 
Telugu  :  chekurtitivva, pulapala 
PART USED: 
Leaf, stem, root 
ORGANOLEPTIC CHARACTER 
Taste       :  slightly sour 
Potency      :  heat 
Transformation   :  sour. 
ACTION: 
Digestive, 
Febrifuge, 
GENERAL CHARACTER: 
 hqt<jtbqe<!lf<kOhkq!Ohvik!'m<jsBl<!Ohil<< < < < < << < < < < << < < < < <!
out<jtosBf<!< << << < kr<gk<jk!ole<lzvix<!< < < << < < << < < < .!Oxit<jtHiq<<< !
OuT!fMr<Guc!Oujzfqgi<!%i<uqpqbib<< < < << < < << < < <!
fiTLh<hq!zir<ogicbq!eiz<< < << < << < <!
It cures indigestion for child, milky diarhoea and uncured fever. 
MEDICINAL USES: 
• It cures stomach bloating due to indigestion when the stem tied over hip 
region. 
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• Leaf juice mixed with breast milk given for indigestional diarhoea. 
• Leaf used for silver and gold parpam preparation. 
Gunapadam Mooligai Vaguppu Page No  
• Taking warm leaf juice as nasal drops to alleviate headache, running nose and 
bodyache. 
• Leaves of this plant are boiled with coconut oil and externally used in cuts and 
wounds. 
Indian Materia Medica Page No:652  
OTHERS PREPARATION OF UPPILANGKODI 
CHANDAMARUTHA KARUKU 
Dose   : 130 mg 
Adjuvant  : honey 
Indication : stomach pain, diarhoea 
-Agathiyar Vaidhya Kaviyam 1500 pg 654 
RAGURAMA BAANAM (THUTHA CHENDOORAM) 
Dose   : 100 mg 
Adjuvant  : honey, hot water 
Indication  : Bloating of stomach, Seetha kalichal,  
-Agathiyar Paripooranam 400 pg 682 
KAALA SARAGATHI KASHAYAM 
Dose   : 30 – 60 ML 
Indication  : Soolai, vomiting, indigestion 
-Agathiyar 2000 Part-3 pg 469 
UPPHILI NEI 
Dose   : 10-15 ml 
Adjuvant  : hot water 
Indication  : Bloating of stomach, stomach pain  
-Pillai Pinni Maruthuvam pg 382 
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3.3.2 BOTANICAL ASPECT 
TAXONOMICAL CLASSIFICATION 
Kingdom :  Plant Kingdom 
Division  : Angiosperms 
Class  : Dicotyledons 
Subclass : bicarpellatae 
Series  : gentianales 
Family  : asclepediaceae 
Genus  : pentatropis. 
HABITAT:  
In tamilnadu, it is growing in guardian region, mountain region. Leaves will 
be thickened but broken easily. It occurs in semi-arid thorny forest and thick forest.   
HABIT:  
It is a twinning perennial herb on shrubs and trees  
A BRIEF HISTORY ABOUT PENTATROPIS MICROPHYLLA 
Leaf : 1 to 3.5 cm long 0.5 to 2.5 cm wide, broadly oblong or  
ovate, elliptic, tip is blunt with a short point, base 
rounded. Lamina is chartaceous Leaf stalk is 4-7 mm 
long, Milky latex present in leaf. 
Inflorescence:  Axillary ambel type  
Flowers :  Flowers are pentamerous. Flowers clusters are carried  
on a short stalk upto 2mm long. Flowers stalk are 1.2 to 
1.3 m long 
Sepals :  Sepals are 1.5mm long. Five greenish sepals, Flowers  
tube is almost divided to the base  
Petals  :  3.5 to 6mm long.Five lobes of purplish corolla. corona  
lobes are 2 -2.5cm long 
Follicles :  3.7 to 6.8cm long 
Seeds  :  6×3 mm. ovate, tip truncate slightly crenulate at the  
   base.  
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MEDICINAL USES: 
• The plant is considered as cooling and alternative agent. 
• The plant is yields a bio active compound cardiac glycoside. It is used 
to treat constipation, colic and diarhoea. 
• In siddha system it is used as paediatric medicine especially children 
suffering from digestive problem and severe fever. 
• The plant extract also contain anti-astringent principle 
• In ayurveda it is equivated as kaka nasika useful in upper respiratory 
infection. 
PHYTO CHEMICALS 
• Chemically the source taxon is rich in compounds such as octacosanal, 
α amyrin, friedelin, β-sitosterol and sallicyclic acid. 
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3.3.3 LATERAL RESEARCH 
1. PHYTO CHEMICAL, ANTI FUNGAL, ANTI MICROBIAL AND ANTI 
OXIDANT STUDIES ON WHOLE PLANT EXTRACT OF PENTATROPIS 
MICROPHYLLA  
Available online at www.ijpcbs.com IJPCBS (International Journal of 
Pharmaceutical, Chemical and Biological Sciences) Mohan Gandhi et al. 2012, 2(4), 
453-463 ISSN: 2249-9504 453  
Author : Mohan Ganthi Bonthu at al 
Abstract 
The genus pentatropis is considered as one of the most important genus used 
in various systems of medicine due to their reported variety of compounds. In the 
present investigation the plant, Pentatropis capensis, was examined chemically for its 
phyto constituents. Investigation revealed the positive results for the presence of 
steroids, flavanoids, tannins and glycosides. The chloroform extract of stem showed 
moderate activity against bacterial organisms like Staphylococcus aureus, Bacillus 
subtilis, and Escherichia coli. The chloroform extract of the whole plant showed no 
antifungal activity at concentrations of 100mg/ml, 300mg/ml against fungal 
organisms. Methanollic extract of the plant showed significant effect on hydrogen 
peroxide radical scavenging activity and less significant effect on nitric oxide radical 
scavenging activity when compared with the standard.  
Keywords: Pentatropis capensis, Scavenging activity, Gram + Ve, Gram –Ve 
 
2. AN OVERVIEW OF SOME PROMISING MEDICINAL PLANTS WITH IN 
VITRO ANTI-UROLITHIATIC ACTIVITY 
IOSR Journal of Pharmacy (e)-ISSN: 2250-3013, (p)-ISSN: 2319-4219 
(www.iosrphr.org) Volume 5, Issue 5 (May 2015), PP. 23-28 23  Author : Anand 
Tiwari, Vivek soni at al  
Abstract:  
Kidney stone formation is so acute in some places that they are called stone 
belts and Gujarat is one of them. Though most prevalent and widespread disease in 
the world no guaranteed cure is found till date. None of the known and available 
treatments prevent the reoccurrence of kidney stone formation. Hence a dire need for 
herbal formulation appears to be the need of the hour. This present review discuses 
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the causes, cure and treatment of kidney stone formation. It emphasizes herbal 
remedies and lists of some of the promising plants which show in vitro anti 
urolithiatic activity. They can be further taken up for in vivo studies or may be used in 
herbal formulations and find a new herbal drug to treat the dreadful diseases  
Key words: kidney stone, anti urolithiatic activity, in vitro, medicinal plants, herbal 
formulation.  
 
3. ANTIMICROBIAL ACTIVITY OF PENTATROPIS MICROPHYLLA 
LEAVES 
International Journal of Pharm Tech Research CODEN (USA): IJPRIF ISSN: 0974-
4304 Vol.2, No.3, pp 2022-2024, July-Sept 2010 Author : M.Ramaprabha and 
K.Vasantha 
Abstract:  
Phytochemical screening and antimicrobial activity of acetone and methanolic 
extracts of Pentatropis microphylla L. (Asclepiadaceae) leaves against various 
pathogens such as Salmonella paratyphi, S. paratyphi A, Bacillus subtilis, B. 
thuringiensis, Proteus vulgaris, Pseudomonas aeruginosa, Staphylococcus aureus, 
Escherichia coli and fungal pathogens like Fusarium oxysporum, Aspergillus flavus, 
Mucor sp., Cladosporium sp. were analysed in the present study. Phytochemical 
screening recorded positive results for alkaloids, tannins, steroids, glycosides, 
saponins and flavonoids. Among which flavonoids, phenols and steroids showed 
maximum degree of precipitation. Negative results are obtained for fixed oils. 
Maximum antibacterial activity was showed against Pseudomonas aeruginosa and 
Salmonella paratyphi B.  
Key Words: Pentatropis microphylla, phytochemical, antimicrobial. 
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3.4. REVIEW OF DISEASE 
KALLADAIPPU 
3.4.1 SIDDHA ASPECT 
 Siddhars classified diseases into 4448 types. One among them is “Kalladaippu 
Noi”.The most prominent and ancient siddha literature is“Yugivaithiya chinthamani  
800”. 
In Siddha system, according to Theran Karisal, Urinary disease are classified 
into 
1. Neerinai perukkal Noi 
2. Neerinai Arukkal Noi 
fQiqVuqjeg<!G{k<jk!fQbxquqk<Ks<!osiz<Ouil<!
fQiqjeh<!ohVg<gozie<Ox!fQiqje!bVg<g!ozie<Ox!
fQiqpqUmOe!ogiz<Zl<!fQi<g<gm<M!uqjegotie<X!
! ! ! ! ! ! ! ! .Okve<!giqsz<< << << <!
! Kalladaippu is one of the urinary disease which comes under Neerinai Arukkal  
Noikal. 
1. SYNONYMS 
 Aachamari 
2. DEFINITION 
A) Sudden Obstruction to the flow of urine, pain in the base of penis in males 
and clitoris in females, burning sensation in external meatus, joint pain, passing of 
small sand like stones along with urine is the cardinal features of this disease. 
       -Siddha maruthuvam 
 B) Indicates a few features of Kalladaippu in the following poem 
  uqPGR<sqz!Ofvl<!uqMhm<M!fQOviMl<!
! ! yPgqb!uibu!oliKr<gqeiz<!OfigiK!
! ! uPgqb!lf<kk<kiz<!uiBuf<Ok!Hgqz<!
! ! gPgq!LkqIf<kqMl<!gz<zjmh<hiGOl/!!
! ! ! ! ! ! .Thirumoolar karukkandai vaidhyam 
C) kioee<x!Lk<kqvk<kqz<!fxfxoue<X 
! ! ! kr<gqbOkiI!ohicobEl<!l{z<kielh<hi!
! ! uioee<x!sqxbokiV!gz<ziukh<hi!
! ! ! utlig!uf<K!uqPl<!Ofib<g<Gk<!kiOe!
! ! Woee<x!n^<liq!Ovigole<x!Ohvil<!
! !
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According to the above quote, kalladaippu noi is due to “deposition of sand-
like grains in urine, which results in formation of gravel, followed by expulsion of 
stones during micturition”. Further, he elaborates that the stones cause obstruction in 
the urinary tract including the kidneys. As the stone surpasses the urinary tract, 
excruciating pain begins and intensifies. When the stones reached the uretheral orifice 
extreme burning sensation occurs in the external genitalia and the pain subsides 
instantly once when the stone gets expelled.!
       -Agasthiar gunavagadam 
3. ETIOLOGY FOR RENAL CALCULI: 
(i) In Siddha system many causes of this disease are mentioned. 
  njxgqOxe<!uqf<kpqf<kiz<!Olglis<S 
! ! ! nLK!upqf<K!SMogi{<miz<!uiB!OsVl<!
! ! hjxgqOxe<!Sjz!Gm<ml<!gqvf<kqh<!Hx<X!
! ! ! hUk<kqv!gt<!hqtju!Ohim<M!g{<mlijz!
!
! ! njxgqOxe<!njvbih<H!ym<cb!H\!
! ! ! nVr<gvh<hie<!sqvr<G!Ge<ll<!lifQIg<gm<M!
! ! GjxbiOu!fQI!ogi{<m!nf<Ofib<!gisl<!
! ! ! Gczlil<!OhkqObiM!gqvi{q!hi{<Om!
! The above poem describe that, when the semen is destroyed by body heat. 
Vatham will add with that, and many diseases will come, including kalladaippu. 
      -Agathiyar vaithiya vallathy600. 
 
(ii)  gzr<gqeOkiI!k{<{QIgt<!Gck<k!Ohig<Gr<!
! ! gz<ozZl<H!lbqI!l{<!kie<!gzf<ke<ek<kqz<!
! ! nzr<gqeOki!ve<er<gtVf<kziZl<!
! ! lzr<gqeOkiI!lih{<m!lVf<kiZl<!
! ! lf<kk<kqz<!uibuie!hkiIkkf<ke<je!
! ! Kzr<gqeOkiI!Vsqke<ekqx<!Sjuk<kziZl<!
! ! SVg<gib<g<!gz<zjmh<H!uf<K!Okie<Xf<kiOe/51!
The above poem describes that chronic mega noi produces small stones in the 
bladder and vitiation of vatham and pitham these small stones become larger in size 
and block the urinary passage. 
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Urinary stones are also formed due to the drinking of contaminated water, 
taking of food mixed with sand small stones, consuming of contaminated food 
articies, food containing more carbohydrates, unhealthy food habits, etc. 
-yugi vaidhya chinthaamani 
(iii)  fQiqjek<!kMk<kz<!osb<bqe<!fQIgm<Mk<!Kuivl< 
! ! hixqMR<!sf<K!sf<kqz<!h{<HX!Ofiu!kiGl<!
! ! Ofiqzr<!gbVr<!gil<bl<!fqs<sb!Ofikz<!osb<Bl<!
! ! Hiiqeq!zhie!uiB!h{<Hxs<!OsVle<Ox!
! ! Sg<gzf<!kjeb!mg<gqe<!SvLm!eQIg<gm<!miGl<!
! ! hg<glir<!jggiz<!sf<K!hivOfib<!upqbqx!r<Gl<!
! ! lqg<gOliI!OfiB{<!miGl<!lqGk<kqMl<!hqvOl!gf<kie<!
! ! kg<gOkiI!OhiKligqe<!kiqk<kqMl<!uiBg<GOx/!
! Urine and semen are the natural urges in the body. Suppression of excreation 
of urine or seminal discharge is one of the predisposing causes for the formation of 
stone in the bladder.  
      -Siddha maruththuvanga churukkam 
4. COMMON SIGNS AND SYMPTOMS 
1. Sudden obstruction to the flow of urine. 
2. Scanty urination. 
3. Frequency of micturition. 
4. Excruciation pain in the penis and anus. 
5. Pain will radiate from loin to groin sometimes radiates to thigh. 
6. Some stones are very sharp and irregular during its movement along 
the urine it will produce intolerable abdominal pain. 
7. Burning micturation and haematuria. 
8. Vomiting. 
9. Headache. 
10. If the surface of the stones is rough and irregular with horny 
projections it may cause extreme pain in the lower abdomen, burning 
sensation in the urethral orifice and even haematuria. 
5. TYPES OF KALLADAIPPU 
 In Siddha System, the Kalladaippu is classified according to its sign and 
symptoms. Types of Kalladaippu in some Tamil Siddha texts are dealt with here. 
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A)  ACCORDING TO YUGI VAIDHYA CHINTHAAMANI 
Okie<xqmOkiI!fizqeqm!filr<Ogtib< 
! ! SXg<gie!uikk<kqe<!gz<zjmh<H!
! ! H,e<xqbOkiI!hqk<kk<kqe<!gz<zjmh<H!
! ! kQe<xqbOkI!okif<flir<!gz<zjmh<H!
! ! Okgk<jkh<!hx<xqOb!sqxqK!gizl<!
! ! kie<xqOb!szh<jhbqz<!uf<kqpqf<K!
! ! gVuqOb!zqr<gk<kqx<Gf<!xiqg<Gf<!kiOe!!
Four types, these are 
ValiKalladaippu, Azhal Kalladaippu, Iyya Kalladaippu,Mukkutra Kalladaippu 
B) ACCORDING TO SIDDHA ARUVAI MARUTHUVAM 
Four types, these are 
Vali Kalladaippu,  
Azhal Kalladaippu,  
Iyya Kalladaippu,  
Venneer Kalladaippu 
C)  ACCORDING TO THANVANTHRI VAITHIYAM 
Four types of ashmari,these are 
Kallarippan,  
Pitha ashmari, 
Slathma ashmari,  
Sukkila ashmari 
6. SIGNS AND SYMPTOMS 
A) ACCORDING TO NOIVILAKKAM, 
1.VALI KALLADAIPPU 
hmIlqgh<!hMkz<!hx<gt<!gck<kz<!
fMr<gz<!df<kqBr<!GxqBl<!hqjskz<!
gsMgQp<!utqobiV!gpzz<!nPkz<!
sqXfQI!Ktqk<kz<!we<iUl<!hqxUl<!
utqhqe<!gz<zjmg<!Gxqobe!olipqOb/!
 Tongue biting, palpitation, shivering, crushing pain of the lower abdomen and 
genital organ, dribbling of urine, the stone are blackish red in colour. 
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2.ANAL KALLADAIPPU 
Sm<ome!fqvqbl<!lqgoul<!hqMkZl<!
OfilZl<!njzg<!gz<zjmg<!GxqOb!
squf<Kr<!gXk<K!lR<seigqBl<!
Osr<GV!ucuqz<!gz<zK!Okie<Xl</!
Burning micturition,dysuria the stone are reddish black (or) yellow in colour and 
passing small stones. 
3.IYYA KALLADAIPPU 
fQvqbr<!Gk<kz<!kq{qk<kz<!Gtqv<kz<!
wElqju!Jbg<!gz<zjmg<!GxqOb!
ouTk<Kl<!Okeqx!ligqB!olitqv<f<Kl<!
ohVuc!Ujmk<kil<!Jbg<!gz<zjm/!
 Pricking pain, forceful pain with severe intensity when passing urine, fever with 
rigor, white (or) honey coloured, shining (or) laminate larger size stone expelled. 
4.KARUNEER KALLADAIPPU 
gVfQvm<g!gzqe<!utq!sqef<okTf<K!
uqjvetq!eMuqz<!nKkje!kMk<kzqe<!
gVfQI!gz<zjm!lVuqM/!
Burning micturition, dysuria, stone black in colour,larger size stone expelled 
B) ACCORDING TO YUGI VAIDHYA CHINTHAAMANI 
1.VALI KALLADAIPPU 
Acute pain in lower abdomen, swelling in abdomen, urinary flow is 
uncontinuous so pain present in penis, sometime mucous discharge in urine, patient 
unable to sit. 
2.AZHAL KALLADAIPPU 
Obstruction of urinary flow, burning sensation, acute pain in urethra, excretion 
of small red coloured stones 
3.IYYA KALLADAIPPU 
Severe pain present in umbilicus, pain radiating towards the thigh, burning 
micturation, excess sweating and small white colour stone sometimes comes with 
urine. 
4.MUKKUTRA KALLADAIPPU 
It is also called Venneer Kalladaippu (or) Manarkalladaippu. 
 Pain in tip of urethra, irregular urinary output and small stone come along with 
urine and semen. 
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7. PATHOGENESIS 
The three Uyir Thaathukkal are formed by combination of the three important 
Naadi with three Vaayus as follows, 
Idakalai + Abaanan = Vatham 
Pinkalai + Praanan = Pitham 
Sulumunai + Samaanan = Kapam 
The Thiri Thaathukkal tend to be in their states of equilibrium (1: ½: ¼) 
during normal conditions of human beings. 
Dx<xOkiI!dmzqe<!%X!
! ! dXh<Hme<!uqvuq!fqe<X!
! ! Lx<XOl!Ofib<gt<!wz<zil<!
! ! LkzkeqOz!Okie<Xl<!OhiK!
! ! hx<XOl!uik!hqk<k!
! ! sqOzx<h{x<kef<ke<eqz<!ye<jxh<!
! ! hx<xqOb!Okiex<Xole<X!
! ! hgIk<keI!LequI!kiOl/!!
.ngk<kqbI!GVfic<<< !
According to the basic principles of siddha a disease and its manifestations are 
a result of the derangement in the above said mukkuttrams, the result of disturbed 
kutrams (ie. vatham, pitham, kapam) 
Through the above poem quoted in siddha maruthuvanga surukkam. siddhars 
emphasize that any changes in diet, water intake and lifestyle leads to a hike in the 
vatha and pitha kutram in the body, causing stagnation of urine in the kidneys. If 
abanan is favourable in the body then these deposits will automatically be expelled 
through urine. if not, they remains in the remain in the urinary tract leading to 
kalladaippu noi. Whatever may be the causes attributed to the occurrence of 
Kalladaippu or any other disease, the siddha concept is that the manifestation of  
disease is the result of disturbed doshas i.e. Vatham, Pitham & Kabam.!
  uiBuqeiOz!lzszr<!gm<cMl<!
! ! hqiqf<kqMl<!hqk<kl<!OhviR<!szk<kqeqOz/!!
.sqk<k!lVk<Kuir<gs<< < < << < < << < < <!SVg<gl</< << << < !
In kalladaippu, due to alteration in once diet and water intake,Vatha and Pitha 
dosham increase in the body and salts in the urine get sedimented in the kidney. If 
abaana vayu is favourable these sedimented deposits get excreated in the urine and if 
the Abaana Vayu is unfavourable the urinary sediments do not get excreated and get 
deposited in at anywhere in the urinary pathway and creates this disease. 
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3.4.2 MODERN ASPECT 
RENAL CALCULI (UROLITHIASIS) 
1. DEFINITION 
 A Kidney is a hard, crystalline mineral formed within the kidney or urinary 
tract. Kidney stones are a common cause of blood in the urine (haematuria) and often 
severe pain in abdomen flank, or groin, Kidney stones are sometimes referred to as 
renal calculi. 
2. PREDISPOSING FACTORS FOR KIDNEY STONES: 
Environmental and dietary causes: 
a) Low urine volumes : high ambient temperatures, low fluid intake 
b) Diet : high protein, high sodium, low calcium 
c) High sodium  excretion 
d) High oxalate  excretion 
e) High urate excretion 
f) Low citrate excretion 
Acquired causes: 
a) Hypercalcaemia of any cause  
b) ileal disease or resection ( Increases oxalate absorption and urinary 
excretion) 
c) Renal tubular acidosis type 1 (distal) 
Congenital and inherited causes: 
a) Familial hypercalciuria  
b) Medullary sponge kidney  
c) Cystinuria 
d) Renal tubular acidosis type 1 (distal) 
e) Primary hyperoxaluria 
3. TYPES OF URINARY CALCULI 
There are four main types of urinary calculi. They are, 
a) Calcium containing stones 
b) Mixed (struvite) stones 
c) Uric acid stones 
d) Cystine stones 
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In addition to these four types, there are few rare types, occurrence of which is less 
than 2%. 
a) CALCIUM  STONES 
Calcium stones are the most common comprising about 75% of all urinary 
calculi. They may be pure stones of calcium oxalate (50%) or calcium 
phosphate (5%) or mixture of calcium oxalate and calcium phosphate (45%). 
a) MIXED (STRUVITE) STONES 
15% of urinary calculi are made of magnesium-ammonium-calcium 
phosphate, often called struvite, hence mixed stones are also called as ‘struvite 
stones’ or triple phosphate stones. 
b) URIC ACID STONES 
Approximately 6% of urinary calculi are made of uric acid. Uric acid 
calculi are radiolucent unlike radio-opaque calcium stones. 
c) CYSTINE STONES 
Cystine stones comprise less than 2% of urinary calculi 
d) OTHER CALCULI 
Less than 2% of urinary calculi consist of other rare types such as due 
to inherited abnormality of enzyme metabolism .ex. hereditary xanthinuria 
developing xanthine stones. 
4. SALIENT FEATURES OF URINARY CALCULI 
Table no: 1 
Type Incidence Etiology Pathogenesis 
Calcium 
stones 
75% Hypercalciuria with or without 
hypercalcaemia; idiopathic 
Supersaturation of ions in 
urine, alkaline  PH of 
urine; low urinary 
volume, oxaluria and 
hyperuricosuria   
Mixed 
stones 
15% Urinary infection with urea-
splitting organisms like proteus 
Alkaline urinary pH 
Produced by ammonia 
from splitting of urea by 
bacterially produced 
urease 
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Uric acid 
stones 
6% Hyperuricosuria with or without 
hyperuricaemia (e.g. in primary 
and secondary gout) 
Acidic urine(pH below 6) 
decreases the solubility of 
uric acid in urine and 
favours its precipitation 
Cystine 
stones 
2% Genetically-determined defect in 
cysteine transport 
Cystinuria containing 
least soluble cysteine 
precipitates as cysteine 
crystals 
Other 
types 
<2% Inherited abnormalities of amino 
acid metabolism 
Xanthinuria 
 
5. MORPHOLOGY 
CALCIUM STONES 
1. Usually small, ovoid (less than a cm) 
2. Hard with granular rough surface 
3. Dark brown due to old blood pigment deposited in them as a result of 
repeated trauma caused in the urinary tract by these sharp edged stones. 
MIXED (STRUVITE STONES) 
1. Yellow-white or grey 
2. Soft and friable and irregular in shape 
3. Stag-horn stone which is a larger, solitary stone that takes the shape of 
renal pelvis. 
URIC ACID STONES 
Smooth, yellowish-brown, hard and often multiple 
CYSTINE STONES 
 Small, rounded, smooth and often multiple 
Yellowish and waxy 
6. SIGNS AND SYMPTONS  
1. In the kidney fixed renal pain, (flank pain)is common. 
2. In the ureter (according to Localisation of stone) 
3. If in upper 1/3 of the ureter pain radiates to the perineum if the pelvic 
brim- pain radiates to the inner aspect of thigh. 
4. If present in middle 1/3 of ureter –pain radiates to the iliac fossa. 
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5. If the stone is localised in the bladder neck (or) Urethra. 
6. Pain may presence as tip of penis. 
7. Frequently of Urination. 
8. Oliguria. 
9. Dribbling of Urine. 
10. Hematuria. 
7. PATHOGENESIS OF STONES 
1. The mechanism of Calcium stone formation is explained on the basis of super 
saturation of ions of forming the stone and the concentration of inhibitors in 
the urine most likely site where the crystal of Calcium Oxalate and /or 
Calcium Phosphate are precipitated is the tubular lining (or) around some 
fragment of debris in the tubule acting as nidus of the stone. The stone grows, 
as more and more crystals are deposited around the nidus. A number of other 
predisposing factors contributing to formation of Calcium stones are alkaline 
Urinary PH decreased Urinary Volume and increased excretion of oxalate and 
uric acid. 
2. The solubility of uric acid at PH of 7 is 200mg/dl while at PH of 5 is l5mg/dl. 
Thus as the urine becomes more acidic, the solubility of uric acid in urine 
decreases and precipitation of uric acid crystals increases favouring the 
formation of uric acid stones hyperuricosuria is the most important factor in 
the production of uric acid stone, while hyperureamia is found in about half 
the case. 
3. Excessive excretions of cystine stones are associated with cystinuria due to 
genetically determined defect which is least soluble of the naturally-occuring 
aminoacid leads to formation of crystals and eventually cystine calculi. 
8. DIAGNOSIS OF KIDNEY STONES: 
 Diagnosis of kidney stones requires a complete health history assessment and 
a physical exam.  Other tests include: 
1. Blood tests for calcium, phosphorus, uric acid and electrolytes. 
2. Blood urea nitrogen (BUN) and creatinine to assess kidney functioning. 
3. Urinalysis to check for crystals, bacteria, blood and white cells. 
4. Examination of passed stones to determine type. 
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9. COMPLICATION OF RENAL CALCULUS 
1. Azotemia: Increased urea and nitrogen containing compounds in the blood due 
to inability to excrete the above compounds. 
2. Acquired distal renal tubular acidosis 
3. Urinary tract infection due to urinary stasis 
4. Hyperkalaemia 
5. Renal hypertension 
6. Chronic unilateral or bilateral hydronephrosis in the presence of  ECV 
Expansion or other renal disease 
7. Polycythaemia – infrequent complication of obstructive uropathy secondary to 
increased erythropoietin production by the obstructed kidney. 
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3.5 PHARMACEUTICALS REVIEW 
CHUNNAM 
Definition: 
The word 'Chunnam' indicative of an alkaline product similar to lime. In 
Tamil language, Caustic lime is also turned as Chunnam.  
Raw meterials in chunnam preparation: 
Many metallic and non metalic mineral drugs are made into chunnam 
preparations. 
Metals: Gold (Thangam), Silver (Velli), Copper (Chembu), Iron (logam), Zinc 
(Naagam), lead (karuvangam), etc. 
Mercurials and other toxic substance: Mercury (Rasam), Cinnabar (lingam), 
Calomel (Pooram), Mercuric perchorid (veeram), thalagam (As2S3) 
Salts (karasaram): fuller's earth (Pooneeru), salt peter (vediuppu), Camphor 
(Karpooram), Kalluppu (salt),etc. 
Mineral origin: (Uparasam) Mica (Abrakam), asbestos (kalnar), Copper Sulphate 
(thurusu), Chalcopyrite(nimilai), etc. 
Zoological product: Kizhinjal (conch shell), Sangu, nandu odu, nathai odu, Muttai 
odu. 
Equipments required: 
• Mortar and pestle 
• Vessels and spoons to handle liquids. 
• Long ribbons of tough cloth and fine clay. 
• Pairs of shallow earthen discs of identical dimensions. 
• Cow dung cakes, sufficient numbers and well dried. 
• Fine cloth pieces for filtering juices and decoction. 
• Spatula for handling powders. 
• Air tight containers. 
General Method of Preparations: 
  The above naturally obtained ingredients are processed sequentially by 
elaborate processes like grinding, melting, triturating, quenching in different plant 
juices with different heat treatments thus changing form from one to another and in 
the end,  making into bio available form. 
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Chunnam are prepared by two different methods one is simple and another is 
complex. Chunnam should be prepared during the hot. Summer months like April and 
May. Simple, Complex method, Crucibles (moosai) used in chunnam. 
a) Simple Method 
In this method either lime stone or calcium group of raw materials are 
subjcctcd to calcinations or incineration in pudam with cow dung cakes as specified in 
the formula. Commonly these medicines are used extensively by physicians examples 
are chunnam as salt peter (vediuppu chunnam) and chunnam of egg shell (anda odu 
chunnam), which are used extensively in urinary, genital disordcrs and in acid peptic 
diseases. 
b) Complex method 
A very systematic, elaborate, stepwisc procedurc is followed in these 
preparations. High metals, gems or any toxic material is detoxified as per recipe and 
then converted it to a fine homogenous substance by triturating with plant juices or 
some distillates called pugai neer or thiravagam or with any solvent (jeyaneer) and 
made into fine paste and are well dried. Tins paste is kept in distinct, specially made 
crucibles called moosai like Panchachunna gugai and scaled. After drying, this 
crucible is heatcd in a hand bellows blower. After sufficient heating, generally up till 
a point when the crucible becomes red hot and itself gives up its structure. The 
contents are allowed to cool and collected. The final product after sufficicnt grinding 
(i) Crucibles (Moosai) Used in Chunnam 
It is very interesting to note that heat resistant crucibles (moosai/gugai) are 
specially made prior to chunnam preparation Special crucible called panchachunna 
gugai is prepared with chunnam of crab shell (nandu), water shell (nathai), conch 
shell (sangu), Pearl oyster shell (chippi), egg shell (anda oodu). latex of Calotropis 
erukkampaal. Egg albumin, venkaram and lime water (chunna neer). Anju chunna 
gugai, pancha bootha gugai are few other crucibles particularly used for chunnam 
preparation. 
(ii) Product Grades: 
The chunnam of many metal and non-metal drugs are graded according to the 
solvents used in the preparation, the type of crucibles used and of heating appliances 
used in the process of particular preparation. If the chunnam is prepared in pancha 
chunna gugai and incinerated with bellows blower is graded as best quality. If the 
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chunnam is prepared with fullers earth (pooneeru chunnam) the drug is graded as 
second quality. If chunnam is prepared by the use of copper sulphate chunnam it is 
classified as third quality. If chunnam is prepared with caustic solvents like jayaneer, 
this variety is classified into 4th quality. Generally physicians prepare a special kind 
of solvent called chunna thiravagam to prepare all kinds of chunnam of salts, 
minerals, metals and various gems. 
Shelf Life: 
When properly stored, they retain then potency up to 500 years. 
Adjuvant: 
It is advised to take the chunnam medicine with ghee, butter or milk. Dosage 
is indicated according to the disease condition as 3 days or 7days or 21 days. 
Colour: 
Chunnams are in powder form and generally soft white to ivory color or 
colourless. 
If white color is not obtained fuller's earth chunnam is added to get the white 
colour 
Character and tests for chunnam: 
Chunnams are odourless, lusterless, smokeless on heating. 
Microfine in particle size wafer like very light in cut 
The end point on purity of chunnam is ascertained by adding a pinch of 
turmeric with few drops of water it turns turmeric from yellow to red perhaps as on 
indicater of the pH value. 
Chunnam also taste like lime and will produce irritation when it comes in to 
contact with mucous membrane. Kadunkara Chunnam is highly alkaline caustic and 
blisher forming. 
Preservation and storage: 
Chunnam should be kept in dry well stoppard glass bottles. 
Uses of Chunnam 
Generally chunnams are acclaimed as best possible medicaments in chronic 
degenerative human ailments with various adjuvants. Chunnam of salt peter, which is 
called as vediuppu chunnam, is used extensively by present day physicians for urinary 
calculi, and in some types of malignant and non-malignant tumours. 
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Chunnam of borax which is called as venkara chunnam are highly preferred in 
metabolic disorders of liver and spleen diseases. Many of these chunnam preparations 
play a vital role in the process of higher order medicines called Kattu (solidified 
metals). One of the best examples is solidified mercury called sootha kattu. 
Among various chunnam preparations a very few preparations are considered 
very indispensable as medicine and in medicine preparation, are termed as Guru 
chunnam, Very few dings like gold, silver, copper sulphate, fuller's earth chunnam 
preparations are considered as gold chunnam and termed as thanga guru, velli guru, 
thurusu guru, muppu guru respectively 
Among the many uniqueness of Siddha medicine, kayakalpam or rejuvenation 
therapy is its epitome. Food and life style modifications with ding therapy are 
indicated in this line of treatment. Muppu chunnam is basic and cardinal component 
in these preparations of antiageing processes and also in alchemical transformations. 
Apart from this, muppu chunnam is also used as an adjuvant for many 
medicaments for chronic degenerative diseases and is a purifier of metals and 
minerals. 
Many chunnam preparations of sal ammoniac (kambi navachara chunnam), 
Borneo camphor (karpoora chunnam), copper sulphate (thurusu ), arsenic thalaga 
chunnam(vanga chunnam), copper (thamira chunnam), gold (thalanga chunnam), 
mercury (rasa chunnam), mercuric per chloride ( veera chunnam), mica (abrakam), 
magnetic ore (kantham iron aya chunnam), arsenic oxide sulphide (gowri), sulphur 
(gandagam), cinnabar (lingam), zinc (nagam) are prepared with muppu chunnam. 
It is worth mentioning that very small quantity of copper sulphate chunnam 
(thurusu) is added to extract juices or latex from very dry natured plants like virali 
(Dodonea riscosa), kuppai meni (Acalypha indica) and erukku (Calotropis gigantica). 
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4. MATERIALS AND METHODS 
4.1 PREPARATION OF VENKARA CHUNNAM 
DRUG SELECTION: 
 In this dissertation VENKARA CHUNNAM is taken as a trial drug for evaluate 
Lithotriptic, Diuretic, and Antispasmodic activity from the Siddha Literature Anuboga 
vaithiya navaneetham, part 3 page no 25, 26, Second Edition - 2002, Hakim P. 
Mohamed Abdulla Sahib, published by thamarai noolagam chennai 26 
 
INGREDIENTS: 
1. Venkaram (Sodium bi borate)    – 1 balam (35gm) 
2. Uppilangodi (pentatropis microphylla) - q.s 
3. Murungai pattai (moringa oliefera)  -q.s 
 
COLLECTION OF THE RAW DRUG AND MINERAL DRUG: 
• The mineral drug Venkaram was purchased from Gopala Asan Naatu 
Marunthukadai, Nagercoil. 
• The Uppilangodi was collected from poyapatti, Dharmapuri District. 
• The Murangai pattai was collected from palayamkottai. 
IDENTIFICATION AND AUTHENTICATION OF THE DRUG: 
 The identification of herbo mineral raw drug is authenticated by the faculties 
of PG Gunapadam Department, Government Siddha Medical College, Palayamkottai. 
PURIFICATION OF THE DRUG: 
 All the herbomineral ingredients purified as per the traditional validation and 
illustration. 
• Venkaram (borax) - The salt is washed in cow’s dung solution. 
• Uppilangodi (ambarvel) – wash with water until soil and dust particles 
removed. 
• Murungai pattai (drumstick tree) – clean the bark with cloth and then 
cut down the outer layer of bark with the help of knife. 
PREPARATION OF VENKARA CHUNNAM 
Purified venkaram was kept in porcelain vessel and deeply soaked 2 inches 
(5cm) in uppilangodi juice for 3 days. Then it was dried in sunlight until the juice dry. 
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After that moringa bark was rubbed as butter consistency then this venkaram was 
covered with rubbed mass of moringa bark. Thus the moringa bark mass covered over 
1 inch on venkaram. Then dry it in sunlight after that seven clay clothes was made 
around this mass, dried and subjected to pudam with 50 balam (1750 gram) varaties. 
After cooling venkara chunnam was taken out and powdered with the help of stone 
mortar.    
STORAGE OF THE DRUG: 
 The prepared test drug was stored in a clean glass air tight container. 
ADMINISTRATION OF DRUG: 
 Form of the medicine – chunnam 
 Dose – 2 – 4 kundrimani (260-520 mg) BID- morning and evening 
 Adjuvant – Honey, Ghee, butter, tender coconut 
 Shelf life – 500 years 
INDICATION: 
 Kalladaippu (Renal Stone) 
Neeradaippu,  
Thasaiadaippu 
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Figure No:1 VENKARAM 
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Figure No: 2: UPPILANGKODI (Pentatropis microphylla) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure No: 3: MURUNGAI PATTAI (Moringa oleifera) 
  
  
 
 
   52 PRE CLINICAL  STUDY OF  VENKARA CHUNNAM 
 
Figure: 4 PREPARATION OF  VENKARA   CHUNNAM 
Purification of Venkaram 
 
 
 
 
 
     Soaked in uppilangodi Juice      Covered with moringa bark mass 
 
 
 
 
 
      Sealed Earthern crucible             Incineration process 
 
 
 
 
 
After Incineration 
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Figure:5 End Process of Venkara Chunnam 
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4.2. STANDARDIZATION OF THE DRUG:  
4.2.1 AS PER SIDDHA CLASSICAL LITERATURE: 
Standardization of drug means confirmation of its quality and purity and 
detection of the nature of adulterant of various parameters like morphological, 
microscopic, physical, chemical and biological observations.  
1) Colour: 
Mostly chunnam is white in colour. VENKARA CHUNNAM is white in 
colour. It shows that the perfect colour of chunnam 
2) Odour: Odourless 
3) Taste: 
Properly prepared chunnam should be completely tasteless. If any taste 
present in chunnam, it indicates the preparation was not well prepared. It 
needs another pudam (incineration) process. A small amount of chunnam 
was kept in the tip of the tongue, which is tasteless and felt mild irritation 
due to its alkaline nature. The final product, VENKARA CHUNNAM was 
analysed as per Siddha classical standardization methods.  
4) Lustre: 
If any glowing particles seen in the chunnam, it shows that the drug is 
not prepared properly and possess unchanged substances like metals and 
other toxic substances. So, there should be no glowing particles present in 
the properly prepared chunnam. The VENKARA CHUNNAM was taken in a 
petri dish and observed for any lustre in daylight via magnifying glass. No 
lustre was observed in the parpam. 
5) Finger print test: 
Well prepared chunnam should be very fine. A pinch of VENKARA 
CHUNNAM was taken and rubbed in between the thumb and index finger. It 
enters into the lines of the fingers. It confirmed the fineness of chunnam. 
6) Floating on water: 
A pinch of VENKARA CHUNNAM was sprinkled over the water in a 
glass container. The chunnam particles did not sink but floated on the water 
surface. It indicates the lightness of VENKARA CHUNNAM. 
Based on the above results it was suitable for further analysis. 
7) Colour change: 
The chunnam was mixed with turmeric powder and add few drops of 
water. The yellow colour changed into red colour. 
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4.2.2. AS PER MODERN ASPECT: 
4.2.2.1. PHYSICO CHEMICAL ANALYSIS: 
Solubility test:   
A. A little amount of the sample was taken in a clean, dry test tube and then 
shaken well with distilled water.  
B. A little amount of the sample was taken in a clean dry test tube and then 
shaken well with Con. HCL and Con.H2SO4. Sparingly soluble character of the 
sample indicates the presence of Silicate.  
Action on heat:  
A small amount of the sample was taken in a clean dry test tube and heated 
gently. If strong white fumes evolve indicate the presence of Carbonate.  
Flame test:  
A small amount of the sample was taken in a clean dry watch glass. It was 
made into paste with concentrated HCL. And then it was introduced into non-
luminous part of the Bunsen flame. If bluish green flame appears, it indicates the 
presence of copper. 
Ash test:  
A small amount of sample was mixed with the cobalt nitrate solution. A filter 
paper was soaked into the mixture. Then it was introduced into the Bunsen flame and 
ignited. If yellow colour flame appears, it reveals the presence of sodium. 
Particle size: 
 25 gm of VENKARA CHUNNAM was taken in a sieve (sieve no: 200). It was 
shaken rotator vertically and horizontal direction by tapping on a hard surface for not 
less than thirty minutes. The amount of remnants was weighed accurately. 
Loss on Drying (Indian Pharmacopoeia, 1996): 
 Loss on drying is the loss of percentage w/w resulting from water and volatile 
matter of any kind that can be driven off under a specified condition. Moisture is one 
of the major factors responsible for the deterioration of the drugs and formulations. 
Low moisture content is always desirable for higher stability of the drugs. 
Determination of Loss on drying: 
 The Loss on drying test is designed to measure the amount of water and 
volatile matters in a sample when the sample is dried under specified conditions. A 
glass stopper and a shallow weighing bottle were weighed accurately and the quantity 
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of the sample as specified was transferred to the bottle covered and weighed. The 
sample was distributed evenly and the bottle was placed in the drying chamber. The 
sample was then dried for a specific period of time, and the bottle was removed from 
the chamber and allowed to cool at room temperature in desiccators before weighing. 
The percentage of loss on drying (1.3%) was within acceptable range (5%-8%), thus 
implying that the formulation can be stored for a long period and would not easily be 
attacked by microbes.  
Ash Value (Indian Pharmacopoeia, 1996): 
 The ash yielded by an organic compound measures the amount of inorganic 
matter present as impurity. Ash values are helpful in determining the quality and 
purity of crude drugs in the powder form. Ash determination judges the identity and 
cleanliness of drugs and provides information regarding adulteration with inorganic 
matter. 
Determination of Total Ash Value: 
 Total ash includes physiological ash, which is derived from the medicine and 
non-physiological, which is often from environment contaminations such as sand and 
soil. 2 g of powdered drug was accurately weighted in a silica crucible which was 
previously ignited and weighed. The powdered drug was spread as a layer on the 
bottom of the crucible. It was then incinerated at a temperature not exceeding 450oC 
until free from carbon. The crucible was then cooled and weighed.  
Water soluble Ash: 
 The total ash is obtained as the above method for preparation of total ash. The 
ash is boiled for 5 minutes with 25ml water. The insoluble ashes is collected using 
filter paper and washed with hot water and then transferred to the silica crucible then 
ignite for 15 minutes at temperature not exceeding 450oC. The silica crucible and 
residue are weighed until constant weight is attained for determination of weight of 
insoluble ash. The weight of the water soluble ash is determined by subtracting the 
weight of insoluble ash from the weight of total ash. 
Determination of Acid insoluble Ash: 
 Total Ash content alone is not sufficient to reflect the quality, thus the acid 
insoluble ash of the drug is quite important. The ash obtained in the determination of 
total ash, was boiled with 25 ml HCL for 5minuts and the insoluble ash was collected 
in a clean filter paper and washed with hot water. The insoluble ash was then 
transferred to a pre weighed silica crucible, ignited cooled and weighed.  
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Determination of extractive value: 
Alcohol soluble extractive value: 
3g of test drug powder is weighed and macerated with 100ml of ethanol in a 
closed container for 24 hours. The resulting solution is shaken continuously for 6 
hours and allowed to stand and soak for 18 hours. The solution is filtered and 
evaporated of the filtrate in a flat bottomed shallow dish and dried at 105oC then 
cooled and weighed. 
Water soluble extractive value: 
3g of test drug powder is weighed and macerated with chloroform and water, 
respectively, at 80oC for 24 hrs. The resulting solution is shaken continuously for 6 
hours and allowed to stand and soak for 24 hrs then filtered. The solution from both 
chloroform and water respectively is filtered and evaporated of the filtrate in a flat 
bottomed shallow dish and dried at 105oC then cooled and weighed. 
4.2.2.2. MICROBIOLOGICAL LIMIT TEST 
Evaluation of total aerobic bacterial count 
1. Preparation of Sample for Experimental Work  
Weighed 10 gm of the homogenized drug sample aseptically and dissolved 
in 10 ml of sterile water and made up to 100 ml with the sterile water. The insoluble 
drug product was suspended in 100 ml of buffered sodium chloride-peptone 
solution (pH7.0) 
2. Serial dilution of Sample 
  A serial dilution is the dilution of a sample, in 10-fold dilutions. From the 
sample, 1 ml of the sample was added to 9 ml of sterile distilled water and mixed it 
well. This dilution was denoted as 10-1 dilution. From this dilution, one ml was 
taken from that mixture is added to 9 ml, and designated as 10-2 dilution. The 
same procedure was repeated up to 10-4
.  
3. Isolation of Total Viable Aerobic Microbial Count 
Isolation of Bacteria by Plate Count Method 
  In this test, the bacteria in sample were made to grow as colonies, by 
inoculating a known volume of sample into a solidifiable nutrient medium (Casein 
Soybean Digest agar or Nutrient agar medium) in petridish. The agar plate was 
prepared by mixing growth medium with agar and then sterilized by autoclaving. 
Once the agar was cooled to 45oC, approximately 15 to 20 ml of medium was 
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poured into a sterile Petri dish under aseptic condition and left to solidify for 15 
minutes. After solidification, each plate was smear with 0.1 ml of sample from the 
dilution of 10-1 and 10-2. After inoculations, all the plates were incubated at 37oC 
for 24 hours. After incubation, the bacterial colonies were developed as visible to 
the naked eye and the number of colonies on a plate was counted using Quebec 
Colony Counter. Plates with an average of from 30 to 300 colonies of the target 
bacterium were selected for colony count. Because of the statistical problems, 
plates with lower than 30 colonies greater than 300 colonies were rejected 
Composition of Nutrient Agar Media 
Peptone  :  5.0 gm 
Sodium chloride :  5.0 gm 
Beef extract  :  1.5 gm 
Yeast extract  :  1.5 gm 
Agar   :  15.0 gm 
Distilled water  :  1000 ml 
pH ( at 25°C)  :  7.4±0.2 
Isolation of Fungi 
  From each of the above prepared samples, 0.1 ml of sample was transferred 
to Sabouraud Dextrose agar (SDA) prepared with Chloramphenicol. The plates 
were then incubated for 5 days at room temperature (20 to 25°C). After incubation, 
the fungal colonies were observed and calculated. 
Composition of SDA 
Dextrose :  40 gm 
Peptone :  10 gm 
Agar  :  15 gm 
Distilled water :  1000 ml 
4. Evaluation of Antimicrobial Activity of Drug 
  Antimicrobial activity was performed by agar well diffusion method on 
agar. 
Preparation of drug extracts solutions for the experiment 
  The dried drugs were weighed and dissolved in sterile distilled water to 
prepare appropriate dilution to get required concentrations of about 10, 20 and 
30µg/ml. They were kept under refrigerated condition unless they were used for the 
experiment. 
  
 
 
   59 PRE CLINICAL  STUDY OF  VENKARA CHUNNAM 
 
Procedure for the Agar Well Diffusion Test 
  The antibacterial screening of the drugs were carried out by determining the 
zone of inhibition using agar well diffusion method. All the drug extracts were 
tested against four pathogenic bacterial strains of gram positive and gram negative 
organism by agar well diffusion method. 
Bacterial Inoculums Preparation 
  Inoculums of Staphylococcus aureus, Escherichia coli, Klebsiella 
pneumoniae, Proteus vulgaris, and Bacillus substilis were prepared in nutrient 
broth medium and kept for incubation at 37°C for 8 hrs. 
Agar well-diffusion method 
  This method was followed to determine the antimicrobial activity. Muller-
Hinton Agar media plates were swabbed (sterile cotton swabs) with 8 hour old - 
broth culture of respective bacteria. After inoculation, wells with the size of 10 mm 
diameter and about 2 cm a part were made in each of these plates using sterile cork 
borer. Stock solution of each drug extract was prepared at a concentration of 1 
mg/ml in water. About 100 µl of different concentrations of drug solvent extracts 
were added into the wells and allowed to diffuse at room temperature for 2 hrs. The 
plates were incubated at 37°C for 24 hrs. After incubation, the diameter of the 
inhibition zone (mm) was measured and the activity index was also calculated. 
Composition of Muller Hinton Agar Media 
Beef Extract   :  02.00 gm 
Acid Hydrolysate of Casein :  17.50 gm 
Starch    :  01.50 gm 
Agar    :  17.00 gm 
5. Evaluation of Specified Microorganisms 
Isolation & Identification of Escherichia coli 
  One ml of the prepared sample was added in a sterile screw-capped 
container containing 50 ml of nutrient broth and mixed well. Then, it was allowed to 
stand for 1 hour and mixed well again. After one hour, the screw caps of the bottle 
was loosened and incubated at 37º for 18 to 24 hours. 
Primary Test 
  From the above prepared enrichment culture, 1.0 ml was taken and 
transferred aseptically into a tube containing 5 ml of Mac- Conkey broth. 
Inoculated tubes were incubated in a water-bath at 36º to 38º for 48 hours. 
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Secondary Test 
  From the primary test, 1.0 ml of the enrichment culture was taken and 
transferred aseptically in to 5 ml of peptone water. It was then incubated in a water-
bath at 43.5º to 44.5º C for 24 hours and observed the tubes for acid and gas. Then, 
the culture was subjected to biochemical tests of imvic and the results were 
observed and correlated. 
Alternative test 
  It was done by a loop full of enriched culture in the primary test was 
streaked on a sterile Mac-Conkey agar medium. Then, the plates were inverted and 
incubated at 37 º C for 24 hours. After incubation, the pink or brick red color 
colonies were examined and transfer them individually into the surface of Eosin 
Methylene Blue agar medium (EMB), on Petri dishes. Inoculated plates were 
inverted and incubated at 37 º C for 24 hours. After incubation, the colonies on 
medium were checked for their color appearance like green metallic sheen under 
reflected light. The colonies were subjected to confirmation by further suitable 
cultural and biochemical tests. 
Components of Eosin Methylene Blue Agar Media 
Pancreatic digest of gelatin  :  10.0 g 
Dibasic potassium phosphate  :  2.0 g 
Lactose    :  10.0 g 
Eosin Y    :  400 mg 
Methylene blue   :  65 mg 
Agar     :  15.0 g 
Distilled water    :  1000 ml 
Isolation & Identification of Salmonella sp 
   One ml of the prepared sample was added in a sterile screw-capped 
container containing 100 ml of nutrient broth and mixed well. Then, it was allowed 
to stand for 1 hour and mixed well again. After one hour, the screw caps of the 
bottle was loosened and incubated at 37º for 18 to 24 hours. 
Primary Test 
  From the above prepared enrichment culture, 1.0 ml was taken and 
transferred aseptically into a tube containing 10 ml of Selenite F broth. Inoculated 
tubes were incubated in a water-bath at 36º to 38º for 48 hours. After incubation, 
the culture was subcultured on two of the agar media namely Bismuth sulphate 
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agar and Deoxy cholate citrate agar and incubated the plates at 36º to 38º for 18 to 
24 hours. After incubation, colonies were observed on the medium and confirmed 
the genus Salmonella based on guidelines. 
Secondary test 
  The suspected colonies of the primary test were subcultured on the slant of 
triple sugar-iron agar in test tube and in urea broth. Both media were incubated at 
37ºC for 24 hours. After incubation, the results were observed according to the 
development of color change and acid / gas in media. The presence of Salmonella 
was confirmed by agglutination tests. 
Composition of Salmonella Shigella Agar Media 
Beef Extract   :  5.0 gm 
Enzymatic Digest of Casein :  2.5 g  
Enzymatic Digest of Animal Tissue: 2.5 gm  
Lactose   :  10 gm 
Bile salts   :  8.5 gm 
Sodium Citrate  :  8.5 gm 
Ferric Citrate   :  1.0 gm 
Brilliant Green  :  0.00033 gm 
Neutral Red   :  0.025 
Agar    :  13.5 gm 
Distilled water   :  1000 ml 
Isolation and Identification of Pseudomonas aeruginosa 
From the above prepared enrichment culture, 1.0 ml was taken and transferred 
aseptically into 100 ml of fluid soyabean-casein digest medium and mixed well.  The 
inoculated tubes were incubated at 37º C for 24 hours. After incubation, the growth of 
bacteria was checked. From this, a loop full of culture was streaked on the surface of 
Cetrimide agar medium and Pseudomonas Isolation Agar medium and incubated at 
incubated at 37º C for 24 hours. After incubation, the colonies from the agar surface 
of these two media were checked for detection of fluorescein and pyocyanin. 
 Composition of Cetrimide Agar Media 
Pancreatic digest of gelatin   : 20.0 g 
Magnesium chloride    : 1.4 g 
Potassium sulphate    : 10.0 g 
Cetrimide     : 0.3 g 
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Agar      : 13.6 g 
Glycerin     : 10.0 g 
Distilled Water t   : 1000 ml 
Isolation and Identification of Staphylococcus aureus 
From the above prepared enrichment culture, a loop full of culture was taken 
and transferred aseptically on Mannitol salt agar and incubated at 37º C for 24 hours.. 
After incubation, the colonies were subjected to confirmation by hem agglutination 
test.  
Composition of Mannitol Salt Agar Media 
Pancreatic digest of gelatin   : 5.0 g 
Peptic digest of animal tissue  : 5.0 g 
Beef extract     : 1.0 g 
D-Mannitol     : 10.0 g 
Sodium chloride    : 75.0 g 
Agar      : 15.0 g 
Phenol red     : 25 mg 
Distilled Water    : 1000 ml 
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4.2.2.3 BIO CHEMICAL ANALYSIS: 
Preliminary Basic and Acidic radical studies: 
Preparation of the extract: 
 100gms of VENKARA CHUNNAM is weighed accurately and placed into a 
250ml clean beaker and added a few drops of concentration Hydrochloric acid and 
evaporated it well. After conc. nitric acid and evaporated it well. After cooling the 
content add 20ml of distilled water and dissolved it well. Then it is transferred to 
100ml volumetric flask and made up to 100ml with distilled water mix well, filter it. 
Then it is taken for analysis.  
 
QUALITATIVE ANALYSIS FOR BASIC RADICALS: 
Test for Calcium: 
  2ml of the above prepared extract is taken in a clean test tube. To this add 
2ml of 4% Ammonium oxalate solution. Formation of white precipitate indicates the 
presence of calcium. 
Test for Iron (Ferric): 
   The extract is acidified with glacial acetic acid and potassium ferro cyanide. 
Formation of blue colour indicates the presence of ferric iron. 
Test for Iron (Ferrous): 
  The extract is treated with concentrated Nitric acid and ammonium thio-
cyanate solution. Formation of blood red colour indicates the presence of ferrous 
iron.  
Test for Zinc: 
  The extract is treated with potassium ferro-cyanide. Formation of white 
precipitate indicates the presence of zinc. 
 
QUALITATIVE ANALYSIS FOR ACIDIC RADICALS: 
Test for Sulphate: 
  2ml of extract is added to 5% barium chloride solution. Formation of white 
precipitate indicates the presence of sulphate. 
Test for Chloride: 
  The extract is treated with silver nitrate solution. Formation of white 
precipitate indicates the presence of chloride. 
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Test for Phosphate: 
  The extract is treated with ammonium molybdate and concentrated nitricacid. 
Formation of yellow precipitate indicates the presence of phosphate. 
Test for Carbonate: 
  On treating the extract with concentrated hydrochloric acid giving brisk 
effervescence indicates the presence of carbonate. 
Test for starch: 
  The extract is added with weak iodine solution. Formation of blue colour 
indicates the presence of starch. 
Test for albumin: 
  The extract is treated with Esbach`s reagent. Formation of yellow 
precipitate indicates the presence of albumin. 
Test for tannic acid: 
  The extract is treated with ferric chloride. Formation of bluish black 
precipitate indicates the presence of tannicacid 
Test for unsaturation:  
  The extract is treated with potassium permanganate solution. The dis- 
colourization of potassium permanganate indicates the presence of unsaturated 
compounds. 
Test for the reducing sugar: 
  5ml of Benedict`s qualitative solution is taken in a test tube and allowed to  
boil for 2 minutes and added 8-10 drops of the extract and again boil it for 2 
minutes. Any colour change indicates the presence of reducing sugar. 
Test for amino acid: 
  One or two drops of the extract is placed on a filter paper and dried it well. 
After drying, 1% Ninhydrin is sprayed over the same and dried it well. Formation 
of violet colour indicates the presence of amino acid. 
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4.2.2.4. PHYTO CHEMICAL ANALYSIS 
Analysis of Test Drug 
Siddha preparation of Venkara chunnam was prepared and used for 
phytochemical analysis. Preliminary test, on siruneer kalluku kudineer was carried 
out for the presence of alkaloids, carbohydrates, glycosides, phytosterols, saponins, 
tannins, phenolic compounds, proteins and free amino acids, flavonoids, lignin, 
fixed oils and fats. The methods adopted for the estimation are as follows: 
Test for Alkaloids (Evans, 1997): 
A small segment of Venkara chunnam was mixed separately with a  few 
drops of dilute hydrochloric acid and filtered. The filtrates were tested carefully 
with various alkaloidal reagents asfollows: 
Mayer’s test (Evans,1997): 
To a few ml of filtrate, a drop of Mayer’s reagent is added by the side of the 
test tube. A white or creamy precipitate indicates that the test as positive. 
Hager’s test (Wagner et al.,1996): 
To a few ml of filtrate, one to 2ml of Hager’s reagent is added. A prominent 
yellow precipitate indicates the test as positive. 
Dragendorff’s test (Waldi,1965): 
To a few ml of filtrate, one to 2ml of Dragendorff’s reagent is added. A 
prominent yellow precipitate indicates the test as positive. 
Test for Carbohydrates (Ramakrishnan et al., 1994) : 
A small quantity of Venkara chunnam was dissolved separately in 5ml of 
distilled water and filtered. The filtrate was subjected to Molisch’s test to detect the 
presence of carbohydrates. Filtrate was treated with 2-3 drops of 1% alcoholic 
alpha naphthol solution and 2ml of concentrated sulphuric acid was added along 
the sides of the test tube. Appearance of brown ring at the junction of 2 layers 
shows the presence of carbohydrates. 
Test for Glycosides: 
Siddha preparation of Venkara chunnam was hydrolyzed with hydrochloric 
acid for few hour on a water bath and the hydrolysate was subjected to Legal’s and 
Borntrager’s test to detect the presence of different glycosides. 
a)Legal’s Test: 
To the hydrolysate, one ml of pyridine and few drops of sodium nitro 
prusside solution were added and then it was made alkaline with sodium hydroxide 
solution. Appearance of pink to red color shows the presence of glycosides and 
aglycones. 
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(b) Borntrager’s Test: 
Hydrolysate was treated with chloroform and the chloroform layer was 
separated. To this equal quantity of dilute ammonia solution was added. 
Ammoniacal layer acquires pink color, shows the presence of glycosides (Evans, 
1997).  
Test for Phytosterols (Finar, 1986) 
 a)Liebermann Burchard Test:  
Small amount of Venkara chunnam was dissolved with 3ml of acetic 
anhydride, a few drops of glacial acetic acid and followed by the addition of few  
drops of concentrated sulphuric acid. Appearance of bluish green color shows the 
presence ofphytosterols.  
b.Salkowski Test:  
Small quantities of Venkara chunnam were dissolved in chloroform 
separately. This chloroform solution was added with few drops of concentrated 
sulphuric acid. The appearance of bluish green color shows the presence of 
phytosterols 
Test for Saponins (Kokate, 1999) 
Frothing Test:  
Venkara chunnam was diluted separately with 20ml of distilled water and it 
was agitated on a graduated cylinder for 15min. Absence of the foam formation 
shows the devoid of saponins. 
Test for Phenolic Compounds and Tannins (Mace, 1963) :  
Small quantities of Venkara chunnam was dissolved separately  in water and 
tested for the presence of phenolic compound and tannins. In the process of testing 
and treating, the following observations were noted: 
a) Dilute ferric chloride solution (5%) gives a dark greencolor. 
b) 10% aqueous potassium dichromate 
solution gives yellowish brownprecipitate. 
c) 10% lead acetate solution gives a whiteprecipitate. 
Test for Proteins and FreeAminoAcids(Fisher,1968; Ruthmann,1970) 
Small quantities of Venkara chunnam was dissolved in few ml of water and the 
following reaction were carried out 
Millon’s Test:  
 To 2ml of filtrate, few drops of Millon’s reagent were added. A white 
precipitate indicates the presence of proteins (Rasch and Swift,1960). 
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Ninhydrin Test: 
  To 2ml of filtrate 2 drops of ninhydrin solution was added. A 
characteristic purple color indicates the presence of amino acids (Yasma and 
Ichikawa,1953). 
Biuret Test:  
 An aliquot of 2ml of filtrate was treated with a drop of 2% copper sulphate 
solution. To this, 1ml of ethanol (95%) was added, followed by excess of potassium 
hydroxide pellets, Pink color in the ethanol layer indicates the presence of protein 
(Gahan,1984)  
Test for Flavanoids 
Shinoda’s Test:  
 Small quantity of Venkara chunnam was treated with alcohol to that a 
piece of magnesium was added followed by an addition of concentrated 
hydrochloric acid drop wise and heated. Appearance of magenta color shows the 
presence of flavanoids (Harborne,1984). 
Florescence Test:  
 Small quantity of Venkara chunnam was dissolved separately in alcohol 
and a drop of that extract was placed on Whatman filter paper and observed under 
UV light. Florescence indicates the presence offlavanoids. 
Tests for Lignin: 
 Small quantities of Venkara chunnam was dissolved separately in few ml 
of alcoholic solution of hydrochloric acid and phloroglucinol gives red color, which 
shows lignin ispresent. 
Tests for Fixed oils and Fats: 
Spot Test: 
 A small quantity of siruneer kalluku kudineer was placed between 2 filter 
papers. Oil stains produced with any extract shows the presence of fats and fixed   
oils  
SaponificationTest: 
 A small quantity of Venkara chunnam was treated with few drops of 0.5N 
alcoholic potassium hydroxide along with 2 to 3 drops of phenolphthalein. Later the 
mixture is refluxed for about 2h. Soap formation indicates the presence of fats and 
fixed oils. 
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4.2.2.5.INSTRUMENTAL ANALYSIS
1. SEM ( SCANNING ELECTRON  MICROSCOPE )
 
MECHANISM 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction: 
The scanning Electron Microscope is one of the most versatile instruments 
available for the examination and analysis of the micro structural characteristics of 
solid objects. The primary reason for the SEM’s usefulness is the high resolution 
which can be obtained when bulk objects are examined; values of the order of 5nm 
(50degreeA) are usually quoted for commercial instruments. Advanced research 
instruments have been described which have achieved resolutions of about 2.5nm 
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(25 degree A). Any solid material can be studied. Sample size is limited to 
specimens less than about 10µm in diameter 
Principle:  
The beam is then rested over the specimen in synchronism with the beam of 
a cathode ray tube display screen. The elastically scattered secondary electrons are 
emitted from the sample surface and collected by a scintillator, the signal from 
which is used to modulate the brightness of the cathode ray tube. In this way the 
secondary electron emission from the sample is used to form an image on the CRT 
display screen. (Goldstein, et. al., 1992) 
Procedure: 
An electron beam passing through an evacuated column is focused by 
electromagnetic lenses onto the specimen surface. Since an electron is a charged 
particle, it has a strong interaction with the specimen (due to coulomb 
interaction).So when an electron beam images on a specimen, it is scattered by 
atomic layers near the surface of the specimen. As a result, the direction of electron 
motion changes and its energy is partially lost. Once an incident electron (primary 
electron) enters a substance, its direction of motion is influenced by various 
obstructions (multiple scattering), and follows a complicated trajectory which is far 
from a straight line. Also, when electrons with the same energy are incident on the 
specimen surface, a portion of electrons is reflected in the opposite direction (back 
scattered) and the remainder is absorbed by the specimen (exciting X- rays or other 
quanta in the process). If the specimen is sufficiently thin, the electron can pass all 
the way through the specimen (transmitted electrons, scattered or non-scattered). 
The depth at which various signals are generated due to electron beam – specimen 
interaction indicates the diffusion area of the signals in the specimen in addition to 
the local chemistry of the specimen. Secondary electrons mainly indicate 
information about the surface of a specimen. Since secondary electrons do not 
diffuse much inside the specimen, they are most suitable for observing the fine-
structures of the specimen surface. That is to say, sharp scanning images with high 
resolution can be expected from secondary electrons, because of the smaller 
influence on resolution by their diffusion.  
As the incident electron energy increases, the probability of incident 
electrons Colliding with elemental components of the specimen and releasing 
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secondary electrons also increases. In other words, as the incident energy increases, 
the emission of electrons from the specimen also increases. However, as the energy 
increases beyond a certain level, the incident electrons penetrate deeper into the 
specimen with the result that the specimen derived electrons use up most of their 
energy to reach the specimen surface. Consequently, the electron emission yield 
decreases. Therefore, the peak secondary electron emission yield occurs at a 
specific entry level of the incident electrons. 
In order to verify the existence of a substance and recognize its shape, the 
image contrast must be well defined. In other words, even if a system boasts 
extremely high resolution, if image contrast is poor, it would be extremely difficult 
to determine the existence of a substance, let alone recognize its shape. Another 
important feature of the SEM is the three-dimensional appearance of the specimen 
image, which is a direct result of the large depth of field.  
Applications: 
 The SEM is capable of examining objects at very low magnification. This 
feature is useful in viewing particle size and shape of any composition at various 
stages of preparation in Siddha system as well as other fields. The large depth of 
field available in the SEM makes it possible to observe 3-dimensional objects in 
stereo. Today, a majority of SEM facilities are equipped with X-ray analytical 
capabilities. Thus topographic crystallographic and compositional information can 
be obtained rapidly, efficiently and simultaneously from the same area. 
 The author was chosen this analysis for detecting Particle size of the 
classical Siddha herbo mineral drug VENKARA CHUNNAM. SEM results of 
VENKARA CHUNNAM were represented in results section. 
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2. FT-IR (Fourier Transform Infrared Spectroscopy) 
 
FTIR INSTRUMENT 
 
Introduction: 
 Vibrational spectroscopy is an extremely useful tool in the elucidations of 
molecular structure. The spectral bands can be assigned to different vibrational 
modes of the molecule. The various functional groups present in the molecule can 
be assigned by a comparison of the spectra with characteristic functional group 
frequencies. As the positions of the bands are directly related to the strength of the 
chemical bond, a large number of investigations including intermolecular 
interactions, phase transitions and chemical kinetics can be carried out using this 
branch of spectroscopy. In IR spectroscopy, the resonance absorption is made 
possible by the change in dipole moment accompanying the vibrational transition. 
The Infrared spectrum originates from the vibrational motion of the molecule. The 
vibrational frequencies are a kind of fingerprint of the compounds. This property is 
used for characterization of organic, inorganic and biological compounds. The 
band intensities are proportional to the concentration of the compound and hence 
qualitative estimations are possible. The IR spectroscopy is carried out by using 
Fourier transform technique.  
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Principle: 
Infra-red spectroscopy involves study of the interaction of electromagnetic 
radiation with matter. Due to this interaction, electromagnetic radiation 
characteristic of the interacting system may be absorbed (or emitted). The 
experimental data consist of the nature (frequency of wave length) and the amount 
(intensity) of the characteristic radiation absorbed or emitted. These data are 
correlated with the molecular and electronic structure of the substance and with 
intra- and inter molecular interactions. 
Source   : Nernst Glower 
Beam splitter  :  It is made up of a transparent material.  
Thin films of Silicon deposited on Potassium 
bromide (KBr)   
Bromide (KBr) Detectors:   Deutrated TriGlycine Sulphate (DTGS). 
Scan Range  :  MIR 450to 4000 cm-1 
Resolution  :   4.0 cm- 1 
Sample required : 50mg, solid or liquid 
Sampling Techniques: There are a variety of techniques for sample 
preparation physical form of the sample to be 
analyzed. 
Solid   : KBr or Nujol mull method. 
Liquid   : Csl / TIBr Cells 
Gas   : Gas cells 
Measurements Techniques: 
The procedure for recording the %T or %A is as follows: 
• Air is first scanned for the reference and stored. The sample is then 
recorded and finally the ratio of the sample and reference data is computed 
to give required %T     or %A at various frequencies. 
• Study of substances with strong absorbance bands and weak absorbance 
bands as well as possible. 
• Small amount of samples are sufficient 
• High resolution is obtained. 
Procedure: 
• Typically, 1.5 mg of protein, dissolved in the buffer used for its 
purification were centrifuged in a 30 K Centric on micro concentrator 
(Amicon) at 3000_g at 4oC until a volume of approximately 40 Al. 
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• Then, 300 Al of 20 mm buffer, prepared in H20 or 2H20, pH or p2H 7.2, 
were added and the sample concentrated again. The p2H value 
corresponds to the Ph meter reading + 0.4. The concentration and 
dilution procedure was repeated several times in order to completely 
replace the original buffer with the Tris buffer. 
• The washings took 24 h, which is the time of contact of the protein with 
the 2H20 medium prior FT-IR analysis. In the last washing, the protein 
was concentrated to fine a volume of approximately 40 Al and used for 
the infrared measurements. 
• The concentrated protein sample was placed in CaF2 windows and a 6 
Am tin spacer or a 25 Am Teflon spacer for the experiments in H20 or 
2H20, respectively. FT-IR spectra were recorded by means of a Perkin-
Elmer -Spectrum-1 FT-IR spectrometer using a deuterated 
triglycinesulfate detector. 
1. At least 24 h before, and during data acquisition, the spectrometer were 
continuously purged with dry air at a dew point of 40oC. Spectra of buffers and 
samples were acquired at 2 cm_1 resolution under the same scanning and 
temperature conditions. In the thermal denaturation experiments, the 
temperature was raised in 5oC steps from 20 to 95oC. 
2. Before spectrum acquisition, samples were maintained at the desired 
temperature for the time necessary for the stabilization of temperature inside 
the cell (6 min).Spectra were collected and processed using the SPECTRUM 
software from Perkin-Elmer. Correct subtraction of H20 was judged to yield an 
approximately flat baseline at 1900-1400 cm_ 1, and subtraction of 2H20 was 
adjusted to the removal of the2H20 bending absorption close to 1220 cm. 
KBr Method 
1. The sample is grounded using an agate mortar and pestle to give a very fine 
powder. 
2. The finely powder sample is then mixed with about 100mg dried KBr salt. 
3. The mixture is then pressed under hydraulic press using a die to yield a 
transparent disc and measure about 13mm diameter and 0.3mm in 
thickness. 
Nujol Mull Method: 
1. The sample is ground using an agate mortar and pestle to give a very fine 
powder. 
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2. A small amount is then mixed with nujol oil to give a paste and this paste is 
then applied between two sodium chloride plates. 
3. The plates are then placed in the instrument sample holder ready for 
scanning. 
Liquids: 
1. Viscous liquids can be smeared in the cell and directly measured. 
2. For dilute solutions, liquid cells and variable path length cells are 
employed. 
Applications: 
   Infrared spectrum is useful in identifying the functional groups like -OH, -
CN, -CO, -CH, -NH2, etc. Also quantitative estimation is possible in certain cases 
for chemicals, pharmaceuticals, petroleum products, etc. Resins from industries, 
water and rubber samples can be analyzed.  
 
Mechanism of FTIR analyzer 
Analytical Capabilities: 
1. Identifies chemical bond functional groups by the absorption of infrared 
radiation which excites vibrational modes in the bond. 
2. Especially capable of identifying the chemical bonds of organic materials  
3. Detects and identifies organic contaminants. 
4. Identifies water, phosphates, sulphates, nitrates, nitrites, and ammonium 
ions  
5. Detection limits vary greatly, but are sometimes <1013 bonds/cm3 or 
sometimes sub monolayer .Useful with solids, liquids, or gases. 
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3. ICP-OES (INDUCTIVELY COUPLED PLASMA OPTIC EMISSION 
SPECTROMETRY) 
 
ICP-OES (INDUCTIVELY COUPLED PLASMA OPTIC EMISSION 
SPECTROMETRY) 
Manufacturer : Perkin Elmer 
Model    :   Optima 5300 DV ICP-OES Inductively Coupled Plasma  
   Spectrometer (ICP) 
Principle : 
 An aqueous sample is converted to aerosols via a nebulizer. The aerosols 
are transported to the inductively coupled plasma which is a high temperature zone 
(8,000– 10,000ºC). The analysts are heated (excited)to different (atomic and/or 
ionic) states and produce characteristic optical emissions (lights). These releases 
are separated based on their respective wavelengths and their strengths are 
measured (spectrometry). The intensities are proportional to the concentrations of 
analyses in the aqueous sample. The quantification is an external multipoint linear 
standardization by comparing the emission intensity of an unknown sample with 
that of a standard sample. Multi-element calibration standard solutions are prepared 
from single- and multi element primary standard solutions. With respect to other 
kinds of analysis where chemical speciation is relevant (such as the concentration 
of ferrous iron or ferric iron), only total essential concentration is analysed by ICP-
OES. 
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Application: 
The analysis of major and minor elements in solution samples 
Objectives: 
a) Determine elemental concentrations of different metals. 
b) Learn principles and operation of the ICP-OES instrument 
c) Develop and put on a method for the ICP-OES sample analysis 
d) Enhance the instrumental conditions for the analysis of different elements 
e) probes the outer electronic structure of atoms  
Mechanism:  
In plasma emission spectroscopy (OES), a sample solution is presented into 
the core of inductively coupled argon plasma (ICP), which generates temperature 
of approximately 8000°C. At this temperature all elements become thermally 
excited and emit light at their characteristic wavelengths. This light is collected by 
the spectrometer and passes through a diffraction grating that serves to resolve the 
light into a spectrum of its essential wavelengths. Within the spectrometer, this 
deflected light is then collected by wavelength and amplified to yield an strength of  
measurement that can be converted to an elemental concentration by comparison 
with standardization values. The Inductively Coupled Plasma Optical Emission 
Spectrometric (ICP-OES) analysis was done in Saif, IIT Madras, and Chennai-36 
using Perkin Elmer Optima 5300 DV. 
Sample preparation: 
Inductively Coupled Plasma Spectroscopy techniques are the so-called 
"wet" sampling methods whereby samples are introduced in liquid form for 
analysis. 
100 mg “VENKARA CHUNNAM”was occupied in a clean, dry test tube. To 
this, 3 ml Nitric acid was added and mixed well and allowedfor few minutes untill 
the reactions were completed. And then, 25 ml of Refined water, was added to 
prepare digested solution.  
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4. X-RAY POWDER DIFFRACTION 
  X-ray powder diffraction (XRD) is a rapid analytical technique primarily 
used for phase identification of a crystalline material and can provide information 
on unit cell dimensions. The analyzed material is finely ground, homogenized, and 
average bulk composition is determined. Max von Laue, in 1912, discovered that 
crystalline substances act as three-dimensional diffraction gratings for X-ray 
wavelengths similar to the spacing of planes in a crystal lattice. X-ray diffraction is 
now a common technique for the study of crystal structures and atomic spacing. 
  X-ray diffraction is based on constructive interference of monochromatic 
X- rays and a crystalline sample. These X-rays are generated by a cathode ray tube, 
filtered to produce monochromatic radiation, collimated to concentrate, and 
directed toward the sample. The interaction of the incident rays with the sample 
produces constructive interference (and a diffracted ray) when conditions satisfy 
Bragg's Law (nX=2d sin 9). This law relates the wavelength of electromagnetic 
radiation to the diffraction angle and the lattice spacing in a crystalline sample. 
These diffracted X- rays are then detected, processed and counted. By scanning the 
sample through a range of 29angles, all possible diffraction directions of the lattice 
should be attained due to the random orientation of the powdered material. 
Conversion of the diffraction peaks to d-spacing’s allows identification of the 
mineral because each mineral has a set of unique d-spacing’s. Typically, this is 
achieved by comparison of d-spacing’s with standard reference patterns. 
  All diffraction methods are based on generation of X-rays in an X-ray tube. 
These X-rays are directed at the sample, and the diffracted rays are collected. A 
key component of all diffraction is the angle between the incident and diffracted 
rays. Powder and single crystal diffraction vary in instrumentation beyond this. 
X-ray Powder Diffraction (XRD) Instrumentation 
  X-ray diffractometers consist of three basic elements: an X-ray tube, a 
sample holder, and an X-ray detector. 
  X-rays are generated in a cathode ray tube by heating a filament to produce 
electrons, accelerating the electrons toward a target by applying a voltage, and 
bombarding the target material with electrons. When electrons have sufficient 
energy to dislodge inner shell electrons of the target material, characteristic X-ray 
spectra are produced. These spectra consist of several components, the most 
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common being Ka and Kp. Ka consists, in part, of Ka1 and Ka2. Ka1 has a slightly 
shorter wavelength and twice the intensity as Ka2. The specific wavelengths are 
characteristic of the target material (Cu, Fe, Cr ). Filtering, by foils or crystal 
monochrometers, is required to produce monochromatic X-rays needed for 
diffraction. Ka1 and Ka2 are sufficiently close in wavelength such that a weighted 
average of the two is used. Copper is the most common target material for single-
crystal diffraction, with CuKa radiation = 1.5418A. These X-rays are collimated 
and directed onto the sample. As the sample and detector are rotated, the intensity 
of the reflected X-rays is recorded. When the geometry of the incident X-rays 
impinging the sample satisfies the Bragg Equation, constructive interference occurs 
and a peak in intensity occurs. A detector records and processes this X-ray signal 
and converts the signal to a count rate which is then output to a device such as a 
printer or computer monitor. 
  The geometry of an X-ray diffractometer is such that the sample rotates in 
the path of the collimated X-ray beam at an angle 9 while the X-ray detector is 
mounted on an arm to collect the diffracted X-rays and rotates at an angle of 29. 
The instrument used to maintain the angle and rotate the sample is termed a 
goniometer. For typical powder patterns, data is collected at 29 from ~5° to 70°, 
angles that are present in the X-ray scan. 
Applications 
  X-ray powder diffraction is most widely used for the identification of 
unknown crystalline materials (e.g. minerals, inorganic compounds). 
Determination of unknown solids is critical to studies in geology, environmental 
science, material science, engineering and biology. 
Other applications include: 
1. characterisation of crystalline materials 
2. identification of fine-grained minerals such as clays and mixed layer clays 
that are difficult to determine optically 
3. determination of unit cell dimensions 
4. measurement of sample purity 
With specialized techniques, XRD can be used to: 
1. determine crystal structures using Rietveld refinement 
2. determine of modal amounts of minerals (quantitative analysis) 
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3. characterize thin films samples by: 
4. determining lattice mismatch between film and substrate and to inferring 
stress and strain 
5. determining dislocation density and quality of the film by rocking curve 
measurements 
6. measuring superlattices in multilayered epitaxial structures 
7. determining the thickness, roughness and density of the film using glancing 
incidence X-ray reflectivity measurements 
8. make textural measurements, such as the orientation of grains, in a 
polycrystalline sample 
Strengths and Limitations of X-ray Powder Diffraction (XRD) 
Strengths 
1. Powerful and rapid (< 20 min) technique for identification of an unknown 
mineral 
2. In most cases, it provides an unambiguous mineral determination 
3. Minimal sample preparation is required 
4. XRD units are widely available 
5. Data interpretation is relatively straight forward 
Limitations 
1. Homogeneous and single phase material is best for identification of an 
unknown 
2. Must have access to a standard reference file of inorganic compounds (d- 
spacings, hkls) 
3. Requires tenths of a gram of material which must be ground into a powder 
4. For mixed materials, detection limit is ~ 2% of sample 
5. For unit cell determinations, indexing of patterns for non-isometric crystal 
systems is complicated 
6. Peak overlay may occur and worsens for high angle 'reflections' 
7. User's Guide - Sample Collection and Preparation 
8. Determination of an unknown requires: the material, an instrument for 
grinding, and a sample holder. 
9. Obtain a few tenths of a gram (or more) of the material, as pure as possible 
Grind the sample to a fine powder, typically in a fluid to minimize inducing 
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extra strain (surface energy) that can offset peak positions, and to 
randomize orientation. Powder less than ~10 ^m(or 200-mesh) in size is 
preferred 
10. Place into a sample holder or onto the sample surface 
11. Packing of fine powder into a sample holder. 
12. Smear uniformly onto a glass slide, assuring a flat upper surface 
13. Pack into a sample container 
14. Sprinkle on double sticky tape 
15. Typically the substrate is amorphous to avoid interference 
16. Care must be taken to create a flat upper surface and to achieve a random 
distribution of lattice orientations unless creating an oriented smear. 
17. For analysis of clays which require a single orientation, specialized 
techniques for preparation of clay samples are given by usages. 
18. For unit cell determinations, a small amount of a standard with known peak 
19. positions (that do not interfere with the sample) can be added and used to 
20. Correct peak positions. 
Data Collection, Results and Presentation 
  Data Collection The intensity of diffracted X-rays is continuously recorded 
as the sample and detector rotate through their respective angles. A peak in 
intensity occurs when the mineral contains lattice planes with d-spacings 
appropriate to diffract X-rays at that value of 9. Although each peak consists of two 
separate reflections (Ka1 and Ka2), at small values of 29 the peak locations overlap 
with Ka2 appearing as a hump on the side of Ka1. Greater separation occurs at 
higher values of 9. Typically these combined peaks are treated as one. The 21 
position of the diffraction peak is typically measured as the center of the peak at 
80% peak height. 
Data Reduction 
  Results are commonly presented as peak positions at 29 and X-ray counts 
(intensity) in the form of a table or an x-y plot. Intensity (I) is either reported as 
peak height intensity, that intensity above background, or as integrated intensity, 
the area under the peak. The relative intensity is recorded as the ratio of the peak 
intensity to that of the most intense peak (relative intensity = I/I1 x 100 ). 
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Determination of an Unknown 
  The d-spacing of each peak is then obtained by solution of the Bragg 
equation for the appropriate value of 1. Once all d-spacings have been determined, 
automated search/match routines compare the ds of the unknown to those of known 
materials. Because each mineral has a unique set of d-spacings, matching these d-
spacings provides an identification of the unknown sample. A systematic procedure 
is used by ordering the d-spacings in terms of their intensity beginning with the 
most intense peak. Files of d-spacings for hundreds of thousands of inorganic 
compounds are available from the International Centre for Diffraction Data as the 
Powder Diffraction File (PDF). Many other sites contain d-spacings of minerals 
such as the American Mineralogist Crystal Structure Database. Commonly this 
information is an integral portion of the software that comes with the 
instrumentation. 
  
 
 
 
POWDER X-RAY DIFFRACTO METER 
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4.3 TOXICOLOGICAL STUDIES 
4.3.1 ACUTE TOXICITY STUDY OF VC IN FEMALE WISTAR ALBINO 
RATS. 
The aim of this Study is to evaluate the toxicity of the test substance VENKARA 
CHUNNAM, when administered orally to Female Wistar albino Rats with different 
doses, so as to provide a rational base for the evaluation of the toxicological risk to 
man and indicate potential target organs. 
Guidelines followed: 
OECD Guidelines No 423. (Organization for Economic Cooperation and   
Development) 
Study Design and Controls: 
1. Female Wistar albino Rats in controlled age and body weight were selected. 
2. The test drug VC was administered at 5 mg/kg, 10 mg/kg, 300 mg/kg, 1000 
mg/kg, and 2000 mg/kg body weight of animal as suspension along with 
water. 
3. The results were recorded on day 0, with single oral dosing period of 14 
days.  
EXPERIMENTAL PROCEDURE 
1. ANIMALS  
Supply 
A total of 15 Female Wistar albino Rats with an approximate age of 6 
weeks and purchased from Trivandrum medical college, Trivandrum. On their 
arrival a sample of animals was chosen at random and weighed to ensure 
compliance with the age requested. The mean weights of Female Wistar Rats were 
100-150 g respectively.  The animals were housed in metabolic cages (55 x 32.7 x 
19 cm), with sawdust litter, in such a way that each cage contained a maximum of 
3 animals of the same sex. 
All animals underwent a period of 20 days of observation and 
acclimatization between the date of arrival and the start of treatment. During the 
course of this period, the animals were inspected by a veterinary surgeon to ensure 
that they fulfilled the health requirements necessary for initiation of the Study. 
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Housing 
The Female Wistar albino Rats were housed in metabolic cages (55 x 32.7 x 
19 cm), placed on racks. From the week before initiation of the treatment, each 
cage contained a maximum of 3 rats of the same sex and treatment group. 
Each cage was identified by a card, color coded according to the dose level. 
This card stated the cage number, number and sex of the animals it contained, 
Study number, test substance code, administration route, dose level and Study 
Director's name, date of the arrival of the animals and initiation of treatment. 
The temperature and relative humidity were continuously monitored. 
Lighting was controlled to supply 12 hours of light (7:00 to 19:00 hours) and 12 
hours of dark for each 24-hour period. 
The cages corresponding to each experimental group were distributed on 
racks in such a manner that external factors, such as environmental conditions, 
were balanced as far as possible. 
2. DIET 
All the rats had free access to a pelleted rat diet. The diet was analyzed by 
the   manufacturer to check its composition and to detect possible contaminants. 
Water 
The water was offered adlibitum in bottles.  
 
3. ADMINISTRATION ROUTE AND PROCEDURE 
The test substance was administered orally. The Female Wistar albino Rats 
belonging to the control group were treated with the vehicle (Water) at the same 
administration volume as the rest of the treatment groups. 
a) Numbering and Identification 
The animals were marked on body with picric acid solution prepared in 
water. The marking within the cage was as below. 
Numbering and Identification 
Group No Animal Marking 
1 Head 
2 Body 
3 Tail 
The group no., cage no., sex of the animal and animal no. were identified as 
indicated below using cage label and body marking on the animals 
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Numbering and Identification 
 
b)  Doses 
The doses for the study were selected based on literature search and range 
finding study. Following the period of fasting, the animals were weighed and then 
drug was administered orally as single dose using a needle fitted onto a disposable 
syringe of approximate size at the following different doses. 
                                             Table no - 2    Doses 
GROUP DOSE 
Group-I 5  mg/kg 
Group-II 50  mg/kg 
Group-III 300  mg/kg 
Group-IV 1000  mg/kg 
Group-V 2000  mg/kg 
The test item was administered as single dose. After single dose 
administration period, all animals were observed for 14days. 
Dose Preparation 
VC was added in distilled water and completely dissolved to form oral for 
administration. The dose was prepared of a required concentration before dosing by 
dissolving, in distilled water. It was mixed well. The preparation for different doses 
was vary in concentrations to allow a constant dosage volume. 
c)  Administration 
The test item was administered orally to each Female Wistar rats as single 
dose using a needle fitted onto a disposable syringe of appropriate size at the 
Cage No Group No 
Animal 
Marking 
Sex 
1 I H,B,T Female 
2 II H,B,T Female 
3 III H,B,T Female 
4 IV H,B,T Female 
5 V H,B,T Female 
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following different doses. The concentration was adjusted according to its body 
weight. The volume was not exceeding 10 ml/kg bodyweight. Variability in test 
volume was minimized by adjusting the concentration to ensure a constant volume 
at all dose levels. 
d) Observation period 
All animals were observed for any abnormal clinical signs and behavioral 
changes. The appearance, change and disappearance of these clinical signs, if any, 
were recorded for approximately 1.0, 3.0 and 4.0 hours post-dose on day of dosing 
and once daily thereafter for14 days. Animals in pain or showing severe signs of 
distress were humanely killed. The cageside observation was included changes in 
skin, fur, eyes and mucous membranes, occurrence of secretions and excretions. 
Autonomic activity like lacrimation,  piloerection, pupil size and unusual 
respiratory pattern, changes in gait, posture, response to handling, presence of 
clonic or tonic movements, stereotypes like excessive grooming and repetitive 
circling or bizarre behavior like self-mutilation, walking backwards etc were 
observed. At the 14th day, sensory reactivity to stimuli of different types (e.g. 
auditory, visual and proprioceptive stimuli) was conducted. Auditory stimuli 
responses were measured by clicker sound from approximately 30 cm to the rats; 
visual stimuli response were measured with the help of shining pen light in the eye 
of rats and placing a blunt object near to the eye of rats. Response to proprioceptive 
stimuli was measured by placing anterior/dorsal surface of animals paw to the table 
edge. The responses of reactions for these three exercises were normal in animals 
belonging to both the controls as well as drug treatment dose groups. 
4.  Mortality and Morbidity 
  All animals were observed daily once for mortality and morbidity at 
approximately 1.0, 3.0 and 4.0 hours post dose on day of dosing and twice daily 
(morning and afternoon) thereafter for 14 days. 
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4.3.2 SUB-ACUTE TOXICITY STUDY IN WISTAR RATS TO EVALUATE 
TOXICITY PROFILE OF VENKARA CHUNNAM (VC) 
1. Objective 
The objective of this ‘Sub-Acute Toxicity Study of VC on Wistar Rats’ was 
to assess the toxicological profile of the test item when treated as a single dose 
daily. Animals should be observed for 28 days after the drug administration. This 
study provides information on the possible health hazards likely to arise from 
exposure over a relatively limited period of time.  
2. Test Guideline Followed 
OECD (Organization for Economic Cooperation and Development) 407 
Method - Sub-Acute Toxic Class Method (Repeated Dose 28-Day Oral Toxicity 
Study in Rodents) 
3. Test Item Detail 
Name: VENKARA CHUNNAM 
4. Test System Detail 
The study was conducted on 5 male 5 female Wistar rats for each group. 
These   animals were selected because of the recommended rodent species for oral 
studies as per followed guideline and availability of Animals 8-12 weeks old male 
and female rats were selected after physical and behavioral examination. The body 
weight range was fallen within ± 20% of the mean body weight at the time of 
Randomization and grouping. The rats were housed in standard laboratory 
condition in Polypropylene cages, provided with food and water adlibitum in the 
Animal at Arulmigu Kalasalingam College, Krishnankoil. The experimental 
protocol was approved by Institutional Animal Ethical Committee as per the 
guidance of Committee for the Purpose of Control and Supervision of Experiments 
on Animals (CPCSEA), Ministry of Environment and Forest, government of India. 
5.  Acclimatization 
The animals were selected after veterinary examination by the veterinarian. 
All the selected animals were kept under acclimatization for a week. 
6. Randomization& grouping 
 One day before the initiation of treatment (days 0- last day of 
acclimatization), the selected animals were randomly grouped into three different 
groups containing minimum 5 male and 5 female animals per group.  
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7. Numbering and Identification 
  The animals were marked on body with picric acid solution prepared in 
water. The marking within the cage was as below. 
Table no – 3 Numbering and Identification acute 
Group No 
( CONCENTRATION/ DOSE) Animal Marking 
1. CONTROL 
H,B,T,HB,NM (MALE) 
H,B,T,HB,NM (FEMALE) 
2. LOW DOSEOF  VC2ml/kg 
H,B,T,HB,NM (MALE) 
H,B,T,HB,NM (FEMALE) 
3. MIDDLEDOSEOF VC5ml/kg 
H,B,T,HB,NM (MALE) 
H,B,T,HB,NM (FEMALE) 
4. HIGH DOSEOF  VC10ml/kg 
H,B,T,HB,NM (MALE) 
H,B,T,HB,NM (FEMALE) 
 
Numbering and Identification 
The group  no., cage no., sex of the animal and animal no. were identified  
as indicated below  using cage  label and body marking on the animals: 
Table no – 4  Numbering and Identification subacute 
 
  
Cage 
No 
Group No 
CONCENTRATION/ 
DOSE 
Animal 
Marking 
Sex 
No 
of 
rats 
1 CONTROL 
H,B,T,HB,NM 
H,B,T,HB, NM 
Male 
Female 
5 
5 
2 LOW DOSE OF  VC 2ml/kg 
H,B,T,HB,NM 
H,B,T,HB,NM 
Male 
Female 
5 
5 
3 
MIDDLEDOSE OF VC 
5ml/kg 
H,B,T,HB,NM 
H,B,T,HB, NM 
Male 
Female 
5 
5 
4 
HIGH DOSE OF  VC 
10ml/kg 
H,B,T,HB,NM 
H,B,T,HB ,NM 
Male 
Female 
5 
5 
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8. Husbandry 
8.1 Housing 
The Wistar rats were housed in standard polypropylene cages with stainless 
steel top grill. Paddy husk was used as bedding. The paddy husk was changed at 
least twice in a week. From the week before initiation of the treatment, each cage 
contained a maximum of 10 rat of the different sex and treatment group. 
8.2 Environmental conditions 
The animals were kept in a clean environment with 12 hour light and 12 
hour dark cycles. The air was conditioned at 22±30C and the relative humidity was 
maintained between 30-70% with 100% exhaust facility. The cages corresponding 
to each experimental group were distributed on racks in such a manner that external 
factors, such as environmental conditions, were balanced as far as possible. 
8.3 Feed & feeding schedule 
Arulmigu Kalasalingam College of Pharmacy Krishnankoil. Feed was 
provided adlibitum throughout the study period, except overnight fasting (18-20 
hours) prior to dose administration. After the substance has been administered, 
food was withheld for a further 3-4 hours. 
8.4 Water 
The water was offered adlibitum in bottles. There was periodically analyzed 
to detect the presence of possible contaminants 
8.5 Doses 
The doses for the study were selected based on literature search and range 
finding study. Following the period of fasting, the animals were weighed and then 
extract was administered orally as single dose using a needle fitted on to a 
disposable syringe of approximate size at the following different doses. 
The test item was administered as single dose daily. After single dose 
administration period, all animals were observed for 28 days. 
Dose Preparation 
VC was added in distilled water and completely dissolved for oral 
administration. The dose was prepared of a required concentration before dosing by 
dissolving VC in distilled water. It was mixed well. The preparation for different 
doses was vary in concentrations to allow a constant dosage volume. 
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8.6 Administration 
The test item was administered orally to each rat as single dose using a 
needle fitted on to a disposable syringe of appropriate size at the following 
different doses. The concentration was adjusted according to its body weight. The 
volume was not exceeding 10 ml/kg body weight. Variability in test volume was 
minimized by adjusting the concentration to ensure a constant volume at all dose 
levels. 
9. OBSERVATIONS  
These observations were also performed on week-ends. The observations 
included but were not limited to changes in skin and fur, in the eyes and mucous 
membranes, in the respiratory, circulatory, central nervous and autonomous 
systems, somatomotor activity and behavior. 
9.1. Clinical signs of toxicity  
All the rats were observed at least twice daily with the purpose of recording 
any symptoms of ill- health or behavioral changes. Clinical signs of toxicity daily 
for 28 days. 
9.2. Food intake  
Prior to the beginning of treatment, and daily, the food intake of each cage 
was recorded for period of 28 days and the mean weekly intake per rats was 
calculated. 
9.3. Water intake 
Water intake was checked by visual observation during the Study. In 
addition, the water consumption in each cage was measured daily for a period of 28 
days. 
9.4 Bodyweight: 
The body weight of each rat was recorded one week before the start of 
treatment, and during the course of the treatment on the day of initial, 3rd, 7th, 
10th, 14th, 17th, 20th, 24th and 28th days (day of sacrifice). The mean weights for 
the different groups and sexes were calculated from the individual weights. 
Blood Collection:  
Blood was collected through retro-orbital sinus from all the animals of 
different groups on 28th day. The blood was collected in tubes containing 
  
  
   90 PRE CLINICAL  STUDY OF  VENKARA CHUNNAM 
Heparin/EDTA as an anticoagulant. Animals were fasted over night prior to the 
blood collection. 
LABORATORY STUDIES  
During the 4th week of treatment, samples of blood were withdrawn from 
the orbital sinus of 6 rats from each group, under light ether anesthesia after fasting 
for 16 hours. The blood samples are used to evaluate Hematological   parameters 
like RBC, WBC, and PLATELETS etc….. The collected blood samples also 
centrifuged 10000 rpm in 10 minutes to separate the serum. The separated serum 
used to evaluate biochemical parameters like SGOT, SGPT, ALP and BILIRUBIN 
etc……... 
Hematology  
The following hematological parameters were analysed using Autoanalyser  
Hb  : Haemoglobin (g %)  
PCV   : Packed Cell Volume 
WBC  : White Blood Corpuscles (x10³/cmm)  
RBC  : Red Blood Corpuscles (x10⁶/cmm)  
Blood Platelet count :(x10³/cmm)  
Differential WBC count:  
N  : Neutrophils (%)  
L  : Lymphocytes (%)  
M  : Monocytes (%)  
E  : Eosinophils (%)  
RDW  : Red Cell Distribution Width. 
MPV  : Mean Platelet Volume 
Clinical Biochemistry:  
The following clinical Bio parameters were analysed using Auto analyser  
Total serum protein (g/dl)  
ALT/SGPT  : Alanine amino transferase (U/L)  
AST/SGOT  : Aspartate amino transferase (U/L)  
ALP    : Alkaline serum phosphatase (U/L)  
CHL    : Cholesterol (mg/dL)  
HDL    : High density lipoprotein 
TG    : Triglyceride 
  
  
   91 PRE CLINICAL  STUDY OF  VENKARA CHUNNAM 
TERMINAL STUDIES  
Sacrifice and macroscopic examination 
On completion of the 4 weeks of treatment, 18 Wister rats were sacrificed 
by ether inhalation. A full autopsy was performed on all animals which included 
examination of the external surface of the body, all orifices, cranial, thoracic and 
abdominal cavities and their contents both in situ and after evisceration. As the 
number of animals exceeded the number that could be sacrificed in one day, the 
autopsies were carried out over three consecutive days at the end of the treatment 
period.  
Organ weights: 
            After the macroscopic examination the following organs were weighed after 
separating the superficial fat: Brain, Heart, Spleen Kidneys, Testes, Liver, Lungs, 
pancreas and stomach. 
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4.4 PHARMACOLOGICAL STUDY 
4.4.1 LITHOTRIPTIC ACTIVITY 
EVALUATION OF LITHOTRIPTIC (ANTILITHIATIC) EFFECT OF VC 
ON 1% ETHYLENE GLYCOL INDUCED LITHIASIS IN ALBINO RATS 
AIM:   
Aim of the study is to evaluate the lithotriptic activity of venkara chunnan 
in male Wistar albino rats. 
Materials and methods 
Animal selection 
Wistar albino rat of either sex weigthing between 25 and 30g were selected 
and healthy adult male Wistar albino rats weigthing between 150 and 200g were 
selected for the antiurolithiatic activity. The animals were acclimatized to standard 
laboratory conditions (temperature: 25±2°C) and maintained on 12-h light: 12-h 
dark cycle. They were provided with regular rat chow (Lipton India Ltd., Mumbai, 
India) and ad libitum. The animal care and experimental protocols were in 
accordance with Institutional Animal Ethical Committee (IAEC). 
Ethylene glycol induced urolithiasis model 
Ethylene glycol induced hyperoxaluria model was used to assess the 
antilithiatic activity in albino rats. Animals were divided into five groups 
containing six animals in each. 
TREATMENT PROTOCOL 
The grouped animal’s received the treatment as follows 
Group I Received normal diet and served as controls. 
Group II Lithiatic control:  The animals were given normal diet     
   and 1% Ethylene glycol in drinking water for 28 days.                              
Group III Received 1% Ethylene glycol in drinking water and then 
treated with cystoneat a dose of 100mg/kg orally for 28 days.   
Group IV       Received 1% ethylene glycol in drinking water and then 
treated with VC at a dose of 200 mg/kg orally for 28 days  
Group V       Received 1% Ethylene glycol in drinking water and then 
treated with VC at a dose of 400mg/kg  orally for 28 days.   
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Collection and analysis of urine 
All animals were kept in individual metabolic cages and 24 h urine samples 
were collected on 14th, and 28th day of calculi induction treatment. The volume 
and calcium content of urine were measured. Calcium in urine was estimated using 
kit by “COBAS MIRA PLUS” auto analyzer. Urine was analyzed for oxalate, 
magnesium, phosphate, uric acid, citrate and total protein. 
Serum analysis 
The blood was collected from the retro-orbital sinus under anesthetic 
condition and serum was separated by centrifugation at 10,000g for 10 min and 
analyzed for creatinine and uric acid. The creatinine kit (Reckon Diagnostics Pvt. 
Ltd., India) and uric acid diagnostic kit (Span Diagnostics Ltd., India) were used to 
estimate serum creatinine and uric acid levels respectively. 
Statistical analysis 
The results were expressed as mean ± standard error mean (SEM). The 
statistical significance was assessed using one-way analysis of variance (ANOVA) 
followed by Newmann keul’s multiple range tests and p < 0.05 was considered 
significant. 
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4.4.2 DIURETIC ACTIVITY 
EVALUATION OF DIURETIC ACTIVITY EFFECT OF VC ON MALE 
ALBINO RATS (LIPSCHITS ET AL METHOD) 
AIM: 
 Aim of the study is to evaluate the diuretic activity of venkara chunnan in 
male Wistar albino rats 
Material and Methods 
Experimental animals  
Healthy male albino rats weighing 180-200 g were used for the study. The 
animals were maintained in polypropylene cages of standard dimensions at a 
temperature of 37 ± 1°C and standard 12h : 12h day/night rhythm. The animals 
were fed with standard rodent pellet diet (Hindustan Lever Ltd.) and water 
adlibitum. Prior to the experiment, the animals were acclimatized to the laboratory 
conditions. The experimental protocol was approved by Institutional Animal 
Ethical Committee (IAEC) constituted under CPCSEA.  
Drug Treatment  
VC at the dose levels of 200, 400 and 600 mg/Kg body wt., p.o. was 
administered once daily for three consecutive days. Furosemide (20 mg/Kg; p.o.) 
was used as standard for diuretic activity. Control group of animals (n=6) received 
normal saline (10 ml/Kg)  
Experimental design   
The animals were divided into 5 groups of 6 rats each as follows; Group I: 
received only 10ml/kg normal saline Group II: received Furosemide 20 mg/kg, 
Group III: received VC 200 mg/kg body weight p.o., Group IV: received VC 400 
mg/kg body weight p.o.  and Group V: received VC 600 mg/kg body weight p.o.  
Diuretic activity  
Rats were fasted overnight and treated with vehicle, Furosemide and 
VENKARA CHUNNAM as stated above along with normal saline (10 ml/kg). The 
rats were placed in metabolic cages and the urine samples were collected for 24h, 
measured using a standard measuring cylinder. The amount of urine (in ml) 
collected for 24 h was compared and tabulated. 
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Natriuretic activity  
 Estimation of Sodium and Potassium content of the urine samples of all 
groups of animals were done by using a laboratory model flame photometer. The 
ratio of Na+/K+ is calculated for Natriuretic activity. A value greater than 2.0 
indicates a favorable Natriuretic effect. Ratio greater than 10.0 indicates a 
potassium sparing effect. Ratio greater than 10.0 indicates a sparing effect. 
Statistical analysis  
The results were expressed as mean ± S.E.M. Statistical comparisons were 
made by means of newmann keuls multiple range tests. P values smaller than 0.05 
was considered as significant. 
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4.4.3 ANTI-SPASMODIC ACTIVITY 
IN-VITRO ANTI-SPASMODIC ACTIVITY OF VC ON EXCISED GUINEA 
PIG (STUDENTS ORGAN BATH) 
 
ISOLATION OF GUINEA PIG:-  
Guinea pigs were anesthetized and sacrificed by cervical displacement 
followed by exsanguinations. The ileum was dissected out, immersed in 
Tyrode’ssolutionand cleaned off the mesentery. Respective segments of 2-3cm 
long were mounted in a 25ml tissue organ bath, filled with a mixture of 95% O2 
and 5% CO2 and maintained at 37 o C. The composition of Tyrode’s solution (in 
mm for l lit) was 9 mg KCl, 0.1 mg NaCl, 0.1mg NaHCO3, 0.42mg NaH2PO4, 0.6 
mg Glucose and pH value was 7.4.  
  
ANTI-SPASMODIC ACTIVITY ASSAY PROCEDURE:-  
1. Firstly concentration dependent responses of acetylcholine were recorded (with 
dose of 0.1ml, 0.2ml, 0.4ml, 0.8ml, 1.6ml, 3.2ml) using Sherrington’s 
recording drum with a frontal writing lever. Contact time of 60 sec, and base 
line of 30sec time cycle were opted for proper recording of the responses in 
presence of plane Tyrode’s solution as stock-I solution.  
2. Then same concentration dependent responses of acetylcholine (Ach) using 
same procedure for a mixture of Tyrode’s solution+ Lantana camara extract 
(with a concentration of 1mg/ml) as a stock-II solution were recorded.  
3. Lastly the same concentration dependent responses of Ach for a mixture of 
Tyrode’s solution+ Atropine (as a standard antispasmodic agent) as a stock-III 
solution were recorded. 
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5. MICROBIOLOGICAL ANALYSIS 
AIM: 
Antimicrobial activity of Venkara chunnam  was performed by agar  well 
diffusion method on agar. 
COMPOSITION OF MULLER HINTON AGAR MEDIA 
Beef Extract      : 02.00 gm 
Acid Hydrolysate of Casein  : 17.50 gm 
Starch     : 01.50 gm 
Agar     : 17.00 gm 
PREPARATION OF DRUG EXTRACTS SOLUTIONS FOR THE   
EXPERIMENT 
The dried drugs were weighed and dissolved in sterile distilled water to 
prepare appropriate dilution to get required concentrations of about 10, 20 and 
30µg/ml. They were kept under refrigerated condition unless they were used for the 
experiment. 
PROCEDURE FOR THE AGAR WELL DIFFUSION TEST 
The antibacterial screening of the drugs were carried out by determining the 
zone of inhibition using agar well diffusion method. All the drug extracts were tested 
against four pathogenic bacterial strains of gram positive and gram negative organism 
by agar well diffusion method. 
BACTERIAL INOCULUMS PREPARATION 
Inoculums of Staphylococcus aureus, Escherichia coli, Klebsiella 
pneumoniae, Proteus vulgaris, and Bacillus substilis were prepared in nutrient broth 
medium and kept for incubation at 37°C for 8 hrs. 
AGAR WELL-DIFFUSION METHOD 
This method was followed to determine the antimicrobial activity. Muller-
Hinton Agar media plates were swabbed (sterile cotton swabs) with 8 hour old - broth 
culture of respective bacteria. After inoculation, wells with the size of 10 mm 
diameter and about 2 cm a part were made in each of these plates using sterile cork 
borer. Stock solution of each drug 135 extract was prepared at a concentration of 1 
mg/ml in water. About 100 µl of different concentrations of drug solvent extracts 
were added into the wells and allowed to diffuse at room temperature for 2 hrs. The 
plates were incubated at 37°C for 24 hrs. After incubation, the diameter of the 
inhibition zone (mm) was measured and the activity index was also calculated. 
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6. RESULTS AND DISCUSSION 
  The Siddha herbal drug VENKARA CHUNNAM had been subjected to 
various studies to establish its efficacy. Literary collections, physicochemical and 
elemental analysis, toxicological study, pharmacological study and clinical study 
are done to prove the activity of VENKARA CHUNNAM in lithontriptic, diuretic, 
anti-spasmodic (smooth muscle relaxant) activity. 
STANDARDISATION OF THE TEST DRUG 
  Standardization of the drug is more essential to derive the efficacy and 
potency of the drug, which was analyzed by the various methods.  The results of 
physicochemical and biochemical analysis have been done and tabulated. 
Pharmacological activity and toxicological results of the drug were derived. The 
results reveal the effectiveness of the trial drug VENKARA CHUNNAM has been 
proved by the following scientific parameters. 
SIDDHA STANDARDIZATION METHODS: 
  Siddhars used these following standardization methods to ensure the safety 
and efficacy of the chunnam. It shows the effectiveness of the drug. 
Table No: 5  Results of Siddha standardization 
S.NO Parameter Results of VC Interpretation 
 
1. Colour White 
Indicates complete calcinations 
process 
 
2. Odour Odourless 
Indicates complete calcinations 
process 
 
3. Taste Tasteles 
Indicates complete calcinations 
process 
 
4. Finger Print Test 
Impinged in the 
furrow of fingers 
Indicates fine particles of 
powder. 
 
5. 
Floating on 
Water Floats on water Lightness of drug. 
6. Luster Lusterless 
No lowing particle seen. It 
indicates complete calcinations 
process 
7. Colour Cahnge Red colour 
Mixed with turmeric powder 
and add few drops of water. 
The yellow colour changed 
into red colour. 
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Interpretation  
• The test drug VC being tasteless, odourless, lustreless and indicates 
complete calcinations process. 
• It is an ideal colour for chunnam. Without shining indicates no free form of 
metals present in that drug. 
• The test drug which was float on water has less specific gravity, possesses 
specific gravity less than the water. 
• On Finger print test, only the particles which are in micro fine size that can 
enter into the furrows of the finger print indicates. 
• VC getting impinged in the furrows of finger print indicates pressure of 
micro fine particles and completes calcinations process. 
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STANDARDIZATION OF VC AS PER SIDDHA LITERATURE
Figure No. 6 
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PHYSICOCHEMICAL ANALYSIS 
PHYSICAL CHARACTERIZATION 
The following characters have been noted in VC 
Table no-6  
Sl.No Parameters Result 
1 Colour in day light White 
2 Smell No significant 
3 Taste Tasteless 
4 Appearance Powder 
5 Touch Nice 
INTERPRETATION: 
 The organoleptic characters of the drug VENKARA CHUNNAM showed 
that the color of the chunnam is white in colour since prepared from dry herbs and 
minerals, tasteless which might be responsible for the activity mentioned earlier 
and on sight they are nice powder.  
 
Table no- 7   physicochemical Analysis 
S.NO Parameter Result 
1 Loss on drying at 70ºC 8.10±0.240 
2 Acid insoluble ash 0.85±0.011 
3 Water soluble ash 7.65±0.011 
4 PH 9.540 
[Values are mean of three determinations ±SEM] 
INTERPRETATION: 
Acid insoluble ash:  
The acid insoluble ash value of the drug denotes the amount of siliceous 
matter present in the plant. The quality of the drug is better if the acid insoluble 
value is low. It is 0.85% for the drug. 
Water soluble ash: 
Water-soluble ash is the part of the total ash content, which is soluble in 
water. It is 7.65% for the drug 
Loss on drying: 
1. The total of volatile content and moisture present in the drug was 
established in loss on drying.  
2. Low Moisture content of the drug reveals the stability and its shelf-life.  
3. High moisture content can adversely affect the active ingredient of the drug.  
4. Thus low moisture content could get maximum stability and better shelf life 
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MICROBIAL LIMIT TESTS 
Table 8 : Results of Microbial Contamination Test 
S.No. Test Particulars Colony Counts (CFU/ g) 
Limits Value 
(CFU/g) 
1. Total  Viable Aerobic Bacterial Count 5x103 1x105 
2. Total  Viable Fungal Count 2x103 1x103 
 
Table 9  Results of Specific Pathogens Test 
S.No. Test for Specified Pathogens Colony Counts (CFU/ g) 
Limits Value 
(CFU/g) 
1. Salmonella sp. No growth - 
2. Staphylococcus aureus No growth - 
3. Escherichia coli No growth 
 
- 
4. 
 
Pseudomonas aeruginosa No growth - 
 
The Results of the microbiological analysis for microbial contamination of the 
drug venkara chunnam was given in Table 8. The total viable aerobic bacterial count 
was observed on Nutrient agar plate was 5 x 103and the fungal count on SDA agar 
plates was 2 x103CFU/ g. This results were found to comply with the specification 
limit for total bacterial count i.e. NMT 1× 105 CFU/ml and not comply with the 
specification limit for total fungal count i.e. NMT 1× 103 CFU/ml (Protocol for testing 
Ayurveda, Siddha and Unani medicines). 
The analytical screening of sample showed in Table 9 that the product is free 
from specific pathogen like Escherichia coli, Salmonella, Pseudomonas aeruginosa 
and Staphylococcus aureus. 
 Microbial contamination usually occurs because of improper drying or storage 
of the plant material which eventually results in degradation of the plant constituents. 
Microbial contamination can also render plant material toxic, either by transforming 
the chemicals in the plant material or through the production of toxic compounds by 
the microbes. Therefore, microbial quality tests should be applied to starting plant 
materials, intermediate and finished products where necessary. During the quality 
analysis, precautions must be taken to ensure that conditions do not adversely affect 
any microorganisms that are to be measured.  
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Thus, the present study proves that Venkara Chunnam is free from microbial 
contamination and also highlighted the safety of the same. The information obtained 
from microbial screening tests will be use full in finding out the quality of the drug 
  From these results, it is accomplished that this study would lead to the 
establishment of several important compounds that have to be used to formulate new, 
different and more potent antimicrobial drugs of natural origin. However, further 
studies are required to screen the biologically active compounds and to evaluate the 
efficiency of this compound against pathogenic microorganisms associated with 
various human diseases. 
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BIO-CHEMICAL ANALYSIS OF “VENKARA CHUNNAM” 
Table No: 10 Preliminary tests for basic and acidic radical: 
S.NO EXPERIMENT INFERENCE 
1. Test For Calcium Present 
2. Test For Sulphate Present 
3. Test For Chloride Present 
4. Test For Carbonate Absent 
5. Test For Starch Absent 
6. Test For Iron Ferric Absent 
7. Test For Iron Ferrous Present 
8. Test For Phosphate Present 
9. Test For Albumin Absent 
10. Test For Tannic Acid Absent 
11. Test For Unsaturation Present 
12. Test For The Reducing Sugar Absent 
13. Test For Amino Acid Absent 
14. Test For Zinc Absent 
 
INTERPRETATION: 
Calcium: 
• Calcium ions are necessary for the maintenance and regulation of acid-base 
balance and water balance in the body. 
• Calcium interacts with troponin C to trigger the muscle contraction. 
• Several reactions in the cascade of blood clotting process are dependent on 
ca2+(factor IV). 
• Calcium influences the membrane structure and transport of water and several 
ions across it. 
Sulphate: 
• Nutritionally essential element. 
• Sulphate has anti bacterial activity and it is one of the macronutrient of cells. 
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• It inhibits growth of yeasts and moulds in low pH and inhibits growth of 
enterobacteriae and other gram negative bacteria in high pH. 
• Sulphate important role for the anti-microbial activity. 
• It is needed to start the cascade of digestive enzymes released from the pancreas.  
Without proteases, lipases and amylases, food is not digested efficiently. 
Chloride 
• Chloride forms the chief anion of the extracellular fluid and exists along with 
sodium mostly. 
• Regulates acid base balance. 
• Formation of HCl in gastric juice. 
• Help to preserve normal neuromuscular irritability by maintaining a state of 
eqilibrium, on account of their relative proportion in  ECF and ICF. 
Iron: 
• Iron is associated with effective immune competence of the body. 
• Iron is important for the formation of Hemoglobin, Myoglobin and other 
substances like cytochrome, cytochrome oxidase, peroxidase and catalase. 
Phosphate: 
• Phosphate is also required for the development of bones and teeth. 
• Adenosine triphosphate, main source of energy in cells, must be bound to the 
Phosphate ion in order to be biologically active. 
• Phosphate is necessary for proper neuromuscular function. 
Unsaturated Compound : 
• Monounsaturated and polyunsaturated fats can replace saturated fat in the diet, 
trans unsaturated fats should not.  
• Replacing saturated fats with unsaturated fats helps to lower levels of total 
cholesterol and LDL cholesterol in the blood. 
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PHYTO-CHEMICAL STUDY OF VENGARA CHUNNAM 
This experimental study was taken up to qualitative analysis of Phyto-
chemicals in the drug of Venkara Chunnam using various test and the results are 
exhibited in Table No..11 
Table No 11: Incidence of various phyto-chemicals in Venkara Chunnam 
S.No. Name of Tests Conducted Result Observed 
Observation of Alkaloids 
1. Mayer’s Test Negative 
2. Dragendroff’s Test Negative 
3. Hager’s Test  Positive 
Observation of Carbohydrates and Glycosides 
4. Molisch Test  Positive 
5. Legal’s Test Negative 
6. Borntrager’s Test for anthraquinones Negative 
Observation of Phytosterols 
7. Liebermann – Burchard Test Negative 
8. Salkowski Test Negative 
Observation of Flavanoids 
9. Shinoda Test (Magnesium turnings & Hydrochloric acid) Negative 
10. Fluorescence Test Negative 
Observation of Tannins 
11. Ferric chloride test Negative 
12. Potassium dichromate test Negative 
13. Lead acetate test Positive 
14. Millon’s test Negative 
15. Biuret test Positive 
16. Ninhydrin test Negative 
Observation of fixed oils and fats 
17. Spot test Negative 
18. Saponification test Negative 
Observation of Lignin 
19. Phloroglucinol test Negative 
Observation of Saponins 
20. Frothing test Negative 
   Note: Positive indicates the presence of Phytochemical;  
Negative indicates the absence of Phytochemical 
RESULTS: 
Result shows the presence of Alkaloids, carbohydrates and glycosides, 
tannins, and absence of phytosterols, flavonoids, fixed oil, fat, proteins, saponins 
and lignin. 
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INTERPRETATION: 
Alkaloids: 
Alkaloids have a wide range of pharmacological activities including 
analgesic, antimicrobial activity. 
Glycosides:  
Serves as reserve food material, means for removal of toxic substances 
inhibit disease producing microorganisms. 
Tannins:  
Tannins are considered antioxidants property, creating an insulating and 
protective layer that soothes irritation and pain of the skin. 
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INSTRUMENTAL ANALYSIS 
SEM RESULT 
Figure no:7 
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INTERPRETATION: 
 The morphology of the VENKARA CHUNNAM sample can be determined 
by Environmental SEM (FEI Quanta). A representative portion of each sample 
must be sprinkled onto a double side carbon tape and mounted on aluminium stubs, 
in order to get a higher quality secondary electron image for SEM examination. We 
have observed from SEM photographs that particles are spherical in shapes and 
sizes are in the range from 10 micron to 5 micron. Although the particle sizes of 
different batches showed similarity, it seems that these particles are aggregates of 
much smaller particles. When dispersed in an aqueous medium, these preparations 
form a negatively charged hydrophobic particle suspension. This hydrophobicity 
gives these particles a tendency to aggregate together to form larger particles. 
VENKARA CHUNNAM exhibited larger sizes and agglomeration of the particles. 
Therefore, the comparatively larger size may be due to the agglomeration of the 
particles by repeated cycles of calcinations involved in preparation.   
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FOURIER TRANSFORM – INFRA RED SPECTRO SCOPY (FTIR) 
Fourier Transform Infra-Red spectroscopy (FTIR) analysis results in 
structure spectra that provide information about the functional group and molecular 
structure of a material IR relates with the sample and the bonds among atoms in the 
molecule stretch and bend absorbing infrared energy and creating the infrared 
spectrum.  It is of two kinds of bending and stretching. 
 FTIR is very useful tool in the recognition of the functional groups of bio 
molecules, thus aiding in their structural elucidation so confirming the presence of 
active molecule responsible for the therapeutic activity of siddha drugs. The result of 
following tables shows the presence of functional groups and inorganic compounds of 
venkara chunnam. 
FTIR RESULTS OF VC: 
Figure No: 8  FTIR Result Graph 
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Table no - 12 Showing represented functional groups 
 
Absorption peak 
cm-1 
 
Stretch 
 
 
Functional group 
2615.47 O-H – Stretch Carboxylic acid 
2441.88 O-H – Stretch Carboxylic acid 
1662.64 -C=C - Stretch Alkene 
1130.29 C-O- Stretch Alchols, Esters, Ethers, Carboxylic 
acid 
1080.14 C-N- Stretch Aliphatic amines 
947.05 N-H-Stretch Primary and Secondary Amines. 
879.54 N-H-Stretch Primary and Secondary Amines. 
831.32 N-H-Stretch Primary and Secondary Amines. 
709.80 N-H-Stretch Primary and Secondary Amines. 
605.65 C-Br- Stretch Alkyl halides 
576.72 C-Br- Stretch Alkyl halides 
524.64 C-Br- Stretch Alkyl halides 
497.63 C-C Stretch Cyloalkane 
462.92 C-C Stretch Cyloalkane 
 
INTERPRETATION: 
In FTIR the wave numbers between 4000cm-1-400cm-1
. 
4000 cm-1-                     
1500 cm-1 is known as functional group area.1500 cm-1-600cm-1 is known as finger 
print area. The identity of FTIR of two compounds is much more characteristic 
than the comparisons of their many physical properties. The corresponding 
absorption frequency by FTIR shows the presence of Carboxylic acid, alkenes, 
alcoholic groups, aliphatic amines, primary and secondary amines, alkyl halides, 
cyloalkane, esters and ethers. 
Alcoholic groups: 
 Alcoholic group of substances act as antimicrobial and antiseptic agents. 
Carboxylic acid: 
 This group of substance has antimicrobial, anticoagulant activity. 
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Amines groups: 
 Amines groups act as neurotransmitters. 
 It is involved in protein synthesis. 
 This group of substances has analgesic activity. 
Alkenes groups: 
 Alkenes have little biological activity. 
 It is predominate in plants. They protect against bacteria and fungi. 
Alkyl halides: 
 These are group of compounds derived from alkanes containing one or 
more halogens.Some are used as anesthetics and antiseptic agents. Some of 
them are used in medicine for the elimination of hook worms. 
Esters: 
 This group is produced a diuresis and natriuresis. So result of a direct 
tubular action together with a pressure diuresis 
Ethers: 
 Ether  which increases the flow of urine 
 It is a best diuretic action. 
 A diffusible stimulant and antispasmodic used chiefly in colic. 
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ICP-OES (Inductively Coupled Plasma Optical Emission 
Spectroscopy): 
The drug VC sample was analysed by the Inductively Coupled Plasma 
Optical Emission Spectroscopy (ICP-OES) to detect the trace elements and other 
elements quantitatively.  
The result of ICP-OES is given on the Venkara Chunnam 
Table No: 13. 
Sample ID Elements Symbol Wavelength(nm) 
Concentration 
(A)P 
1. Al 396.152 BDL 
2. As 188.979 BDL 
3 B 249.677 405.214mg/L 
4. Ca 315.807 2.170 mg/L 
5. Cd 228.802 BDL 
6. Cu 327.393 BDL 
7. Fe 238.204 0.016mg/L 
8. Hg 253.652 BDL 
9. K 766.491 03.004 mg/L 
10. Mg 285.213 01.004 mg/L 
11. Na 589.592 701.100 mg/L 
12. Ni 231.604 BDL 
13. Pb 220.353 BDL 
14. P 213.617 106.351 mg/L 
BDL:Below Detectable Limit ( Normal – 1 ppm) 
1% = 10000ppm, 
1ppm = 1/1000000 or 1ppm = 0.0001% 
The toxic metals and the permissible limits 
Heavy metals  WHO & FDA limits  
Arsenic (As)  10ppm 
Mercury (Hg)  1ppm 
Lead (Pb)  10ppm 
Cadmium (Cd) 0.3ppm 
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Plants are the rich source of elements. These elements have vital function. 
They were significant role against a variety of diseases. Hence they were used for 
several health problems. 
The VC showed presence of K, Mg, P, Na, B, Fe, Ca. In VENKARA 
CHUNNAM, the heavy metals like As, Hg, Cd, Pb, Cu, Ni, Al were below 
detectable level. The result indicate that the formulation is extremely safe as it 
contains heavy metals within specified limits.  
Interpretation: 
Potassium:  
 In the presence of Sodium and Potassium regulate the acid-base balance of 
the body fluids.They regulate the water balance of the body fluids.They help to 
preserve the neuromuscular irritability by maintaining a state of equilibrium on 
account of their relative proportion in the Extra cellular fluid and Intra cellular 
fluid.Potassiumis an electrolyte critical in maintaining proper acid-alkaline balance. 
Potassium is highly present inintra cellular fluid( ICF), while its partner, sodium, is 
highly present in extra cellular fluid( ECF).It is their perfect ratio that maintains 
fluid and electrolyte balance. Potassium dilates the arteries and relaxes the smooth 
muscles and increases the blood flow (F.J. Haddy, 2012). 
Magnesium:   
Magnesium inhibits the formation of calcium-oxalate crystals in the urine. 
It also inhibits the stone formation by inhibition of growth of crystals as well as 
aggregation. Inhibition of crystal attachment of calcium oxalate appears to require 
supra-physiologic concentrations. Magnesium reduces the formation of stones by 
reducing the calcium oxalate in the blood that makes up the stones. 
Phosphorus: 
Phosphorus is an important constituent of phosphate buffers in the blood 
and urine. It is required for the formation of certain physiologically important 
phosphorus containing compounds like phospholipids, coenzymes and enzymes of 
intermediary metabolism. 
Sodium: 
Sodium regulates the acid base balance of the body fluids. Sodium is 
required for the maintenance of the osmotic pressure.  It is necessary for the normal 
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muscle irritability and permeability of cells.  Sodium is involved in the intestinal 
absorption of glucose and amino acids. 
Boran 
 Boricacid is anti-microbial and several natural boran containing organic 
anti-biotics.  Boran supplementation markedly reduced urinary calcium excreation 
and elevated the serum concentration of 17 beta estradiol and testosterone. 
Ferrous iron 
 Iron supplementation resulted in a significant decreases eosinophilia, while 
systemic iron injections lead to a significant suppression of both allergen-induced 
eosinophilia and hyperactivity compared to placebo 
Calcium: 
Calcium is an improntant comonent of cell memberane it control permiability 
and electrical properties of the cell membrane. Calcium necessary for the 
maintenance and regulation of acid - base balance and water balance in the body.  
Calcium helps to prevent kidney stone formulation. 
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XRD (X-RAY POWDER DIFFRACTION) 
The drug VC sample was analysed by the X-ray powder diffraction (XRD) 
to checking the quality control of above mineral medicines 
The result of XRD is given on the Venkara Chunnam 
Figure no. 9 
XRD Image of VENKARA CHUNNAM 
 
Interpretation: 
This XRD finger print shows both the similarities and difference of the sample 
successfully and is a valuable primary tool for checking the quality control of above 
mineral medicines.  Modern techniques are necessary to standardize and bring out 
high quality herbal product owing to their complex nature.  The different peak shows 
the presence of minerals in the sample. 
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TOXICITY STUDIES 
EVALUATION OF ACUTE TOXICITY STUDY ON VENKARA 
CHUNNAM 
Effect of Acute Toxicity Study (14 Days) of VC 
Table no –14   Physical and behavioral examinations. 
Group No. Dose(mg/kg) Observation sign No. of animal affected. 
Group-I 5mg/kg Normal 0 of 3 
Group- II 50mg/kg Normal 0 of 3 
Group-III 300mg/kg Normal 0 of 3 
Group-IV 1000mg/kg Normal 0 of 3 
Group-V 2000mg/kg Normal 0 of 3 
Table no-15    Home cage activity 
Functional and 
Behavioural 
observation 
Observation 
5mg/kg 
Group 
(G-I) 
50 
mg/kg 
(G-II) 
300 
mg/kg 
(G-III) 
 
1000 
mg/kg 
(G-IV) 
2000 
mg/kg 
(G-V) 
Female 
n=3 
Female  
n=3 
Female  
n=3 
Female 
 n=3 
Female  
n=3 
Body position Normal 3 3 3 3 3 
Respiration Normal 3 3 3 3 3 
Clonic 
involuntary 
Movement 
Normal 3 3 3 3 3 
Tonic involuntary 
Movement Normal 3 3 3 3 3 
Palpebral closure Normal 3 3 3 3 3 
Approach 
response Normal 3 3 3 3 3 
Touch response Normal 3 3 3 3 3 
Pinna reflex Normal 3 3 3 3 3 
Tail pinch 
response Normal 3 3 3 3 3 
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Table no-16  Hand  held  observation 
Functional 
and 
Behavioral 
observation 
Observation 
Control 
5  
mg/ kg 
(G-I) 
50 
mg/kg 
(G-II) 
300 
mg/kg 
(G-III) 
1000 
mg/kg 
(G-IV) 
2000 
mg/kg 
(G-V) 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Reactivity Normal 3 3 3 3 3 3 
Handling Normal 3 3 3 3 3 3 
Palpebral 
closure 
Normal 3 3 3 3 3 3 
Lacrimation Normal 3 3 3 3 3 3 
Salivation Normal 3 3 3 3 3 3 
Piloerection Normal 3 3 3 3 3 3 
Pupillary 
reflex 
Normal 3 3 3 3 3 3 
Abdominal 
tone 
Normal 3 3 3 3 3 3 
Limb tone Normal 3 3 3 3 3 3 
 
Table no-17   Mortality 
Group no Dose no(mg/kg) Mortality 
Group-I 5(mg/kg) 0 of 3 
Group-II 50(mg/kg) 0 of 3 
Group-III 300(mg/kg) 0 of 3 
Group-IV 1000(mg/kg) 0 of 3 
Group-V 2000(mg/kg) 0 of 3 
 
RESULT: 
  From acute toxicity study it was observed that the administration of VC at a 
dose of 2000 mg/kg to the rats do not produce drug-related toxicity and mortality. 
So No-Observed-Adverse-Effect- Level (NOAEL) of VC is 2000 mg/kg. 
DISCUSSION 
  VENKARA CHUNNAM was administered single time at the dose of 
5mg/kg, 50mg/kg, 300mg/kg, 1000mg/kg and 2000mg/kg to rats and observed for 
consecutive 14 days after administration. Doses were selected based on the pilot 
study and literature review. All animals were observed daily once for any abnormal 
clinical signs. Weekly body weight and food consumption were recorded. No 
mortality was observed during the entire period of the study. Data obtained in this 
study indicated no significance physical and behavioral signs of any toxicity due to 
administration of VC at the doses of 5mg/kg, 50mg/kg, 300mg/kg, 1000mg/kg and 
2000mg/kg to rats.  
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  At the 14th day, all animals were observed for functional and behavioral 
examination. In functional and behavioral examination, home cage activity, hand 
held activity were observed. Home cage activities like Body position, Respiration, 
Clonic involuntary movement, Tonic involuntary movement, Palpebral closure, 
Approach response, Touch response, Pinna reflex, Sound responses, Tail pinch 
response were observed. Handheld activities like Reactivity, Handling, Palpebral 
closure, Lacrimation, Salivation, Piloercetion, Papillary reflex, abdominal tone, 
Limb tone were observed. Functional and behavioral examination was normal in all 
treated groups. Food consumption of all treated animals was found normal as 
compared to normal group. 
  Body weight at weekly interval was measured to find out the effect of 
VENKARA CHUNNAM    on the growth rate. Body weight change in drug treated 
animals was found normal. 
INTERPRETATION: 
 VENKARA CHUNNAM was administered single time at the dose of 
5mg/kg, 50mg/kg, 300mg/kg, 1000mg/kg and 2000mg/kg to rats and observed for 
consecutive 14 days after administration. Doses were selected based on the pilot 
study and literature review. All animals were observed daily once for any abnormal 
clinical signs. Weekly body weight and food consumption were recorded. No 
mortality was observed during the entire period of the study. Data obtained in this 
study indicated no significance physical and behavioral signs of any toxicity due to 
administration of VENKARA CHUNNAM at the doses of 5mg/kg, 50mg/kg, 
300mg/kg, 1000mg/kg and 2000mg/kg to rats.  
  At the 14th day, all animals were observed for functional and behavioral 
examination. In functional and behavioral examination, home cage activity, hand 
held activity were observed. Home cage activities like Body position, Respiration, 
Clonic involuntary movement, Tonic involuntary movement, Palpebral closure, 
Approach response, Touch response, Pinna reflex, Sound responses, Tail pinch 
response were observed. Handheld activities like Reactivity, Handling, Palpebral 
closure, Lacrimation, Salivation, Piloercetion, Papillary reflex, abdominal tone, 
Limb tone were observed. Functional and behavioral examination was normal in all 
treated groups. Food consumption of all treated animals was found normal as 
compared to normal group. 
  Body weight at weekly interval was measured to find out the effect of 
VENKARA CHUNNAM on the growth rate. Body weight change in drug treated 
animals was found normal. 
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SUB-ACUTE TOXICITY STUDY IN WISTAR RATS TO EVALUATE 
TOXICITY PROFILE OF VC 
Table: 18 EFFECT OF SUB- ACUTE DOSE (28 DAYS) OF VC ON BODY 
WEIGHT IN GRAM 
GROUP CONTROL 
VC 
(200mg/kg) 
VC 
(400mg/kg) 
VC 
(600mg/kg) 
1stDAY 126.3±1.430 130±1.943 128.3±2.631 130.3±2.63 
7th DAY 136.3±1.430 135.3±1.443 135±2.513 141±2.510 
14th DAY 140.1±1.404 106.3±1.520 106.4±2.412 107.4±2.412 
21st DAY 107.3±2.520 116.2±1.901 108±1.531 109±1.530 
28th DAY 117.3±1.441 116.3±1.602 147±2.4405 150±2.440 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one 
way ANOVA followed by Dunnett’s (n=6); ns p>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groups with control group. 
 
BODY WEIGHT 
Figure 10: 
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EFFECT OF SUBACUTE DOSE (28 DAYS) OF VENKARA CHUNNAM 
Table: 19 VC ON ORGAN WEIGHT (PHYSICAL PARAMETER) IN GRAM 
GROUP CONTROL 
VC 
(200mg/kg) 
VC 
(400mg/kg) 
VC 
(600mg/kg) 
HEART 0.57±0.42 0.88±0.44 1.05±0.51 0.45±0.42 
LIVER 2.35± 0.63 2.37±0.63 2.24±0.41 2.27± 0.63 
LUNGS 1.35±0.50 0.85±0.54 0.84±0.64 0.47±0.50 
 
KIDNEY 
Left 0.47±0.42 0.56±0.43 0.47±0.42 0.45±0.42 
Right 0.45±0.424 0.59±0.42 0.45±0.424 0.46±0.424 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one 
way ANOVA followed by Dunnett’s (n=6); ns p>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groups with control group.  
 
Figure 11: 
ORGAN WEIGHT 
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EFFECT OF SUB- ACUTE DOSE (28 DAYS) OF VENKARA CHUNNAM ON 
HAEMATOLOGICAL PARAMETERS 
Table no 20 
Drug 
treatme
nt 
RBC 
million 
cells 
/cu mm 
WBC  
cells/cu 
mm 
Haemoglo
bin gm % 
Differential count % 
Neutrop
hils 
Eosinoph
il’s 
Monocy
te 
Lymphocy
tes 
Control 5.25±0.80 
5252.45±23
.72 12.44±0.85 
31.31±1.6
0 3.57±0.51 
0.69±0.
55 23.17±3.72 
LOW 5.51±0.60 
5334.08±23
.62 13.24±0.83 
25.58±1.8
1 2.14±0.54 
0616±0.
70 23.26±3.91 
MID 4.37±0.61 
5304.29±32
.75 14.15±1.43 
30.36±2.6
2 2.48±0.52 
0.66±0.
80 23.17±3.72 
HIGH 5.30±0.61 
5818.29±32
.75 16.15±1.43 
28.36±2.6
2 2.54±0.52 
0.68±0.
80 24.17±3.72 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one 
way ANOVA followed by Dunnett’s (n=6); ns p>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groups with control group.  
 
Effect of Sub acute dose (28 days) of VC on Hematological parameters 
Figure 12: 
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EFFECT OF SUB ACUTE DOSE (28 DAYS) OF VC ON 
HEMATOLOGICAL PARAMETERS 
 
Table: 21 EFFECT OF SUB- ACUTE DOSE (28 DAYS) OF VC ON 
BIOCHEMICAL PARAMETERS 
GROUP CONTROL VC (200mg/kg) 
VC 
(400mg/kg) 
VC 
(600mg/kg) 
SGOT 
(units/min/liter/m
g protein) 
52.18±4.71 51.17±4.41 54.15±2.61 50.15±2.61 
SGPT 
(units/min/liter/m
g protein) 
42.18±3.42 42.17±3.62 40.25±4.84 42.25±4.84 
ALP 
(units/min/liter/m
g protein) 
143.16±11.72 151.15±12.82 145.49±4.54 134.49±4.54 
 
 
Figure 13: BIO CHEMICAL PARAMETERS 
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EFFECT OF SUB- ACUTE DOSE (28 DAYS) OF VENKARA CHUNNAM 
BIOCHEMICAL PARAMETERS 
Table 22 
GROUP CONTROL VC 
(200mg/kg) 
VC 
(400mg/kg) 
VC 
(600mg/kg) 
TOTAL 
BILIRUBIN 
(mg/dl) 
0.8±057 0.68±0.27 0.88±0.36 0.504±0.199 
  
Values are expressed as mean ± SEM Statistical significance (p) calculated by one-
way ANOVA followed by Dunnett’s (n=6); ns p>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groups with control group.  
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Table: 23 EFFECT OF SUB- ACUTE DOSE (28 DAYS) OF VENKARA 
CHUNNAM ON BIOCHEMICAL PARAMETERS 
GROUP CONTROL VC (200mg/kg) 
VC 
(400mg/kg) 
VC 
(600mg/kg) 
 
CREATININE 
(mg/dl) 
 
0.58±0.43 0.54±0.44 0.99±0.44 0.50±0.44 
 
UREA (mg/dl) 
 
45.39±3.40 50.57±2.82 53.16±2.62 40.16±2.62 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one-
way ANOVA followed by Dunnett’s (n=6); ns p>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groups with control group.  
 
Figure 14: BIOCHEMICAL PARAMETERS OF UREA AND CREATININE 
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Table: 24 EFFECT OF SUB- ACUTE DOSE (28 DAYS) OF VENKARA 
CHUNNAM ON FOOD INTAKE IN GRAM 
GROUP CONTROL VC (200mg/kg) 
VC 
(400mg/kg) 
VC 
(600mg/kg) 
1st DAY 16.37±3.10 18.1-6±1.7 12.14±2.1 17.9±8.02 
7th DAY 13.9±1=1.4 11.7±3.07 16.77±1.23 11.21±14.81 
14th 
DAY 15.87±0.12 10.8±.68 14±16.36 19.76±9.381 
21st DAY 15.91±2.8 15.4±8.8 15.92±9.83 19.21±8.42 
28th 
DAY 13.14±1.78 18.2±11.0 10.4±9.30 10.4±7.97 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one-
way ANOVA followed by Dunnett’s (n=6); ns p>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groups with control group 
 
Figure 15: FOOD INTAKE 
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Table: 25 EFFECT OF SUB- ACUTE DOSE (28 DAYS) OF VENKARA 
CHUNNAM ON WATER INTAKE IN ML 
 
GROUP CONTROL VC (200mg/kg) 
VC 
(400mg/kg) 
VC 
(600mg/kg) 
1st DAY 98.8±13.10 89.72±14.36 102.10±21.99 77.5±7.203 
7th DAY 85.5±11.738 100.863±12.60 76.63±9.3 81.17±14.40 
14th 
DAY 88.33±8.727 90.83±14.2812 80±13.2 89.1672±8.981 
21st DAY 91.87±12.49 85±8.462 75.38±9.40 89.1717±8.92 
28th 
DAY 82.10±11.30 88.48±11.04 80±8.1 70±7.53 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one-
way ANOVA followed by Dunnett’s (n=6); ns p>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groups with control group 
 
Figure 16: WATER INTAKE 
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Table: 26 EFFECT OF SUB ACUTE DOSES (28 DAY) OF VENKARA 
CHUNNAM ON ELECTROLYTES: 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one-
way ANOVA followed by Dunnett’s (n=6); NS- non-significant, *p<0.05, 
**p<0.01, ***p<0.001,  
 
Figure 17: ELECTROLYTES 
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GROUP CONTROL 
VC 
(200mg/kg) 
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(400mg/kg) 
VC 
(600mg/kg) 
Sodium (mg/dl) 143.910±0.5 145.30±0.2 151±0.71 141.80±0.0 
Calcium(mg/dl) 12.80±0.19 13.20±0.73 12.7±0.9* 12.0±0.** 
Phosphorus 
(U/L) 
8.28±0.7 6.10±0.05ns 7.30±0.9ns 6.0±0.2* 
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6.0 RESULTS: 
CLINICAL SIGNS: 
All animals in this study were free of toxic clinical signs throughout the 
dosing   period of 28 days. 
Mortality: 
All animals in control and in all the treated dose groups survived 
throughout the dosing period of 28 days. 
Body weight: 
Results of body weight determination of animals from control and different 
dose groups exhibited comparable body weight gain throughout the dosing period 
of 28 days. 
Food consumption: 
During dosing and the post-dosing recovery period, the quantity of food 
consumed by animals from different dose groups was found to be comparable with 
that by control animals. 
Organ Weight: 
Group Mean Relative Organ Weights (% of body weight) are recorded in 
Table No.19 Comparison of organ weights of treated animals with respective 
control animals on day 29 was found to be comparable similarly. 
Hematological investigations: 
The results of hematological investigations conducted on day 29 revealed 
following significant changes in the values of different parameters investigated 
when compared with those of respective controls; however, the increase or 
decrease in the values obtained was within normal biological and laboratory limits 
or the effect was not dose dependent. 
Biochemical Investigations: 
Results of Biochemical investigations conducted on the day 29th and 
recorded in Table no 21, 22 revealed the following significant changes in the 
values of hepatic serum enzymes studied. When compared with those of respective 
control. However, the increase or decrease in the values obtained was within 
normal biological and laboratory limits. 
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INTERPRETATION: 
1) All the animals from control and all the treated dose groups up to 15ml/kg 
survived throughout the dosing period of 28 days. 
2) No signs of toxicity were observed in animals from different dose groups 
during the dosing period of 28 days. 
3) Animals from all the treated dose groups exhibited comparable body 
weight gain with that of controls throughout the dosing period of 28 days. 
4) Food consumption of control and treated animals was found to be 
comparable throughout the dosing period of 28 days 
5) Haematological analysis conducted at the end of the dosing period on day 
29th, revealed no abnormalities attributable to the treatment. 
6) Biochemical analysis conducted at the end of the dosing period on day 29th, 
no abnormalities attributable to the treatment. 
7) Organ weight data of animals sacrificed at the end of the dosing period was 
found to be comparable with that of respective controls. 
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PHARMACOLOGICAL STUDY 
1. LITHOTRIPTIC ACTIVITY 
Effect on urinary output in urolithiasis induced rats  
Table No: 27 
Days GP1 GP2 GP3 GP4 GP5 
0 
7.26± 
1.41 
7.19± 
1.41 
8.57± 
1.73 
7.66± 
1.75 
8.46± 
1.75 
14 
7.84± 
1.66 
6.39± 
1.45**a 
11.46± 
2.64**b 
8.46± 
1.94**b 
9.21± 
2.37**b 
28 
8.39± 
1.65 
6.91± 
1.24**a 
11.75± 
2.76**b 
8.66± 
2.25-**b 
10.21± 
2.36**b 
 
GP1- Normal; GP2- Lithiatic Control; GP3-  Cystone standard control (100mg/kg)  
GP4 -   VC (200mg/kg); GP5 – VC (400mg/kg)  
• Values are expressed as mean ± SEM 
• Values were found out by using ONE WAY ANOVA Followed by Newman keul’s 
multiple range tests. 
• **(a) Values were significantly different from normal control (GP1) at P< 0.01 
• **(b) Values were significantly different from Lithiatic control (GP2) at P<0.01   
 
Figure 18: LITHOTRIPTIC ACTIVITY 
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EFFECT ON URINARY BIOCHEMICAL PARAMETERS ON THE DAY 14 
Table No: 28 
 
GP1- Normal; GP2- Lithiatic Control; GP3-  Cystone standard control (100mg/kg)  
GP4 -   VC (200mg/kg); GP5 – VC (400mg/kg)  
• Values are expressed as mean ± SEM 
• Values were found out by using ONE WAY ANOVA Followed by Newman keul’s 
multiple range tests. 
• **(a) Values were significantly different from normal control (GP1) at P< 0.01 
• **(b) Values were significantly different from Lithiatic control (GP2) at P<0.01    
 
 
Figure 19: EFFECT ON URINARY BIOCHEMICAL PARAMETERS ON THE DAY 14 
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GP Protein (mg/dl) 
Magnesiu
m 
(mg/dl) 
Calciu
m 
(mg/dl) 
Uric 
acid 
(mg/dl) 
Creatinine 
(mg/dl) 
Oxalate 
(mg/dl) 
Phosphat
e 
(mg/dl) 
GP1 
74.96± 
1.73 
3.95± 
0.54 
5.49± 
0.76 
8.76± 
0.88 
0.82± 
0.13 
17.85± 
1.54 
37.70± 
2.78 
GP2 
83.31 ± 
4.53**(a) 
1.34 ± 
0.24**(a) 
25.25± 
1.90**(a) 
16.65 ± 
1.54**(a
)
 
1.64 ± 
0.18**(a) 
31.70 ± 
3.25**(a) 
78.65 ± 
4.30**(a) 
GP3 
80.34± 
2.85**(b) 
3.34 ± 
0.60**(b) 
16.63 ± 
0.45**(b) 
8.92 ± 
0.83**(b
)
 
0.82 ± 
0.14**(b) 
21.15 ± 
1.76**(b) 
35.25 ± 
2.55**(b) 
GP4 
88.38 ± 
3.95 **(b) 
2.60 ± 
0.32**(b) 
19.30 ± 
2.15**(b) 
10.65 ± 
0.93**(b
)
 
0.96 ± 
0.12**(b) 
25.32 ± 
2.68**(b) 
46.60 ± 
3.75**(b) 
GP5 
86.52 ± 
3.74**(b) 
2.56 ± 
0.55**(b) 
12.42 ± 
0.83**(b) 
12.34 ± 
0.63**(b
)
 
0.94 ± 
0.14**(b) 
23.80 ± 
2.54**(b) 
42.40 ± 
3.26**(b) 
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EFFECT ON URINARY BIOCHEMICAL PARAMETERS ON THE 28TH DAY 
Table No: 29 
GP Protein (mg/dl) 
Magnesium 
(mg/dl) 
Calcium 
(mg/dl) 
Uric acid 
(mg/dl) 
Creatinine 
(mg/dl) 
Oxalate 
(mg/dl) 
Phosphate 
(mg/dl) 
GP1 
76.85 
±3.74 
4.36 
±0.40 
7.25 
±0.64 
3.42 
±0.73 
0.90 
±0.32 
18.64 
±1.41 
32.25 
±3.48 
GP2 
95.30 
±7.26**(a) 
1.78 
±0.57**(a) 
22.82 
±1.58**(a) 
12.52 
±1.40**(a) 
1.67 
±0.55**(a) 
51.42 
±4.46**(a) 
81.51 
±4.78**(a) 
GP3 
84.65 
±4.84**(b) 
3.55 
±0.46*(b) 
10.80 
±0.49**(b) 
7.22± 
0.39**(b) 
1.24 
±0.51**(b) 
20.70 
±2.19**(b) 
41.61 
±2.30**(b) 
GP4 
91.20 
±5.61**(b) 
2.46 
±0.40**(b) 
13.70 
±1.07**(b) 
8.63 
±0.41**(b) 
1.28 
±0.75**(b) 
26.84 
±2.65**(b) 
45.68 
±3.42**(b) 
GP5 
88.76 
±5.72**(b) 
3.91 
±0.54**(b) 
11.65 
±0.94**(b) 
8.31 
±0.43**(b) 
1.26 
±0.45**(b) 
23.45 
±2.54**(b) 
44.56 
±3.18**(b) 
 
GP1- Normal; GP2- Lithiatic Control; GP3-  Cystone standard control (100mg/kg)  
GP4 -   VC (200mg/kg); GP5 – VC (400mg/kg)  
• Values are expressed as mean ± SEM 
• Values were found out by using ONE WAY ANOVA Followed by Newman keul’s 
multiple range tests. 
• **(a) Values were significantly different from normal control (GP1) at P< 0.01 
• **(b) Values were significantly different from Lithiatic control (GP2) at P<0.01    
 
Figure 20: Effect on urinary biochemical parameters on the 28th day 
 
0
20
40
60
80
100
120
GP1 GP2 GP3 GP4 GP5
Protein
Magnesium
Calcium
Uric acid
Creatinine
Oxalate
Phosphate
  
  
   136 PRE CLINICAL  STUDY OF  VENKARA CHUNNAM 
EFFECT ON SERUM PARAMETERS ON THE 28th DAY 
Table No: 30 
GP Magnesium (mg/dl) 
Calcium 
(mg/dl) 
Uric 
acid 
(mg/dl) 
Creatinine 
(mg/dl) 
Oxalate 
(mg/dl) 
Phosphate 
(mg/dl) 
GP1 
4.88 
±0.55 
8.15 
±0.19 
3.30 
±0.26 
5.20 
±2.15 
6.32 
±0.68 
3.015 
±4.250 
GP2 
1.64 
±0.40**(a) 
21.50 
±25.40**(a) 
9.70 
±1.28**
(a)
 
2.75 
±3.66**(a) 
13.54 
±1.66**(a) 
4.938 
±2.35**(a) 
GP3 
4.12 
±0.33**(b) 
10.20 
±1.40**(b) 
3.15 
±0.45**
(b)
 
0.54 
±0.36**(b) 
7.15 
±0.32**(b) 
17.28 
±1.53**(b) 
GP4 
3.76 
±0.54**(b) 
15.70 
±3.41**(b) 
4.30 
±0.78**
(b)
 
2.40 
±35.75**(b) 
9.54 
±0.95**(b) 
2.40 
±6.75**(b) 
GP5 
3.84 
±0.24**(b) 
16.72 
±1.23*(b) 
4.20 
±0.51**
(b)
 
3.55 
±16.22**(b) 
8.80 
±0.84**(b) 
3.50 
±0.87**(b) 
 
GP1- Normal; GP2- Lithiatic Control; GP3-  Cystone standard control (100mg/kg)  
GP4 -   VC (200mg/kg); GP5 - VC(400mg/kg)  
• Values are expressed as mean ± SEM 
• Values were found out by using ONE WAY ANOVA Followed by Newman keul’s 
multiple range tests. 
• **(a) Values were significantly different from normal control (GP1) at P< 0.01 
• **(b) Values were significantly different from Lithiatic control (GP2) at P<0.01   
 
Figure 21: EFFECT ON SERUM PARAMETERS ON THE 28th DAY 
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RESULT AND DISCUSSION 
In the present study, chronic administration of 1% (v/v) ethylene glycol 
aqueous solution to Wister rats resulted in hyperoxaluria. Urinary concentration of the 
various ions investigated varied drastically, following ethylene glycol treatment. 
EFFECT OF VC ON URINARY PARAMETERS ON DAY 14 & 28 
 The oxalate excretion was 24hr on day 14th& 28th respectively for GP1. It 
increased significantly (P < 0.001) on day 14th& 28th day in GP2 following ethylene 
glycol treatment. Treatment at a dose of cystone herbal tablet 100mg/kg, and  VC at 
the dose of  200mg/kg, 400mg/kg (GP3 to GP5) reduced the oxalate excretion 
significantly to (P<0.01) on 14th day treatment. Likewise on 28th day, treatment with 
this VC reduced the oxalate excretion significantly to (P<0.01) in (GP3 toGP6) rats 
respectively. The results are shown in the table no: 29 & 30. 
  The urinary calcium excretion was increased significantly on day 14th and 28th 
day in GP2 following ethylene glycol treatment. The calcium excretion was 
significantly reduced to treatment with a dose of cystone herbal tablet 100mg/kg, and  
VC at the dose of  200mg/kg, 400mg/kg (GP3 to GP5) reduce the calcium excretion 
significantly to on 14th day treatment likewise on 28th day calcium excretion was 
significantly reduced to s24hr (P<0.01) in (Gp3 to Gp5) rats respectively.  
Likewise phosphate and creatinine excretion values gradually increased in GP2 
on the 14th& 28th day. However in (GP3 to GP5) grouped treated animals these 
elevated values were significantly reduced on 14th and 28th day respectively. 
However, regarding creatinine in (GP3 to GP5) these elevated values were 
significantly reduced on 14th day and on 28th day respectively.  
Likewise urinary protein and uric acid concentration increased following 
ethylene glycol treatment in GP2 and it reached maximum respectively on the 14th& 
28th day. On treatment with a dose of cystone herbal tablet 100mg/kg, and  VC at the 
dose of  200mg/kg, 400mg/kg (GP3 to GP5)  the protein and uric acid excretion was 
restored to near normal limits in (GP3 to GP5) for protein on 14thday and on 28th day 
(p<0.001) and for uric acid on 14th day and on 28th day (P<0.01).  
In GP2 lithiatic control rats, the magnesium level in urine gradually decreased 
following ethylene glycol treatment on the 14th & 28th day. Subsequent administration 
of the VC and cystone herbal tablets enhanced the magnesium excretion significantly 
on 14th day & 28th day. 
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EFFECT OF VC ON SERUM PARAMETERS ON DAY 28 
In prophylactic study the serum parameters such as calcium, uric acid, 
creatinine, oxalate, phosphate levels were increased significantly in GP2 (Lithiatic 
control) following ethylene glycol treatment, treatment with a dose of cystone herbal 
tablet 100mg/kg, and  VC at the dose of  200mg/kg, 400mg/kg (GP3 to GP5)  reduce 
the all above mentioned parameters  significantly. On the contrary the magnesium 
levels were decreased significantly in GP2 (Lithiatic control) following ethylene 
glycol treatment. After treatment with a dose of cystone herbal tablet 100mg/kg, and 
VC at the dose of 200mg/kg, 400mg/kg (GP3 to GP5) the magnesium level was 
restored near to normal levels.  
INTERPRETATION 
The result shows that the VC at a dose of 200, 400mg/kg and cystone herbal 
tablet at a dose of 100 mg/kg  increased elimination of oxalate, calcium, phosphate, 
magnesium, uricacid, creatinine which decreased circulating level of those minerals 
and as  prevent calculi formation of kidneys. 
  The test drug VENKARA CHUNNAM prevent calculi formation of kidney. 
so the test drug is responsible for antilithiatic activity. 
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LITHOTRIPTIC ACTIVITY 
Effect on urinary output in urolithiasis induced rats  
HISTO PATHOLOGY 
Name   : LITHOTRIPTIC - NORMAL             
Clinical Details: 
LG -1 Normal control  
Clinical Diagnosis :  
 
Macroscopic : 
 
Microscopic: 
Normal renal tissue is seen.  
 
 
HISTOPATHOLOGY 
Name   :  LITHOTRIPTIC - TOXIC    
Clinical Details: 
LG – 2 (Toxic)  
Clinical Diagnosis :  
 
Macroscopic : 
 
Microscopic: 
Toxic renal tissue seen.  
 crystals/stones or calcification.  
  
Figure:22 
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HISTOPATHOLOGY 
Name   :  LITHOTRIPTIC – STD/ CONTROL    
Clinical Details: 
LG – 3 Standard/control  
Clinical Diagnosis :  
 
Macroscopic : 
 
Microscopic:  
Normal renal tissue seen  
 
 
 
Name :  LITHOTRIPTIC –  LOW DOSE  
Clinical Details: 
LG -4 ; low dose 
Clinical Diagnosis :  
 
Macroscopic : 
 
Microscopic:  
Normal renal tissue seen.   
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Name   : LITHOTRIPTIC – HIGH DOSE 
Clinical Details: 
LG – 5; High dose  
 
Clinical Diagnosis :  
 
Macroscopic : 
 
Microscopic:  
Normal renal tissue seen.  
 
Histopathology: 
 
Group I: The normal section of renal tissue seen 
Group II: The renal section showing the damaging cells seen. 
Group III: The normal renal tissues are seen compare to damaging renal tissue  
Group IV: The normal renal tissues are seen nearest compare with the                
standard drug. 
Group V: The normal renal tissues are seen compare to low dose of VC. 
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2. DIURETIC ACTIVITY 
Diuretic activity of VC (urine Volume) in 24 h 
Table No: 31 
Group Treatment Urine Volume 
I Normal saline 10ml/kg 10.23±0.56 
II Frusemide 20mg/kg 15.80±0.98 
III 
VENKARA CHUNNAM 
200mg/kg 
17.33±0.73** 
IV 
VENKARA CHUNNAM 
400mg/kg 
17.1±0.71** 
V 
VENKARA CHUNNAM 
600mg/kg 
17.81±0.93** 
Values are Mean ± SEM, n=6, **p<0.01. 
 
Figure 23: Diuretic activity of VC (urine Volume) in 24 h 
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Natriuretic activity of VC 
Table No: 32 
Group 
Treatment 
 
Urine Volume 
I Normal saline 10ml/kg 7.20±0.53 
II Frusemide 20mg/kg 12.77±0.95 
III 
VENKARA CHUNNAM 
200mg/kg 
11.27±0.67** 
IV 
VENKARA CHUNNAM 
400mg/kg 
14.1±0.68** 
V 
VENKARA CHUNNAM 
600mg/kg 
14.78±0.90** 
Values are Mean ± SEM, n=6, **p<0.05, **p<0.01.NS – Not significant. 
 
Figure 24: Natriuretic activity of VC 
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Results: 
Table -32 shows the urine volume collected in 24 h for all the groups. It is 
evident that the VC treated groups excreted more urine than the control groups. The 
VC at 200, 400 and 600 mg/kg exhibited comparable effect with that of the reference 
drug Frusemide 20 mg / kg and the results were statistically significant Table -33 
shows the sodium and potassium content of the urine for all groups. The amount of 
Sodium excreted was increased for Frusemide treated group; statistically significant 
rise in Na+ excretion was also noticed for VC treated groups. The potassium content 
excreted in the urine was statistically insignificant for all the groups. The Natriuretic 
effect was calculated by employing the formula Na+ / K+. It was found that the VC 
treated groups possess favorable Natriuretic effect. The present study showed that the 
VC significantly increases the urine output and excretion of urinary sodium and had 
no effect on the urinary potassium excretion. Diuretics have two separate 
connotations; increase urinary par se and net loss of solute (i.e. electrolyte) and water 
(i.e. saluretic). These two processes are involved in the suppression of renal tubular 
reabsorption of electrolytes, water and low molecular weight organic compounds into 
the blood stream and a consequence; promote the formation of urine . An attempt to 
extrapolate the diuretic action of plant extract from rats to man using the activity of 
Frusemide in the organism as a guideline has been reported.  
 
INTERPRETATION: 
The results clearly shows that the VC at doses of 200, 400 and 600 mg / kg 
produced significant dose dependent increase in urinary excretion and urinary sodium 
loss but no effect on urinary potassium loss with respect to control and standard drug 
treated groups. The data demonstrates that the VC has diuretic effect, Natriuretic 
effect but no potassium sparing effect and is as potent as Frusemide.   
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3. ANTI-SPASMODIC ACTIVITY (Smooth muscle relaxant) 
 
Dose Response Relationship Observations of Acetylcholine 
Table No: 33 
S.No Concentration/dose 
Acetylcholine 
Response (cm) 
1 0.1 ml 3.4 cm 
2 0.2 ml 4 cm 
3 0.4 ml 4.3 cm 
4 0.8 ml 4..3 cm 
5 1.6 ml 5.7 cm 
 
 
Dose Response Relationship Observations of Atropine 
Table 34 
Si.No Concentration/dose 
atropine 
Response (cm) 
1 0.1 ml - 
2 0.2 ml - 
3 0.4 ml - 
4 0.8 ml - 
5 1.6 ml - 
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Comparative Dose Response of Acetylcholine followed by VC 
Table No: 35 
Sl. No Treatment Dose(ml) response % of response 
1 
 
Acetylcholine 
0.1 ml 3.4 cm  
2 0.2 ml 4 cm  
3 0.4 ml 4.3 cm  
4 0.8 ml 4..3 cm  
5 1.6 ml 5.7 cm  
6 
 
Acetylcholine  +VC 
0.1 ml+0.1 ml 3.8 cm  
7 0.2 ml+0.2 ml 4.2 cm  
8 0.4 ml+0.4 ml 4.8 cm  
9 0.8 ml+0.8 ml 5.2 cm  
10 1.6 ml+1.6 ml 6 cm  
 
Figure 25: Comparative Dose Response of Acetylcholine followed by VC 
 
RESULTS:-  
 Effect of Acetylcholine on excised rat ileum reflected an increase in 
spasmodic activity (response) with an increase in dose. 
 
INTERPRETATION: 
             From the present study results it was observed that acetylcholine (Ach) alone 
cause contraction of excised rat ileum but when acetylcholine was given in presence 
of VC there was a marked decrease in contraction of ileum was observed. This 
revealed that VC possess a high degree of anti-spasmodic (smooth muscle relaxant)  
activity by blocking cholinergic receptors. 
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MICRO BIOLOGICAL ANALYSIS 
Antimicrobial Activity 
Table no. 36 
S.No. Test Pathogens Result Zone of Inhibition (mm) at 30µl 
Positive Control 
(Gentamycin) 
Size of Inhibition 
1. Escherichia coli Sensitive 20 mm 18 mm 
2 Klebsiella pneumoniae Sensitive 22 mm 16 mm 
3 Staphylococcus aureus Sensitive 21 mm 11 mm 
4 Pseudomonas aeruginosa Resistant 17 mm 17 mm 
5. Salmonella typhi Sensitive 19 mm 13 mm 
Figure no : 26 Anti – Microbial Activity of VENKARA CHUNNAM 
       
S.No. 
Bacterial Pathogens Plates 
1. Escherichia coli 
 
2. Staphylococcu aureus 
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3. Klebsiella sps. 
 
4. Pseudomonas aeruginosa 
 
5. Candida sp 
 
  
Results and Discussion: 
 The good antibacterial activity of herbal medicines implies that the 
antimicrobial compounds present in herbal medicines are possibly controlling the 
microbial activity. Herbal medicines showed varying degrees of in vitro antibacterial 
activity against test bacteria. 
  Both Gram positive and Gram negative bacteria E.coli, Klebsiella 
pneumoniae, Staphylococcus aureus and Salmonella typhi were found to be high 
sensitive to herbal medicines when compared to the standard drug Gentamycin (Broad 
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spectrum). The herbal drug VENKARA CHUNNAM exhibited broad spectrum 
activity against bacterial pathogens at 100mg / ml concentration of the drug. 
  From these results, it is accomplished that this study would lead to the 
establishment of several important compounds that have to be used to formulate new, 
different and more potent antimicrobial drugs of natural origin. However, further 
studies are required to screen the biologically active compounds and to evaluate the 
efficiency of this compound against pathogenic microorganisms associated with 
various human diseases. 
 
INTERPRETATION:  
 From the above results the test drug VC is sensitive against Klebsiella 
pneumonia, Pseudomonas aeruginosa, Escherichia coli, Staphylococcus 
aureus and Salmonella typhi when compared to the standard drug 
(Gentamycin 100 mcg) which was evident from the zone of inhibition. 
 As the above bacterial organisms reponsible for pneumonia, bronchitis, 
pharyngitis, diarrhoea, typhoid fever, headache, urinary tract infectiona nd 
skin infections. 
 Our results confirmed the traditional use of VC has anti-microbial activity. 
 
  
  
  
   150 PRE CLINICAL  STUDY OF  VENKARA CHUNNAM 
7. SUMMARY 
 
1. The trial drug VENKARA CHUNNAM is a herbo mineral formulation selected 
from the Siddha Literature Anuboga vaithiya navaneetham, part 3 page no 25, 
26, Second Edition - 2002, Hakim P. Mohamed Abdulla Sahib, published by 
thamarai noolagam chennai 26 for the validation of safety, efficacy and 
therapeutic potency on Kalladaippu for its lithotriptic, diuretics and 
antispasmodic activities. 
2. The raw drug Venkaram, Uppilangodi, Muurungai pattai were identified and 
authenticated by Gunapadam department, Govt. Siddha Medical College, 
Palayamkottai, Tamil Nadu.  
3. A review of the literatures and lateral research works reveals that all the 
ingredient of VENKARA CHUNNAM traditionally used in treating 
kalladaippu. 
4. Physicochemical analysis shows determination of moisture content it was 
within acceptable range. It indicates the longer shelf life period. 
5. Biochemical analysis shows the presence of calcium, sulphate, chloride, 
ferrous iron, phosphate and unsaturation. Sulphate has antibacterial activity, 
Chloride has diuretic activity, Ferrous iorn  has antioxidant activity. 
6. Phyto-chemicals in the drug of Venkara Chunnam using various test and the 
results are the presence of Alkaloids, carbohydrates and glycosides, tannins, 
and absence of phytosterols, flavonoids, fixed oil, fat, proteins, saponins and 
lignin. Alkaloids have antimicrobial activity. Glycosides inhibit diseases 
producing microorganisms. Tannins has antioxidant property. 
7. SEM analysis of these drugs shows the smaller particles are rounded in 
shapes and sizes are in the range from 10 micron to 5 micron. The smaller 
size of the particles enables better absorption which denotes that the trial 
drug could have potent drug delivery. 
8. FTIR analysis of this drug revealed the presence of Carboxylic acid, 
alkenes, alcoholic groups, aliphatic amines, primary and secondary amines, 
alkyl halides, cyloalkane, esters and ethers. Alcoholic acids, act as 
antimicrobial and antiseptic agents prevent the formation of renal calculi 
(infective cause), carboxylic acid substance has antimicrobial, anticoagulant 
activity. Amines are good pain relievers. Alkenes groups protect against 
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bacteria and fungi.Alkyl halides used as anesthetics and antiseptic agents. 
Esters group is produced a diuresis and natriuresis. So result of a direct 
tubular action together with a pressure diuresis. Ethers increases the flow of 
urine, It is a best diuretic action. A diffusible stimulant and antispasmodic 
used chiefly in colic. 
9. ICP-OES analysis of VC shows presence of K, Mg, P, Na, B, Fe, Ca and 
heavy metals like As, Hg, Cd, Pb, Cu, Ni, Al were below detectable level. 
The result indicate that the formulation is extremely safe as it contains 
heavy metals within specified limits. Presence of potassium, relaxes the 
smooth muscles, so it have smooth muscle relaxant acticity. Presence of 
magnesium inhibits the formation of calcium oxalate crystals, it also inhibit 
the stone formation by inhibition of growth of crystals as well as 
aggregation. Sodium regulates the acid base balance of the body fluids. 
Sodium is required for the maintenance of the osmotic pressure. 
10. This XRD finger print shows both the similarities and difference of the sample 
successfully and is a valuable primary tool for checking the quality control of 
above mineral medicines.  Modern techniques are necessary to standardize and 
bring out high quality herbal product owing to their complex nature.  The 
different peak shows the presence of minerals in the sample. 
11. The pharmacological study revealed that trial drug VENKARA CHUNNAM 
possesses significant lithotriptic activity, Increased elimination of oxalate, 
calcium, phosphate, magnesium, uric acid, creatinine which decreased 
circulating level of those minerals and as prevent calculi formation of kidneys. 
So the test drug are responsible for antilithiatic activity.   
12. Significant dose dependent increase in urinary excretion and urinary sodium 
loss but no effect on urinary potassium loss with respect to control and 
standard drug treated groups. The data demonstrates that the VENKARA 
CHUNNAM has diuretic effect and possesses a high degree of antispasmodic 
activity. 
13. Microbiological analysis of VENKARA CHUNNAM showed that it is 
moderate sensitive against staphylococcus aureus, pseudomonus aeruginosa, 
and E.coli. so it has antimicrobial activity. 
14. The trial drug Venkara chunnam has sweet and astringent taste. The deranged 
pitha humour, decreases the excretion of urine and increases the urine 
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concentration which resulted in kalladaippu. So these tastes of the trial drug 
neutralize the pitha humour, increase the excretion of urine, decreases the 
concentration of urine and prevent the formation of kalladaippu. 
15. The acute toxicity result shows the test drug VC does not produce any toxic 
signs and mortality up to its maximum dose level of 2000 mg/animal body 
weight in Wistar albino rats. Morphological characters like changes in skin, 
eyes, fur, and nose appeared normal and behavioural changes are normal. 
According to OECD guidelines, LD50 dose up to 2000mg/kg of the drug the 
test drug VENKARA CHUNNAM is a safe herbo mineral drug and can be used 
for long time administration.  
16. Finally all the parameters and histopathological studies results revealed the 
drug was safe in rats. Acute oral toxicity of VC observed no toxicity. Acute 
and sub-acute toxicity study of VENKARA CHUNNAM represents nontoxic 
and safe drug in wistar albino rats. biochemical parameters and histopathology 
results it can be concluded that the dose level of VC 100 mg mentioned in the 
Siddha Literature “Pathartha Gunavilakkam” is the safety dose for human 
consumption. So the test drug of VC hope fully use for human trails. 
17. Acute and sub-acute toxicity were carried out in wistar albino rats according 
to OECD guidelines (423,407). This drug has no acute toxicity as there was no 
mortality seen in sub-acute toxicity is carried by repeated dose of test drug for 
28 days, which reveals there are no behavioural changes, morphological 
changes, haematological changes, biochemical changes observed in rats. 
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8. CONCLUSION 
 
The trial drug VENKARA CHUNNAM was selected for the elaborate 
study of its efficacy on Kalladaippu. From the literature review, 
physiochemical, biochemical, Phytochemical, Instrumental analysis, 
pharmacological, microbiological analysis It has been concluded that 
VENKARA CHUNNAM has got a good Lithotriptic (Anti lithiatic), Diuretic, 
Anti – spasmodic activities and its efficacy is scientifically validated.  
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9. FUTURE SCOPE 
 
The trial drug VENKARA CHUNNAM has its own potency in treating 
urolithiasis in animal model which has been established in this study. 
However, the mechanism of action by which VENKARA CHUNNAM 
produced its effect on the urolithiasis in experimental animal models and also 
multicenter clinical trials are required to understand the exact molecular 
mechanisms of action. So it could be used worldwide in treatment of 
urolithiasis. 
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